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i  Abstract  
  
A  healthy  cognition  rests  on  a  balanced  interaction  of  neuronal  and  glial  cell  
populations.  Astrocytes  are  most  numerous  glial  cells  in  the  brain.  Their  functions  
include  modulation  of  signalling  and  plasticity  at  the  tripartite  synapse  and  
homeostasis  of  the  brain,  in  particularly  the  control  of  potassium  and  glutamate  in  
the  extracellular  space.  This  project  aimed  at  bridging  the  two  pools  of  astrocytic  
functions,  by  investigating  molecular  links  between  ionotropic  channels  and  
potassium  currents  of  astrocytes.  Whole-­‐‑cell  potassium  currents  were  recorded  in  
the  acutely  isolated  astrocytes  of  somatosensory  cortex  layer  II/III  in  young  and  
old  mice,  and  both  the  capacitance  and  the  current  density  of  the  voltage-­‐‑gated  
but  not  of  inwardly  rectifying  potassium  currents  increased  with  age.  The  
modulation  of  potassium  currents  by  other  ionic  channels,  including  P2X1/5,  
NMDARs  and  PAR-­‐‑1  receptors  was  established.  Activation  of  these  channels  was  
found  to  potentiate  outward  potassium  current  by  15  -­‐‑  35%,  and  this  mechanism  
was  found  to  be  calcium-­‐‑dependent.  The  addition  of  4-­‐‑aminopyridine  blocked  this  
facilitation,  whereas  barium  chloride  did  not.  This  effect  was  explored  in  Light  
Transmittance  experiments  where  tissue  swelling  was  measured.  Activation  of  
this  mechanism  increased  the  extent  of  tissue  swelling  during  neuronal  activity  in  
young  adult  mice.  This  modulation  was  found  to  diminish  with  age,  as  the  effect  
dramatically  reduced  in  group  II  mice.  It  is  believed  that  this  could  be  an  
important  step  in  the  initiation  of  potassium  buffering  in  the  cortex.  The  data  
contributes  to  the  current  understanding  of  the  molecular  processes  linking  
signalling  and  physiological  functions  of  astrocytes.  
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Chapter  1  -­‐‑  Introduction  
Astrocytes  –  from  ‘brain  glue’’  to  active  players  in  brain  functioning  
1.1  Current  aims  of  neuroscience  
  
The  importance  of  neuroscience  cannot  easily  be  overestimated.  In  the  last  century  
and  a  half,  a  great  progress  in  studying  the  brain  has  been  achieved.  Partially,  this  
is  due  to  the  development  of  a  whole  new  range  of  techniques,  making  it  possible  
to  intricately  investigate  the  processes  taking  place  in  the  brain  within  a  set  of  
physiological  conditions,  such  as  development  of  various  electrophysiological  
techniques  (Verkhratsky,  Krishtal,  and  Petersen  2006)  and,  more  recently,    
optogenetics  (Boyden	  et	  al.	  2005).    
  
With  the  global  population  higher  than  ever  before  and  still  on  the  rise  (it  is  
projected  to  reach  9.7  billion  people  by  2050)(United	  Nations	  2015),  the  number  of  
people  of  all  ages  is  increasing.  Coupled  with  improved  healthcare  and  current  
knowledge  of  disease  prevention  and  prophylaxes  the  average  lifespan  has  
increased  significantly  in  the  last  100  years.  This  means  that  the  proportion  of  
people  whose  brains  is  undergoing  to  the  process  of  senility  will  keep  on  rising  
too.  Therefore,  understanding  the  processes  underlying  the  ageing  phenomenon  
in  the  human  brain  is  a  chief  task  that  science  is  currently  faced  with.  It  is  only  
through  having  a  detailed  understanding  of  age-­‐‑related  diseases  and  conditions  
that  their  devastating  consequences  may  be  averted.    
  
However,  before  going  any  further,  it  is  important  to  discuss  what  is  meant  by  the  
term  ‘senescent  brain’  and  how  it  is  different  from  dementia  and  other  age-­‐‑related  
conditions.  In  1924  Lhermitte  and  Nicolas  proposed  the  term  “psychic  senescence”  
referring  to  the  physiological  state  of  brain  in  healthy  old  age:  “The  outstanding  
features  include  diminished  acuity  of  memory,  or  better  a  loss  of  adherence  to  
         2  
recent  events;  impaired  faculty  of  rapid  evocation  of  events;  loss  of  fluidity;  and  
weakness  of  creative  imagination”  (Critchley	  1931).    
  
It  is  widely  believed  that  healthy  cognition  rests  on  a  balanced  interaction  of  two  
populations  of  cells  –  electrically  active  neurones  and  passive  glial  cells  (J.	  Martin	  and	  Gorenstein	  2010).  Historically,  quite  distinct  roles  of  these  two  cell  types  were  
assigned:  signalling  and  metabolic  support  were  considered  to  be  neuronal  and  
glial  functions  respectively  (Henn,	  Haljamae,	  and	  Hamberger	  1972).  In  the  last  20  
years,  however,  a  vast  amount  of  evidence  has  been  collected  to  show  that  glial  
involvement  in  brain  function  is  omnipresent  and  crucial  (Bezzi	  and	  Volterra	  2001;	  Allen	  and	  Barres	  2005).  Neuroscience  has  been  more  closely  focused  on  
investigating  the  structures  and  functions  of  neurones,  hence  the  name  of  the  field,  
despite  glial  cells  being  the  more  numerous  cell  type  (Pelvig	  et	  al.	  2008).  This  
project  set  out  to  investigate  the  functions  of  astrocytes,  with  the  specific  focus  on  
the  potassium  channels.  In  this  chapter  first  the  evolution  of  the  field  of  glial  
science  will  be  covered,  following  the  review  on  the  recent  progress  in  the  field.  
The  objectives  of  this  project  will  be  explained  in  the  context  of  current  
knowledge,  with  the  overall  aim  being  to  propagate  the  understanding  of  the  
molecular  mechanisms  taking  place  in  astrocytes  and  their  respective  functions.    
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1.2  Evolution  of  the  view  on  the  roles  of  glia  
  
Historically,  neuroscience  has  always  expressed  a  very  neurocentric  view,  with  
the  excitable  cells  carrying  out  the  vital  processes,  underlying  the  functioning  of  
the  brain.  Non-­‐‑excitable,  or  glial  cells,  despite  being  the  most  numerous  cell  type  
in  the  organ  (Herculano-­‐Houzel	  2014),  for  a  long  time  were  considered  to  only  be  
responsible  for  metabolic  and  supportive  functions  for  the  organ.  Quoting  Rudolf  
Virchow  -­‐‑  the  neuroscientist  that  put  forward  the  concept  of  neuroglia  first,  back  
in  1858:  
  
“Hitherto,  gentlemen,  in  considering  the  nervous  system,  I  have  only  spoken  of  the  
really  nervous  parts  of  it.  But  if  we  would  study  the  nervous  system  in  its  real  
relations  in  the  body,  it  is  extremely  important  to  have  a  knowledge  of  that  substance  
also  which  lies  between  the  proper  nervous  parts,  holds  them  together  and  gives  the  
whole  its  form  in  a  greater  or  lesser  degree”  (Taylor	  1895).    
  
The  19th  century  was  the  golden  era  for  histology,  with  many  different  types  of  
glial  cells  having  been  described  as  a  result  of  these  studies.  The  most  famous  
histologist,  whose  drawings  remain  the  most  recognisable  depictions  of  astrocytes,  
was  the  1906  Nobel  Prize  laureate  Ramon  y  Cajal.    Figure  1.1  shows  an  example  of  
Cajal’s  histological  preparations  and  drawings  of  glial  cells  (Garcia-­‐Lopez	  2010).  
Cajals  preparations  clearly  suggested  the  heterogeneity  of  glial  cells  and  a  whole  
range  of  distinct  functions,  although  these  were  laid  uncovered  for  the  bigger  half  
of  the  20th  century,  as  the  view  of  glia  as  a  support  structure  persisted.  This  distinct  
functional  division  between  glia  and  neurons  is  still  a  view  of  many  
neuroscientists  (Kettenmann	  and	  Verkhratsky	  2008).  
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Figure  1.1:  Cajal’s  histological  preparations  and  drawings.  A  –  Fibrous  astrocyte  in  the  white  
matter  of  adult  brain  (formalin-­‐‑uranium  nitrate  and  gold-­‐‑sublimated  chloride);  B  –  Protoplasmic  
astrocyte  in  an  adult  brain  (silver  carbonate  (del  Rio)  and  formalin-­‐‑uranium  nitrate);  C-­‐‑  Twin  
astrocytes  in  the  human  hippocampus  (formalin-­‐‑uranium  nitrate);  D  –  Fibrous  astrocytes  from  the  
white  substance  of  adult  brain  (Golgi  methods);  E  –  Oligodendrocytes  (ammoniacal  silver  oxide  
and  Nissl);  F  –  Microglial  cells  (ammonical  silver  oxide,  reduced  silver  nitrate  and  silver  carbonate  
(del  Rio)  methods).  (Drawings  reproduced  with  the  permission  of  the  Inheritor  of  Santiago  Ramon  
y  Cajal)  (Garcia-­‐‑Lopez  2010).  
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Despite  the  persistence  of  this  view  of  glia  as  a  “space  not  occupied  by  neurons”  (Taylor	  1895);  glia’s  function  was  being  further  investigated  into.  Throughout  the  
second  half  of  the  20th  century  glial  and  specifically  astrocytic  functions  were  
investigated,  with  the  main  focus  on  neurovascular  control  by  the  astrocytes.  The  
specific  structural  peculiarity  –  the  fact  that  the  endfeet  of  astrocytic  cells  wrap  
around  the  blood  vessels  of  the  brain,  suggested  the  probable  function  in  blood  
flow  regulation.  Golgi  observed  this  phenomenon  first,  and  so  proposed  a  
nutritional  role  for  astrocytes  (Oberheim,	  Goldman,	  and	  Nedergaard	  2011).  This  
eventually  developed  into  a  separate  research  field  with  specialised  
methodologies.  
  
At  present,  a  separate  research  field  is  devoted  to  studying  neuronal-­‐‑glial-­‐‑vascular  
unit  (Hirase	  2005;	  Verkhratsky	  and	  Toescu	  2008).  The  studies  of  the  connections  
between  metabolism  and  neuronal  functioning  are  using  neuroimaging  
techniques,  with  the  increasing  amount  of  data  generated  through  in  vivo  imaging  
techniques  (2008).  Magnetic  resonance  being  one  of  the  most  commonly  used  
technique  that  uses  deoxyhemoglobin  in  venous  blood  (BOLD  –  blood  oxygen  
level  dependent),  yielding  in  vivo  images  of  the  amount  of  oxygen  carried  in  the  
microvasculature  of  the  brain  (Ogawa	  et	  al.	  1990).  However,  it  has  been  recently  
suggested  that  the  haemodynamic  responses  of  blood  vessels  are  not  directly  
linked  to  the  local  energy  need  of  the  brain  but  neurotransmitter-­‐‑related  
signalling;  evidence  was  gathered  to  show  that  most  brain  energy  is  used  to  power  
postsynaptic  currents  and  action  potentials  rather  than  presynaptic  or  glial  activity  
(J.  Larson  and  Munkácsy  2014;  Attwell  et  al.  2010). 
  
As  metabolic  functions  of  astrocytes  were  researched  into,  their  function  of  
sustaining  metabolism  started  to  include  control  of  the  cerebral  blood  flow.  
Previously,  the  main  hypothesis  included  a  local  negative-­‐‑feedback  system,  
depending  on  the  neural  activity.  If  an  increased  supply  of  oxygen  is  demanded,  a  
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signal,  such  as  production  of  CO2  or  lack  of  O2,  could  cause  the  greater  blood  flow  (Sofroniew	  and	  Vinters	  2009).  However,  changes  in  the  O2  levels  experimentally  
proved  against  this  hypothesis  (Lynch	  et	  al.	  2008).  Similarly,  it  was  shown  that  
accumulation  of  CO2  in  the  blood  causes  initial  pH  to  rise,  as  expected.  Increased  
blood  flow  takes  the  CO2  away  rapidly  and  higher  neuronal  activity  causes  Ca2+,  
H+,  -­‐‑  ATPase  pump  to  alkalinize  the  extracellular  space  (Makani  and  Chesler  
2010).  Current  hypothesis  includes  both  neurons  and  astrocytes  acting  
simultaneously  to  control  the  blood  flow  of  the  brain.  Neurons  can  use  
neurotransmitters  to  implement  changes  in  the  local  blood  flow,  as  can  
gliotransmitters  as  well  as  metabolic  agents  (Malenka	  1994;	  Kuo	  and	  Dringenberg	  2012).  One  of  the  key  players  in  this  regulation  is  glutamate  (Rasooli-­‐Nejad	  et	  al.	  2014).    
  
Apart  from  controlling  cerebral  blood  flow  glial  cells  were  found  to  be  
participating  in  other  aspects  of  the  brain  functioning  on  the  control  levels.  
Starting  with  Carl  Ludwig  Schleich  in  1898(Lalo	  et	  al.	  2014)  suggesting  that  glial  
cells  control  neuronal  communication,  it  is  known  that  some  glial  cells  are  able  to  
rapidly  grow  and  retrieve  their  processes  in  relevant  situations  (	  Ma,	  Mufti,	  and	  Leung	  2015).    Furthermore,  in  1970s  several  studies  have  shown  that  neuroactive  
substances  can  be  released  from  nerve  endings  by  cells  other  than  neurons  (Talantova	  et	  al.	  2013).  A  couple  of  decades  later  it  was  confirmed  that  astrocytes  
are  able  to  release  a  list  of  chemical,  some  of  which  have  neuroactive  properties  (Ahmed	  et	  al.	  2004).  Within  the  next  few  years  multiple  laboratories  have  reported  
that  astrocytes  not  only  respond  to  various  stimuli  by  elevating  intracellular  
calcium  concentrations,  but  also  that  these  so  called  ‘’calcium  waves’’  propagate  
along  the  glial  syncytium(Corner-­‐‑Bell  et  al.  1990;  Parpura  et  al.  1994).  It  was  
proposed  by  Araque  et  al.  (1999)  that  astrocytes  are  an  active  participant  in  
synaptic  signalling.  In  particular  astrocytes  and  perisynaptic  Schwann  cells,  
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should  “be  viewed  as  integral  modulatory  elements  of  tripartite  synapse”(Araque	  et	  al.	  1999).    
  
Tripartite  synapse  (Figure  1.2)  is  a  term  used  to  describe  a  synapse  that  consists  of  
three  parts:  pre  and  post  synaptic  neurons  and  an  astrocyte,  enveloping  the  
synapse,  thus  being  in  the  position  to  actively  participate  in  the  signalling  process.  
Astrocytes  were  also  shown  to  activate  following  certain  stimuli,  such  as  
glutamate,  aspartate  and  gamma-­‐‑aminobutyric  acid  (Kettenmann,	  Backus,	  and	  Schachner	  1984)  via  corresponding  ion  channels  and  neurotransmitter  receptors  (Verkhratsky	  and	  Steinhäuser	  2000).    
  
  
Figure  1.2:  An  EM  image  (left)  and  a  diagram  representation  showing  the  structure  of  a  tripartite  
synapse.  Synaptic  vesicles  can  be  seen  on  both  pre-­‐‑  and  postsynaptic  neurons  as  well  as  astrocytes  
(Halassa,  Fellin,  and  Haydon  2007).  
Numerous  studies  done  in  this  field  have  shown  that  astrocytes  are  capable  of  
feeding  back  to  neurones  using  a  whole  range  of  transmitters,  named  
gliotransmitters,  including  glutamate  (Parpura	  et	  al.	  1994;	  Bezzi	  et	  al.	  1998),  D-­‐‑
serine  (Mothet	  et	  al.	  2000),  ATP  (Coco	  et	  al.	  2003;	  Pankratov	  et	  al.	  2007),  and  many  
others  (Benz,	  Grima,	  and	  Do	  2004;	  Mongin	  2004;	  Krzan	  et	  al.	  2003).  This  evolution  
of  understanding  of  glial  cells  has  been  scrupulously  depicted  at  every  stage  (Steinhäuser	  and	  Gallo	  1996;	  Volterra	  and	  Meldolesi	  2005;	  Allen	  and	  Barres	  2005;	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Parpura	  and	  Verkhratsky	  2012),  and  historical  overviews  are  also  available,  such  as  
Kettenmann  and  Verkhratsky’s  and  Hatton’s  reviews  in  2008  and  2004,  
respectively  (Kettenmann	  and	  Verkhratsky	  2008;	  Hatton	  2004).  There  are  studies  
debating  the  mechanisms  of  gliotransmission,  for  example  Li  et  al.  2013  argues  
that  there  is  a  lack  of  evidence  supporting  the  vesicular  glutamate  transport  
hypothesis  as  proposed  by  Montana  et  al.  2004  (Dongdong	  Li	  et	  al.	  2013;	  Montana	  2004).    
  
A  vast  amount  of  research  on  the  roles  of  glial  cells  has  unearthed  that  glial  cells  
are  in  fact  an  active  key  players  in  bi-­‐‑directional  glial-­‐‑neural  communication.  This  
discovery,  however,  split  the  neuroscience  community  into  two  camps,  one  
supporting  the  neurocentric  view,  and  tripartite  synapse  supporters.  With  such  a  
large  number  of  laboratories  around  the  world  and  study  models  from  several  
study  models  including  robust  in  vitro  techniques  and  an  increasing  number  of  in  
vivo  techniques  there  is  no  doubt  the  neuroscience  community  will  be  expecting  
tremendous  progress  in  this  field  in  the  foreseeable  future.  A  thorough  
understanding  of  glial-­‐‑neuronal  interactions  will  pave  the  way  to  investigating  the  
age-­‐‑related  changes  and  potentially  developing  prophylaxis  for  dementia  and  
other  numerous  diseases  linked  to  senility.    
1.3  Age-­‐‑related  changes  and  non  pathological  ageing  
  
As  stated  above,  the  subject  of  ageing  in  respect  to  human  brain  has  interested  
scientific  community  for  a  long  time.  Non-­‐‑pathological  or  normal  ageing  is  
generally  considered  to  be  a  slow  accumulation  of  changes  in  the  brain  
parenchyma  without  development  of  clinical  symptoms  of  dementia.  Normal  
ageing  –  just  like  normality  itself  is  of  course  a  very  hard  concept  to  define  and  it  
varies  immensely  with  time,  place  and  many  other  variables.  For  instance,  in  the  
study  by  Silver  et  al.  2002,  brains  of  centenarians  that  participated  in  the  cognitive  
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test  assessment  were  then  assessed  postmortem  for  the  deposition  of  neuritic  
amyloid  plaques.  For  some  cases  it  was  found  hard  to  distinguish  between  the  two  
states  of  brain  functioning  (pathological  and  non-­‐‑pathological),  especially  with  the  
high  degree  of  variation  between  the  extents  to  which  different  individuals  may  
be  affected.  Such,  some  subjects  showed  no  dementia  but  upon  examination  
showed  to  have  enough  of  the  plaques  deposition  to  be  considered  a  possible  case  
of  AD  (Alzheimer’s  Disease)  and  vice  versa  (Silver	  et	  al.	  2002).    
  
Since  the  flourishing  of  molecular  biology  and  neuroimaging,  it  is  now  generally  
agreed  that  normal  brain  ageing  consists  of  small  functional  and  morphological  
alterations,  and  that  these  changes  are  incredibly  varied  in  different  brain  regions.  
The  process  of  ageing  is  very  similar  across  mammalian  species,  which  makes  
rodents  a  good  study  model  for  ageing.  It  has  been  established  that  with  age  
multiple  brain  areas  shrink  in  size,  and  there  are  alterations  on  all  levels  from  
molecular  to  structural  changes  in  tissue:  protein  synthesis  and  degradation  
processes  undergo  changes,  various  channels  undergo  remodeling,  dendritic  
spines  reduce  in  numbers,  and  various  different  cell  types  have  different  patterns  
of  age-­‐‑related  changes  (Scheibel	  et	  al.	  1975;	  Sloane	  et	  al.	  2000;	  Shimada	  et	  al.	  2006;	  Staff	  et	  al.	  2006;	  Hayakawa	  et	  al.	  2008;	  Pelvig	  et	  al.	  2008;	  Stephens	  et	  al.	  2011;	  Lalo,	  Palygin,	  et	  al.	  2011;	  Kremsky	  et	  al.	  2012).  Alterations  in  the  vascular  landscape  of  
the  brain  and  in  the  metabolism  was  found  to  differ  between  young  and  older  
rodents  (A.	  J.	  Martin	  et	  al.	  1991;	  Meltzer	  et	  al.	  2000).  Synaptic  changes  in  different  
regions  of  the  brain,  including  hippocampus  and  cortex  were  examined  and  after  
a  large  number  of  studies  it  was  concluded  that  there  is  no  large  scale  decrease  in  
the  number  of  synapses  (Morrison	  and	  Baxter	  2012).  Instead,  more  subtle  
morphological  changes  take  place  (Brunso-­‐Bechtold,	  Linville,	  and	  Sonntag	  2000;	  Mostany	  et	  al.	  2013);  often  these  changes  vary  across  the  different  brain  regions  (Petralia,	  Mattson,	  and	  Yao	  2014).  A  decrease  in  the  amounts  of  pre  and  post-­‐‑
synaptic  proteins  were  found  to  take  place  (VanGuilder	  et	  al.	  2010),  as  well  as  
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higher  levels  of  expression  of  pro-­‐‑inflammatory  genes  and  proteins  fighting  
oxidative  stress  (Lee,	  Weindruch,	  and	  Prolla	  2000).    
  
Age-­‐‑related  changes  occur  in  both  neurons  and  glial  cells;  for  instance,  the  levels  
of  expression  of  GFAP  (glial  fibrillary  acidic  protein)  in  the  astrocytes  of  mice  were  
found  to  increase  with  age  in  some  brain  regions  (Nichols	  et	  al.	  1993).  Increased  
production  of  GFAP  has  been  linked  to  a  rise  in  reactive  astrocytes  population  –  
first  step  towards  astrogliosis  and  degeneration  (Kamphuis	  et	  al.	  2014;	  Le	  Prince	  et	  al.	  1993;	  Jalenques	  et	  al.	  1995).  Since  astrocytes  carry  out  multiple  functions,  such  
as  control  of  vascular  tone  and  metabolism,  mediation  of  signaling  via  the  
tripartite  synapse  and  the  calcium  signaling  changes  due  to  age  will  have  drastic  
consequences  on  these  processes.  One  of  the  main  characteristics  of  astrocytes  is  
the  expression  of  a  list  of  potassium  channels    -­‐‑  they  are  involved  in  the  vast  
majority  of  astrocytic  functions.  This  makes  potassium  channels  a  good  meeting  
point  of  integration  of  messengers  from  various  functions.  Astrocytic  functions  are  
discussed  in  the  next  section.      
1.4  Functions  of  astrocytes    
  
Various  functions  of  astrocytes  can  roughly  be  divided  into  two  major  categories:  
the  sustainment  of  metabolic  functioning,  such  as  cerebral  blood  flow  and  nutrient  
exchange  control  and  the  participation  in  signalling  in  the  brain.  Below  the  
descriptions  of  the  current  understanding  and  the  future  questions  posing  in  the  
context  of  these  functions  are  discussed.    
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1.4.1  Metabolic  
  
Astrocytic  potassium  channels  are  known  to  be  involved  in  the  clearance  of  excess  
extracellular  potassium  (Walz	  2000).  During  neuronal  activity  the  amount  of  
potassium  ions  in  the  extracellular  matrix  rises,  making  the  membrane  more  
susceptible  to  further  depolarization  after  the  refractory  period.  In  non-­‐‑
pathological  scenarios  the  concentration  of  potassium  fluctuates  between  3mM  at  
rest  and  up  to  8  mM  (in  a  pathological  condition,  however,  this  value  can  be  
greater).  The  excess  potassium  is  cleared  away,  however  it  is  still  a  matter  of  
debate,  which  exact  mechanism  takes  place  or  if  more  than  one  pathway  is  
involved,  how  does  each  of  the  multiple  mechanisms  contribute  to  the  overall  
function  (Kofuji	  and	  Newman	  2004).  The  neuronal  reuptake  of  potassium  is  too  
slow  to  prevent  the  build  up  of  excess  potassium  ion  and  thus  alter  the  kinetics  of  
the  synapses  involved  and  those  nearby.  Idea  first  put  forward  by  Hertz  (1965),  of  
astrocytes  removing  potassium  from  the  areas  of  extracellular  space  with  higher  
concentration,  had  two  main  mechanisms  that  were  thought  to  be  mutually  
exclusive:  uptake  of  the  excess  potassium  followed  by  its  accumulation  and  then  
release  into  other  area  of  extracellular  space  (Hertz	  1965)  and  the  removal  of  
excess  potassium  without  its  subsequent  accumulation,  but  instead  a  
simultaneous  release  of  potassium  at  a  distant  area  of  the  astrocytic  syncytium  (Kuffler,	  Nicholls,	  and	  Orkand	  1966).    
  
It  is  now  believed  that  both  net  uptake  of  potassium  as  well  as  ‘’buffering’’  takes  
place  in  the  brain  (Kofuji	  and	  Newman	  2004).  The  influx  of  potassium  ions  into  the  
astrocytic  syncytium  may  also  be  a  metabolic  signal  that  can  subsequently  control  
the  glial  energy  metabolism.  According  to  a  recent  review  by  MacAulay  and  
Zeuthen  (2012),  main  candidates  for  the  role  of  key  transporters  of  potassium  ions  
are  the  Na+,  K+-­‐‑ATPase  (NKA),  the  Na+,  K+,  Cl-­‐‑  co-­‐‑transporter  (NKCC1),  the  K+,  Cl-­‐‑  
co-­‐‑transporter  (KCC),  and  the  inwardly  rectifying  K+  channel,  Kir  4.1  is  capable  of  
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conducting  both  inward  or  outward  current,  depending  on  the  equilibrium  
potential  of  the  ion  and  the  membrane  potential  (Butt	  and	  Kalsi	  2006).  This  
channel  subtype  is  expressed  in  astrocytes,  with  more  dense  presence  on  the  
membrane  around  the  perisynaptic  feet  (Higashi	  et	  al.	  2001).  Kir4.1  channel  is  
closely  co-­‐‑expressed  with  Aquaporin-­‐‑4  (AQPR4)  –  a  water  channel  that  is  highly  
expressed  in  the  CNS  (Amiry-­‐Moghaddam,	  Frydenlund,	  and	  Ottersen	  2004).  Both  of  
these  channels  are  perfectly  located  around  the  blood  vessels  and  the  brain  blood  
barrier  to  make  them  primary  candidates  for  controlling  the  water  fluxes  in  the  
brain  (Nagelhus,	  Mathiisen,	  and	  Ottersen	  2004).  It  is  also  known  that  Kir  4.1  
channel  type  can  be  affected  by  external  cations,  which  can  trigger  the  process  of  
buffering  (Edvinsson,	  Shah,	  and	  Palmer	  2011).  Kir  4.1  is  thought  to  be  the  major  
glial  subtype  of  potassium  channel  and  its  down  regulation  causes  malfunctioning  
of  astrocytic  resting  potential  as  well  as  the  uptake  of  glutamate  by  astrocytes  (Djukic	  et	  al.	  2007;	  Y.	  V.	  Kucheryavykh	  et	  al.	  2006).  However,  different  groups  
conclude  the  opposing  results  from  this  finding.  Such,  Haj-­‐‑Yasein  argues  a  key  
role  for  Kir  4.1  in  the  mechanism  of  potassium  buffering,  whereas  Chever  propose  
this  channel  to  have  little  importance  in  the  matter  (Haj-­‐Yasein	  et	  al.	  2011;	  Chever	  et	  al.	  2010).    
  
It  has  been  shown  that  potassium  fluctuations  may  well  be  involved  in  the  control  
of  cerebral  blood  flow.  Schielke  et  al.  demonstrate  that  an  increase  in  the  
extracellular  concentration  of  potassium  ([KO])  may  stimulate  transport  across  the  
cerebral  capillary,  yet  have  little  effect  on  Na,  K-­‐‑pump  activity  in  neurons  (Schielke,	  Moises,	  and	  Betz	  1990).  It  is  also  unfortunate  that  the  subcellular  
localization  of  potassium  channels  has  only  been  assessed  in  a  few  brain  regions,  
and  primarily  in  neurons  (Vacher,	  Mohapatra,	  and	  Trimmer	  2008;	  Trimmer	  2015).  
This  is  due  to  technical  morphological  peculiarities  of  astrocytes:  having  a  
relatively  small  cell  body  and  a  large  volume  of  fine  branches  and  projections,  
         13  




The  concept  of  tripartite  synapse  has  already  been  introduced  above.  It  has  been  
shown  that  astrocytes  are  not  only  located  near  chemical  synapses,  and  often  
enwrap  them  (Ventura	  and	  Harris	  1999);  astrocytes  release  a  long  list  of  
gliotransmitters  and  the  mechanisms  of  the  release  are  varied  and  are  still  a  
subject  of  debate  (Lalo	  et	  al.	  2014;	  Dongdong	  Li	  et	  al.	  2013;	  Pankratov	  et	  al.	  2007;	  Coco	  et	  al.	  2003;	  Parpura	  and	  Zorec	  2010).  It  is  now  widely  accepted  that  astrocytes  
signal  to  each  other  via  calcium  waves,  but  the  complexity  and  lack  of  universality  
of  these  signals  leads  to  a  question:  are  there  multiple  types  of  calcium  signalling  (Agulhon	  et	  al.	  2008;	  Nedergaard	  and	  Verkhratsky	  2012;	  Rusakov	  2015).  More  
precise  methods  for  studying  calcium  signalling  (e.g.  GCAMP  calcium  indicator  (Nakai,	  Ohkura,	  and	  Imoto	  2001))  have  determined  that  there  are  some  very  local  
increases  in  intracellular  calcium,  and  the  concentration  within  a  single  cell  varies  
enormously  (Zheng	  et	  al.	  2015).  One  of  the  main  tasks  in  this  are  of  research  is  the  
disentanglement  of  calcium  signalling  in  astrocytes  and  finding  a  true  
understanding:  what  exactly  is  the  function  of  gliotransmission  and  how  it  affect  
plasticity  (Rusakov	  et	  al.	  2014;	  Volterra,	  Liaudet,	  and	  Savtchouk	  2014;	  Araque	  et	  al.	  2014;	  Rusakov	  2015;	  Covelo	  and	  Araque	  2016)?      
1.4.3  Glutamate  uptake  and  recycling  
  
The  glutamate-­‐‑glutamine  cycle  is  a  well-­‐‑known  cellular  mechanism  that  consists  
of  transfer  of  glutamine  to  neurons  and  glutamate  from  neurons  to  astrocytes.  
Astrocytes  uptake  and  recycle  glutamate  using  an  enzyme  called  glutamine  
synthetase.  Glutamine  synthetase  is  expressed  exclusively  in  astrocytes(Norenberg  
and  Martinez-­‐‑Hernandez  1979).  Since  glutamate  is  considered  to  be  the  major  
neurotransmitter,  its  concentration  must  be  tightly  controlled,  providing  a  high  
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signal-­‐‑to-­‐‑noise  ratio  for  quicker  detection  of  increasing  concentration  of  
glutamate(Danbolt  2001).  Failure  to  remove  synaptic  glutamate  effectively  could  
cause  increased  levels  of  extracellular  glutamate,  which  in  turn  begins  the  process  
of  excitotoxicity.    
  
Glutamate  is  taken  up  by  astrocytes  via  glutamate  transporters  (GLAST  and  GLT-­‐‑
1)  by  an  electrogenic  process.  The  expression  of  these  transporters  near  the  
synaptic  cleft  and  the  high  affinity  to  the  substrate  ensures  a  rapid  clearance  of  
glutamate  from  the  extracellular  matrix.  Glutamate  transporters  utilise  the  energy  
from  the  exchange  of  Na+  and  K+  ions  (3  Na+  in:  2K+  out),  which  increases  the  
extracellular  concentration  of  potassium(Diniz  et  al.  2010;  Vandenberg  and  Ryan  
2013).  This  tight  coupling  of  potassium  and  glutamate  homeostasis  introduces  
limitations  into  experimental  set  ups  and  the  conclusion,  that  can  be  drawn  from  
the  data  acquired  (See  Chapter  6).  Once  glutamate  is  taken  up  by  astrocytes,  and  
subsequently  detoxified  into  glutamine,  it  can  be  transported  to  glutamatergic  or  
GABAergic  neurons.  There  it  can  be  used  converted  into  neurotransmitter  
glutamate  or  GABA,  respectively(Walls  et  al.  2014).  Many  diseases,  including  age-­‐‑
related  Alzheimer’s  and  others  are  linked  to  misbalance  in  glutamate  uptake  and  
as  a  consequence  –  in  potassium  homeostasis  (Liévens  et  al.  2001;  Scott  et  al.  2011;  
Rivera-­‐‑Aponte  et  al.  2015).    
1.5  Astrocytic  channels  
  
‘’Electricity  plays  an  unavoidable  role  in  biology.  Whenever  solutes  like  phosphate  
compounds,  amino  acids,  or  inorganic  ions  are  transported  across  membranes,  the  
movement  of  their  charge  constitutes  an  electrical  current  that  produces  a  voltage  
difference  across  the  membrane.  Beyond  managing  to  keep  this  accumulation  of  
charge  from  getting  too  far  out  of  balance,  all  living  cells  have  developed  the  ability  
to  exploit  a  transmembrane  electrical  potential  as  an  intermediate  in  the  storage  of  
energy  and  the  synthesis  of  ATP.’’  (Yellen	  2002)  
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Astrocytes  express  a  great  number  of  both  ionotropic  and  metabotropic  receptors,  
but  due  to  space  constraints  of  this  introduction  only  channels,  directly  relevant  to  
this  project  are  discussed  below.  For  more  information  on  glial  channels  see  the  
following  reviews  (Bradley	  and	  Challiss	  2012;	  Barbara	  A	  Barres	  et	  al.	  1990;	  Verkhratsky	  and	  Steinhäuser	  2000).  
  
1.5.1  Potassium  channels  
 
Potassium  channels  are  the  most  ubiquitous  channels  that  can  be  found  in  
virtually  every  living  cell  of  both  prokaryotes  and  eukaryotes.  Potassium  channels  
are  tetrameric  integral  membrane  proteins  that  form  aqueous  channels  allowing  
the  passage  of  K+  ions.  There  are  normally  30-­‐‑100  K+  genes  in  each  living  organism  
and  some  possess  mechanisms  of  alternative  splicing.  Many  super  families  of  
potassium  channels  vary  on  their  mechanisms  of  gating  and  the  function  they  
carry  out  in  the  body  (Miller	  2000).  As  one  of  the  most  abundant  channels  types,  
potassium  channels  are  present  in  every  cell  type.  More  specifically,  in  astrocytes  
potassium  channels  are  by  far  the  most  dominantly  expressed  channel  type.  
Classification  of  potassium  channels  utilises  their  functions  and  hallmark  
properties.  Figure  1.3  summarises  the  subclasses  of  potassium  channels.  Here,  the  
potassium  channels  are  classified  based  on  their  structure.  
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Figure  1.3:  Classification  of  potassium  ion  channels.  TMD,  trans-­‐‑membrane  domain;  KATP,  ATP-­‐‑
sensitive  K+  channel;  Kir,  inward-­‐‑rectifier  channel;  TASK,  tandem-­‐‑  pore  domain  K+  channel;  KV,  
voltage-­‐‑gated  K+  channel;  EAG,  ether-­‐‑á-­‐‑go-­‐‑go  channel;  KCa,  Ca
2+-­‐‑activated  channel;  BKCa,  large  
conductance  KCa  channel;  SKCa,  small  conductance  KCa  channel  (W.  M.  Liu  2013). 
Current  knowledge  of  potassium  channels  in  astrocytes  remains  rather  irregular,  
partially  due  to  a  great  degree  of  variation  in  the  structure,  stoichiometry  and  
expression  of  potassium  channels  in  various  tissues.  Below  the  three  classes  of  
potassium  channels  are  discussed  in  more  details.  
Inwardly  rectifying  channels    
  
Inward  rectifying  potassium  channels  were  first  identified  in  skeletal  muscles  (L.	  Y.	  Jan	  and	  Yan	  1994).  The  voltage  relationship  of  these  potassium  channels  did  not  
fit  Hodgkin  –  Huxley  kinetics  and  was  therefore  named  the  ‘’anomalous’’  
potassium  channel  (Hodgkin	  and	  Huxley	  1952;	  Hibino	  et	  al.	  2010).  These  channels  
are  much  more  likely  to  allow  the  influx  of  potassium  ions  than  the  voltage-­‐‑gated  
potassium  channels  (Guo	  et	  al.	  2003).  Being  voltage-­‐‑independent  channels,  Kir  
channels  are  lacking  the  S4  voltage  sensor  sequence,  whereas  in  other  types  of  K+,  
Na+,  and  Ca2+  channels  this  feature  is  conserved  (Guo	  et	  al.	  2003).  Main  elements  of  
control  of  the  activity  of  the  inward  rectifying  potassium  channels  are  therefore  
said  to  be  the  membrane  potential  (EM)  and  the  equilibrium  potential  for  
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potassium  ions,  or  EK.  Under  permitting  EM  and  EK,  and  also  absence  of  any  
mechanism  of  the  blockage  of  potassium  channels,  such  as  ATP  blocking  K-­‐‑ATP  
channels;  inwardly  rectifying  potassium  channels  will  be  active  at  all  voltage  
steps.  There  are  15  genes  encoding  various  potassium  channel  subtypes  classified  
as  inward  rectifiers.  These  are  divided  into  7  families:  Kir  1.x  to  Kir  7.x.  They  are  
further  classified  by  their  function.  Thus,  there  are  said  to  be  4  classes  of  inwardly  
rectifying  potassium  channels  (Figure  1.4).  
  
Figure  1.4:  Diversity  of  potassium  channels.  A  -­‐‑  Comparison  of  the  structure  of  inwardly  
rectifying  (left)  and  voltage-­‐‑gated  (right)  potassium  channels.  B  -­‐‑  Classification  of  inward  rectifiers  
based  on  sequence  identity  and  function  (Hibino  et  al.  2010).  
Classical  Kir  channels  
  
Potassium  channels  found  in  both  skeletal  and  cardiac  muscle  types  belong  to  the  
Kir2.x  channel  family.  They  determine  and  sustain  a  highly  negative  EM  and  
contribute  to  the  action  potential  plateau  in  various  cells.  Starting  from  Kir  2.1,  
three  other  subunits  were  cloned,  Kir2.2,  Kir2.3  and  Kir2.4  (Kubo	  et	  al.	  1993;	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Topert	  et	  al.	  1998).  Kir2.1  subtype,  expressed  in  mouse  brain  has  70,  61  and  63%  
identity  with  the  three  respective  channel  subtypes.  Conserved  sequences  
constitute  predominantly  to  the  two  membrane  spanning  regions  and  H5  region  
also.  Despite  historical  opinion  of  Kir2.x  channel  types  being  strictly  homomeric  (Tinker,	  Jan,	  and	  Jan	  1996),  it  has  been  shown  with  the  use  of  electrophysiological  
experiments  that  each  of  the  four  subtypes  can  assemble  with  any  other  subtype  
and  that  the  heteromers  have  distinct  properties  to  their  respective  homomeric  
channels  (Preisig-­‐Muller	  et	  al.	  2002).  The  Kir2.1/2.4  channel  is  expressed  in  the  
brain  (Schram	  et	  al.	  2004).  
  
Using  techniques  such  as  immune-­‐‑histochemistry  and  in  situ  hybridization,  the  
localization  of  Classical  Kir  channels  was  studied.  Kir2.1  is  expressed  in  the  entire  
brain,  although  quite  weakly.  Kir  2.2  is  expressed  strongly  in  cerebellum  and  
temperately  within  the  whole  brain  (Horio  et  al.  1996).  Forebrain  and  olfactory  
bulb  express  Kir2.3  and  Kir2.4  is  located  exclusively  in  the  cranial  nerve  motor  
nuclei  in  the  midbrain,  pons  and  medulla,  but  the  expression  is  mainly  limited  to  
the  dendrites  and  soma  (Karschin	  et	  al.	  1996;	  Topert	  et	  al.	  1998;	  Prüss	  et	  al.	  2005).  
Using  electrophysiological  techniques  it  was  established  that  different  heteromers  
of  Kir2.x  channel  subtypes  are  present  in  neurons  in  several  brain  regions,  such  as  
hippocampus  and  spinal  motor  neurons  (Brown	  et	  al.	  1990;	  Takahashi	  1990).  
These  channels  are  involved  with  the  EM  and  the  control  of  neuronal  excitability;  
hence  the  Ba2+  block  of  Kir2.x  channels  in  neurons  causes  depolarization  and  
initiated  action  potential  firing  (Day  et  al.  2005).  In  Schwann  cells  surrounding  the  
peripheral  nerve  fibers,  specifically  in  the  microvilli  of  these  cells,  both  Kir  2.1  and  
Kir  2.3  were  detected,  using  immune-­‐‑histochemical  analysis  (Wilson	  and	  Chiu	  1990;	  Mi	  et	  al.	  1996).  These  channels  may  be  involved  with  maintaining  the  [K+]O  
by  collecting  the  excess  K+  released  from  the  nearby  axons.  This  function  of  
peripheral  Schwann  cells  is  similar  to  the  K+  buffering  of  the  excess  extracellular  
potassium  ions  by  the  astrocytes  in  the  central  nervous  system  (Hibino	  et	  al.	  2010).  
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G-­‐‑protein  gated  Kir  channels  (Kir3.x)    
  
There  are  thousands  of  GPCRs  in  the  human  genome;  they  are  target  to  various  
signaling  molecules  and  in  response  to  stimulation  two  effector  molecules  (Gα  
and  Gβγ)  dissociate  and  can  pass  on  the  signal  inside  the  cell.  There  are  four  
subunit  types:  Kir  3.1  –  Kir  3.4.  They  can  also  form  various  homo-­‐‑  or  heteromers  
and  their  functions  are  defined  by  the  exact  cellular  localisations,  nearby  protein  
complexes  and  a  range  of  signalling  substances  (Lesage	  et	  al.	  1995;	  Jelacic	  et	  al.	  2000).  
  
Kir  3.1  (GIRK1)  was  the  first  cDNA  to  be  isolated  and  it  is  39  and  42%  identical  to  
the  Kir  1.1  and  Kir2.1  channel  subtypes  respectively  (Kubo	  et	  al.	  1993).  Kir3.2  
channel  subtype  possesses  at  least  four  different  isoforms,  due  to  alternative  
splicing  of  the  GIRK2  gene.  These  isoforms  are  named  Kir3.2a  –  Kir3.2d  
respectively.  It  is  suggested  that  Kir3.2  isoforms  usually  form  heteromers  with  
other  subunits,  for  example  Kir3.1  or  Kir3.3.  Kir  3.3  channel  subtype  is  expressed  
in  the  mouse  brain,  in  at  least  two  variants  (17  AAs  length  difference)  (Lesage	  et	  al.	  1995;	  Jelacic,	  Sims,	  and	  Clapham	  1999).  The  rat  and  human  Kir3.3  subunits  are  
nearly  matching  the  longer  variant  of  the  mouse  Kir3.3  (Jelacic,	  Sims,	  and	  Clapham	  1999).  Studies  of  various  heteromeric  combinations  of  all  the  KG  channels  are  
numerous  and  sometimes  conflicting.  Some  heteromers  are  expressed  in  some  
species  but  not  others  and  the  combinations  may  vary  depending  on  tissue  and  
cell  type  and  intracellular  localization.  Most  KG  channels  (Kir3.1,  Kir3.2  and  Kir3.3)  
are  evenly  expressed  throughout  the  brain  (Hibino	  et	  al.	  2010).  Kir3.1  and  Kir3.2  
are  localized  in  both  post-­‐‑  and  pre-­‐‑synaptic  regions,  as  shown  by  electron  
microscopy.  Kir3.3  and  Kir3.4,  however,  have  only  been  detected  in  the  axons  of  
neurons  (Iizuka	  et	  al.	  1997;	  Grosse	  et	  al.	  2003).  This  localization  hints  at  KG  
channels’  involvement  with  not  only  the  post-­‐‑synaptic  but  also  presynaptic  
modulation  of  neuronal  activity.  Homomeric  complexes  of  Kir3.2  isoforms  were  
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found  in  dopaminergic  neurons  of  the  substantia  nigra  (Inanobe	  et	  al.	  1999).  These  
homomers  thus  could  potentially  be  involved  in  the  age-­‐‑related  degeneration  
process  in  the  dopaminergic  neurons.  Once  activated  by  any  of  the  known  GPCRs  
at  either  post-­‐‑  or  presynaptic  site,  the  KG  channels  produce  a  slow  inhibitory  
postsynaptic  potential  (sIPSP)  and  thus  suppress  the  cells  excitability  (Thompson	  and	  Gahwiller	  1992;	  Muller	  and	  Misgeld	  1989).  This  function  of  potassium  channels  
in  hippocampal  and  cerebral  neurons  comprise  of  Kir3.2  channels,  as  shown  by  
the  knockout  experiments  where  KO  mice  had  spontaneous  seizures  and  were  
generally  more  susceptible  to  induced  seizures  (Signorini	  et	  al.	  1997;	  Luscher	  et	  al.	  1997).  This  phenotype  seems  to  be  related  to  the  lack  of  Kir3.2  function  in  
providing  IPSPs.  If  the  Kir3.2  was  knocked  out,  there  was  a  clear  reduction  in  the  
Kir3.1  expression  levels  as  well  (Signorini	  et	  al.	  1997).  In  a  study  in  the  
hippocampus,  a  null  Kir3.4  channel  resulted  in  a  decrease  in  spatial  learning  and  
memory  task  test,  despite  localization  experiments  demonstrating  that  Kir3.4  is  
expressed  weakly  in  the  hippocampus  (Wickman	  et	  al.	  2000).  KG  could  be  similarly  
involved  in  a  negative  feedback  loop,  set  to  control  neuronal  excitability.  
Trafficking  of  these  channels  can  be  affected  by  neuronal  activity  of  the  cell.  A  
study  by  Chung  et  al  2009  illustrated  how  Kir3.1/3.2  heteromers  are  present  
predominantly  in  the  cytoplasmic  regions,  until  the  stimulation  of  NMDA  
receptors  by  glutamate.  The  number  of  Kir3.1/3.2  channels  on  the  soma,  dendrites  
and  dendritic  spines  membranes  doubles  on  a  time  scale  of  15  minutes  (H.	  J.	  Chung	  et	  al.	  2009).  
K-­‐‑ATP  channels  (Kir6.x/SURx)  
  
K-­‐‑ATP  is  a  type  of  inwardly  rectifying  potassium  channels  that  can  be  blocked  by  
the  internal  ATP.  These  channels  are  only  weak  inward  rectifiers.  It  is  believed  
that  K-­‐‑ATP  might  provide  a  link  between  the  metabolic  state  of  the  cells  and  the  
excitability.  When  expression  cloning  isolated  both,  a  classic  Kir  2.1  and  K-­‐‑ATP  1.1  (Kubo	  et	  al.	  1993),  the  conserved  features  present  in  these  types  were  the  TM1  and  
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TM2  membrane-­‐‑spanning  regions  and  the  H5  extracellular  loop  that  forms  the  
pore  of  the  channel  (see  Figure  1.4).  Functional  K-­‐‑ATP  channels  comprise  of  four  
Kir  subunits  forming  the  pore  as  well  as  four  auxiliary  proteins,  the  SUR  or  
sulfonylurea  receptors.  These  SUR  subunits  are  susceptible  to  inhibitory  agents  
such  as  sulfonylureas  (tolbutamide  and  glibenclamide)  that  are  used  for  treating  
type  II  diabetes.  K-­‐‑ATP  channels  play  a  vital  role  in  pathogenesis  of  type  II  
diabetes:  they  are  present  in  the  β-­‐‑cells  of  the  pancreas  and  are  a  key  player  in  the  
insulin  secretion  into  the  ducts.  K-­‐‑ATP  channels  are  expressed  throughout  the  
organism,  participating  in  the  control  and  regulation  of  glucose  level  inside  and  
outside  of  the  cells.  Kir6.1  channel  subtype  was  found  in  the  mitochondrial  
membrane  of  rat  liver  and  it  was  blocked  by  ATP  application  to  the  luminal  
matrix  face  as  well  as  4-­‐‑AP  and  glibenclamide  (Inoue	  et	  al.	  1991).  Other  studies  
also  identified  Kir6.1,  Kir6.2  and  SUR2A  subunits  in  the  mitochondria  of  both  
heart  and  brain  (Lacza	  2003;	  Lacza	  et	  al.	  2003).  These  channels  are  also  expressed  
moderately  in  the  brain,  however  the  main  focus  of  investigation  of  these  channels  
remains  metabolic  and  blood  glucose  regulation  (Minami	  et	  al.	  2004;	  Dongliang	  Li	  et	  al.	  2013).  
  
As  well  as  carrying  out  this  important  function  of  facilitating  the  insulin  secretion  
in  the  pancreas,  these  ATP-­‐‑sensitive  channels  play  another  significant  role  in  the  
brain,  by  protecting  neurons  against  ischemic  damage.  The  vulnerability  to  stroke  
is  varied  among  distinct  regions  of  the  brain,  and  this  is  one  of  the  higher  causes  of  
death  in  the  UK  (152,000  strokes  a  year  according  to  Stroke  Association,  UK  (stroke.org.uk	  2016)).  A  recent  study  has  compared  the  Kir6.2  knockout  with  the  
wild-­‐‑type  mouse  and  concluded  that  Kir6.2  channels  provide  a  protection  from  
neuronal  death  following  a  15-­‐‑minute  induction  of  ischemia  in  vivo.  This  result  
suggests  that  cortical  K-­‐‑ATP  channels  are  part  of  a  specific  mechanism  aimed  at  
limiting  the  damage  of  neurons  that  can  be  caused  by  a  cerebral  ischemic  stroke  (Sun	  et	  al.	  2007).  These  channels  were  also  investigated  in  the  hypothalamus,  in  
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the  so-­‐‑called  “glucose-­‐‑sensitive”  neurons.  For  instance,  orexin  neurons  can  be  
inhibited  by  an  increase  in  glucose  concentration  thus  affected  regulation  of  
wakefulness,  locomotor  activity  and  appetite;  whereas  neurons,  concentrating  
melanin  hormone  are  excited  upon  an  increase  in  the  glucose  level  (R.	  Wang	  et	  al.	  2004).  The  details  of  the  mechanisms  of  inhibition  and  stimulation  of  neuronal  
activity  are  elusive  and  still  being  debated  (Karnani	  and	  Burdakov	  2011;	  De	  Backer	  et	  al.	  2016).  
K-­‐‑transport  channels  (Kir1.1,  Kir4.x,  Kir5.x  and  Kir7.x)  
  
Kir1.1  channel  subtype  possesses  an  ER  retention  signal  in  its  -­‐‑  COOH  terminus  (D.	  Ma	  et	  al.	  2001).  Several  proteins,  including  PKA  and  SGK,  are  involved  with  
Kir1.1  channels  trafficking  to  and  from  the  surface  membrane.  This  channel  
subtype  plays  a  vital  role  in  the  nephron  of  kidneys,  which  will  be  described  later.  
In  situ  hybridization  has  also  shown  that  Kir1.1  is  expressed  in  neurons  of  both  
cortex  and  hippocampus,  however,  its  physiological  function  remains  unknown  (Kenna	  et	  al.	  1994).  Another  type  of  transport  potassium  channel  is  Kir4.1  channel  
(KCNJ10),  which  has  53,  43  and  43%  amino  acid  sequence  identity  with  Kir1.1,  
Kir2.1,  and  Kir3.1  channels  (for  Kir5.1  it  is  39,  50  and  40%  identity  respectively)  (Hibino	  et	  al.	  2010).  Kir4.1  subtype  can  form  both  hetero-­‐‑  and  homomers,  unlike  
Kir5.1  channel  that  is  only  fully  functional  if  co-­‐‑expressed  with  Kir4.1  (Butt	  and	  Kalsi	  2006).    Pessia  et  al.  1996  has  shown  that  a  homo-­‐‑tetrameric  Kir4.1  channel  
can  produce  potassium  current.  Biophysical  properties,  such  as  pH  sensitivity,  of  
Kir4.1/4.1  are  distinct  to  those  of  Kir4.1/5.1  (Pessia	  et	  al.	  2001).  Kir4.2  (KCNJ15)  
was  first  isolated  from  a  human  kidney  cDNA  library  (Pearson	  et	  al.	  2004).  This  
channel  subtype  possesses  a  62%  identity  to  Kir4.1,  but  it  is  lacking  an  ATP-­‐‑
binging  cassette  in  its’  COOH  terminus  (Takumi	  et	  al.	  1995).  Kir4.2  can  form  a  
homomer  as  well  as  co-­‐‑express  with  Kir5.1.  This  heteromer  produces  a  different  
single  channel  conductance  and  is  present  on  a  greater  cell  surface  (Pearson	  et	  al.	  1999;	  Pessia	  et	  al.	  2001).  Three  groups  identified  channel  subtype  Kir7.1  
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simultaneously  (Derst	  et	  al.	  1998;	  Krapivinsky	  et	  al.	  1998;	  Partiseti	  et	  al.	  1998).  To  
date  there  are  no  reports  of  any  heteromeric  combinations  of  Kir7.1  channel.  In  
general,  there  is  a  fair  degree  of  variation  within  the  four  classes  of  Kir  channels.  
Their  sequences  are  quite  distinct  from  one  another,  and  hence  the  behavior,  such  
as  formation  of  homo-­‐‑  or  heteromers  and  the  existence  of  alternative  splice  forms,  
varies  from  transport  potassium  channels  to  ATP-­‐‑sensitive  potassium  channels.    
  
In  situ  hybridization  indicated  that  Kir4.1  is  predominantly  expressed  in  
astrocytes  (Takumi	  et	  al.	  1995).  It  is  said  to  be  involved  in  the  “potassium  
buffering”  by  astrocytes,  thus  regulating  the  neuronal  excitability  and  carrying  out  
a  neuroprotective  function.    As  well  as  being  expressed  in  astrocytes  Kir  4.1  is  
present  in  oligodendrocytes  and  is  linked  to  the  vital  process  of  myelination  of  the  
developing  nervous  system  (Neusch	  et	  al.	  2001).  The  gene  expressing  Kir  4.1  is  
located  on  chromosome  1.  Kir4.1  forms  both  homomeric  and  heteromeric  (with  
Kir5.1)  channels  in  astrocytes  that  appear  to  have  distinct  localization  patterns;  
perisynaptic  processes  both  types  of  channels,  unlike  the  endfeet  projections,  that  
only  contain  the  heteromers.  Another  type  of  glial  cells  that  expresses  Kir4.1  
channels  is  the  satellite  cells  (Hibino	  et	  al.	  1999).  These  cells  wrap  around  ganglion  
neurons  in  the  peripheral  nervous  system.  In  fibrocytes  of  cochlea,  a  non-­‐‑
functional  homomer  of  Kir5.1  and  a  fully  functional  Kir4.1  channels  are  present  (Hibino,	  Higashi-­‐Shingai,	  et	  al.	  2004).  Kir4.1  in  astroglial  cells  constitutes  to  the  
basal  conductance  of  potassium  ions  in  brain,  spinal  cord  and  retina  (T.	  M.	  Ishii	  et	  al.	  1997;	  Kaiser	  et	  al.	  2006;	  Neusch	  2006;	  Olsen,	  Campbell,	  and	  Sontheimer	  2007).  A  
knockout  in  the  Kir4.1  gene  causes  a  decrease  in  potassium  conductance,  
depolarization  of  EM  in  astrocytes  (Neusch	  2006).  Homomeric  Kir4.1  and  Kir4.1/5.1  
have  different  location  configurations  in  astrocytes  (M.	  Ishii	  et	  al.	  2003;	  Hibino,	  Fujita,	  et	  al.	  2004).  On  the  perisynaptic  projections  of  the  astrocytes  both  homo-­‐‑  
and  heteromeric  Kir  channels  are  present,  whereas  the  endfeet  of  astrocytes  only  
show  presence  of  the  heteromeric  Kir4.1/5.1.  Since  astrocytes  are  believed  to  expel  
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potassium  ions  onto  the  blood  vessels  one  may  assume  that  this  is  done  via  the  
heteromeric  Kir4.1/5.1  channels.  Homomeric  Kir4.1  channels  may  then  be  
responsible  for  taking  up  the  potassium  ions  into  the  cell.  The  main  difference  
between  the  Kir4.1  homomer  and  the  Kir4.1/5.1  channel  is  their  sensitivity  to  pH.  
Within  the  physiological  pH  range  (6.5-­‐‑8)  the  homomeric  Kir4.1  channel  is  
inhibited  by  acidification  with  a  pKa  of  6  (Pessia	  et	  al.	  2001).  Dissimilarly  to  that,  
the  heteromeric  channel  is  suppressed  by  only  a  slight  acidification  of  the  pH  and  
its  activity  is  heightened  by  alkalization  (Zhenjiang	  Yang	  et	  al.	  2000).  During  the  
developmental  stage  Kir4.1  is  expressed  in  both  astrocytes  and  oligodendrocytes,  
however  10-­‐‑20  days  after  birth  the  expression  of  this  channel  subtype  only  
proceeds  in  the  astrocytes  (Kaiser	  et	  al.	  2006;	  Neusch	  et	  al.	  2001).  There  is  a  
suggestion  that  Kir4.1  is  functionally  coupled  to  glutamate  transporters,  since  
GLT-­‐‑1  and  GLAST  transporters  are  also  expressed  in  astrocytes  and  the  knockout  
experiments  with  Kir4.1  lead  to  an  impaired  glutamate  uptake  by  astrocytes  (Olsen,	  Campbell,	  and	  Sontheimer	  2007;	  Djukic	  et	  al.	  2007).    
  
Kir  4.2,  also  called  Kir1.3,  is  important  in  development  of  kidney,  lung,  heart,  
thymus  and  thyroid,  is  located  on  chromosome  21  in  humans.  This  means  that  
Kir4.2  channel  may  play  a  role  in  the  pathogenesis  of  the  Down’s  syndrome.    
Often  Kir4.2  forms  a  hetero-­‐‑channel  with  Kir  5.1  (works  in  kidney  and  pancreas).  
Kir4.2  has  been  found  in  mouse  liver,  where  its  function  is  unknown  (Pearson	  et	  al.	  1999);  and  as  a  part  of  the  heteromeric  Kir4.2/5.1  in  the  renal  epithelial  cells  (Pessia	  et	  al.	  2001).  The  Kir4.2  channels  are  largely  internalised  if  expressed  alone  
in  heterologous  systems,  and  so  only  produce  small  potassium  current  (Pearson	  et	  al.	  1999).    
  
Kir7.1  channel  type  is  widely  expressed  in  different  epithelial  cells,  for  instance  in  
DCT,  PCT  and  the  collecting  duct  of  kidney.  In  these  cells  this  channel  is  
expressed  on  the  basolateral  membrane  (Nakamura	  et	  al.	  1999;	  Kusaka	  et	  al.	  2001).  
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However,  in  the  choroid  plexus  Kir7.1  channels  are  present  on  the  apical  
membrane  of  the  cell  only  (Nakamura	  et	  al.	  1999).  Some  of  the  mechanisms  
underlying  the  targeting  and  expression  of  each  of  the  potassium  channel  
subtypes  are  not  clear  yet.  Choroid  plexus  and  RPE  (Retinal  Pigment  Epithelium)  
have  a  strong  polarity,  produced  by  the  activity  of  Na+-­‐‑K+-­‐‑  ATPase  on  their  apical  
membrane  (Okami	  et	  al.	  1990).  Kir7.1  homomers  seem  to  aid  maintain  this  
polarity.  In  thyroid  follicular  cells  and  renal  epithelial  cells  Kir  channels  are  
located  on  the  basolateral  membrane,  close  to  the  Na+-­‐‑K+-­‐‑ATPase  pump,  thus  
suggesting  that  the  function  of  these  Kir7.1  channels  is  to  provide  the  potassium  
ions  for  their  respective  pumps.  Kir7.1  are  the  least  heavily  researched  into  
channels  and  many  physiological  functions  of  this  channel  are  still  not  proven  or  
in  some  cases  unknown.    
  
Kir4.x  and  Kir5.1  channels  participate  in  potassium  recycling  in  the  basolateral  
membrane  of  kidneys  and  stomach  epithelium.  Providing  potassium  ions  to  the  
extracellular  site  of  Na+,  K+-­‐‑ATPase  helps  to  maintain  its  activity.  This  process  can  
be  blocked  by  the  addition  of  Ba2+  (Schafer	  and	  Troutman	  1987).  Either  Kir4.1  or  
Kir4.2  can  affect  Ca2+  sensing  receptors  in  the  basolateral  membrane  of  DCT,  
resulting  in  a  decreased  current  produced  by  the  subunits  (Huang	  et	  al.	  2007).  
These  channels  are  involved  in  Calcium  and  Magnesium  homeostasis  (Blaine,	  Chonchol,	  and	  Levi	  2015).  A  homomer  of  Kir4.1  is  co-­‐‑localized  with  the  H+-­‐‑K+-­‐‑
ATPase  at  the  apical  membrane  of  gastric  parietal  cells.  Kir4.1  is  presumably  
aiding  to  maintain  the  activity  of  the  pump,  by  delivering  potassium  ions  for  the  
pump.  Another  tissue  where  Kir4.1  is  expressed  is  the  endolymph  of  the  cochlea  
of  the  inner  ear.  It  contains  an  approximate  concentration  of  150mM  K+  and  has  a  
very  positive  membrane  potential  of  +80  mV  relative  to  that  of  blood.  These  
unique  conditions  are  essential  for  hearing  to  take  place.  Kir4.1  knockout  mice  are  
deaf,  providing  more  evidence  for  the  importance  of  this  channel  subtype  in  the  
         26  
cochlea.  Application  of  Ba2+  to  the  membrane  suppressed  the  endocochlear  
potential  (Marcus	  et	  al.	  2002;	  Chen	  and	  Zhao	  2014).    
Voltage-­‐‑gated  potassium  channels  
  
There  are  more  than  40  genes  encoding  subunits  for  voltage-­‐‑gated  potassium  
channels.  Voltage-­‐‑gated  potassium  channels  are  homo-­‐‑tetrameric,  with  each  of  the  
alpha  subunits  possessing  a  voltage  sensor  (S4)  and  six  trans-­‐‑membrane  domains  
(S1-­‐‑S6),  with  both  termini  located  on  the  intracellular  side  of  the  membrane  (Yellen	  2002).    These  6  domains  contribute  to  alpha  subunits,  of  which  there  are  20  types  
described  to  date.  These  alpha  subunits  are  classified  into  6  subfamilies  Kv1  
(Shaker),  Kv2  (Shab),  Kv3  (Shaw),  Kv4  (Shal),  KyLOT  and  EAG.  Since  the  pore  
domain  (H5)  is  highly  conserved,  potassium  channels  are  able  to  preferentially  
conduct  K+  ions  over  Na+  ions  (over  1000  fold  preference),  despite  these  two  ions  
being  of  similar  size  (MacKinnon	  2003).  Voltage  gated  potassium  channels  can  
form  channels  from  alpha  subunits  from  the  same  subfamily  as  well  as  other  
subfamilies  (Christie	  et	  al.	  1990;	  Shahidullah	  et	  al.	  1995).  For  instance,  Kv1.2  and  
Kv1.4  co-­‐‑precipitate  together  from  extract  of  the  brain,  they  appear  to  form  
functional  multi-­‐‑heteromers  on  the  terminals  of  neurons  and  produce  A-­‐‑type  
(rapidly  inactivating)  current  (H.	  Wang	  et	  al.	  1993).  There  is  an  immense  potential  
for  variation  of  all  the  possible  multi-­‐‑heteromers  that  can  be  build  from  the  alpha  
subunits.  Some  of  the  subfamilies,  however,  do  not  express  currents  by  themselves  
(Kv5,  Kv6,  Kv8  and  Kv9)  (Coetzee	  et	  al.	  2002).    
  
Another  subfamily  of  voltage  gated  potassium  channels  is  the  Calcium  dependent  
voltage-­‐‑gated  potassium  channels,  containing  three  members:  SK  (Small),  IK  
(Intermediate)  and  BK  (Big)  conductance  –  termed  so  based  on  the  extent  of  the  
conductance  of  potassium  ions.  An  increase  in  the  intracellular  calcium  reduced  
the  conductance  of  these  channels.  These  channel  types  are  involved  in  multiple  
processes  in  the  brain,  including  response  to  injury  (Armstead	  2005),  sensing  
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osmotic  changes  in  the  paraventricular  nucleus  (Feetham	  et	  al.	  2015),  cerebral  
blood  flow  regulation  (Philip	  and	  Armstead	  2004),  synaptic  activity  modulation  (Carlson	  2014)  and  many  more.  KCa3.1  expression  is  up-­‐‑regulated  in  glioblastoma  
multiform  (GBM)  and  was  shown  to  play  a  pro-­‐‑invasive  role  in  a  malignant  
glioma  (Turner	  et	  al.	  2014).  
  
Voltage-­‐‑gated  potassium  channels  carry  a  great  importance  in  neurons  in  the  
brain,  where  they  lead  the  repolarisation  process  of  the  action  potential  (Pathak,	  Guan,	  and	  Foehring	  2016).  Since  voltage  gated  potassium  channels  may  underlie  
both  the  sub-­‐‑threshold  and  larger  currents  during  spikes,  thus  producing  even  
more  complexity  for  studying  the  individual  roles  of  these  channels.  Any  
mutations  in  voltage-­‐‑gated  potassium  channels  can  lead  to  devastating  
consequences;  many  channel  impairments  are  involved  in  epilepsy  –  termed  
‘channelepsy’  (D'Adamo	  et	  al.	  2013;	  Simons	  et	  al.	  2014).  Even  single  base  mutations  
can  give  rise  to  severe  phenotypes,  such  as  ‘shaker’  in  Drosophila.  These  diseases  
are  called  channelopathies  (Lehmann,	  Bette,	  and	  Engele	  2009).    
  
In  astrocytes,  as  in  other  glial  cells,  high  densities  of  potassium  channels  are  
expressed,  which  is  expected  due  to  their  function  of  controlling  K+  homeostasis.  
Surprisingly  though,  both  types  of  outward  potassium  current,  rapidly  
inactivating  and  delayed  rectifier  are  also  present.  Some  propose  that  these  
channels  are  important  for  regulating  glial  proliferation.  However,  high  densities  
of  these  channels  persist  in  mature  age  as  well.  Their  relevance  is  yet  to  be  fully  
understood  (Verkhratsky	  and	  Steinhäuser	  2000).  According  to  Expression  Atlas  
database,  which  stores  both  microarray  and  RNA-­‐‑sequencing  data,  two  most  
prominently  expressed  voltage-­‐‑gated  potassium  channels  are  Kv1.2  and  Kv3.4  (Petryszak	  et	  al.	  2016).  They  correspond  to  KD  and  KA  types  of  currents  
respectively  (Smith,	  Rosenheimer,	  and	  Kalil	  2008;	  Angulo	  et	  al.	  2004).  
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Leak  potassium  channels  
  
A  third  subfamily  of  potassium  channels  is  the  two  pore  or  ‘’leaky’’  potassium  
channels.  They  contain  four  trans-­‐‑membrane  domains  and  two  pore  domains  (Coetzee	  et	  al.	  2002).  The  structure  of  leak  channels  is  similar  to  a  doubled  up  Kir  
subunit  conformation.  Unlike  the  other  two  classes,  4  domain  potassium  channels  
form  dimers,  thus  keeping  the  symmetry  of  the  central  pore.  Two-­‐‑pore  potassium  
channels  largely  lack  any  time-­‐‑  and  voltage  dependence  (Verkhratsky	  and	  Steinhäuser	  2000).  The  first  gene  (KCNK0)  encoding  a  two-­‐‑pore  subunit  was  
cloned  from  Drosophila  melanogaster  in  1996,  and  since  then  at  least  14  subunits  
have  been  cloned  and  formally  studied  (Goldstein	  et	  al.	  1998;	  Goldstein	  et	  al.	  2001).  
Since  two-­‐‑pore  potassium  channels  are  subjects  to  both  physical  (stretching,  
temperature  and  pH  fluctuations)  and  chemical  (a  vast  number  of  signalling  
molecules,  e.g.  lipids)  regulation,  it  is  said  to  be  a  high  controlled  class  of  channels.  
Coupled  with  their  distribution  in  the  central  nervous  system,  this  makes  these  
channels,  such  as  TREK-­‐‑1,  a  potential  therapeutic  target  (Vivier	  et	  al.	  2016).  A  
further  regulatory  mechanism  of  the  2  -­‐‑  pore  channels  has  recently  been  described  
–  a  non-­‐‑traditional  voltage  gating  mechanism,  where  the  sensitivity  arises  from  
the  interaction  of  3-­‐‑4  potassium  ions  with  the  electric  field  of  the  selectivity  filter,  
which  act  similar  to  a  ‘’check  valve’’  (Schewe	  et	  al.	  2016).    
  
It  was  reported  that  two  isoforms  of  two-­‐‑pore  potassium  channels  were  expressed  
in  astrocytes  of  the  mouse  forebrain:  TWIK-­‐‑1  (K2P1.1)  and  TREK-­‐‑1  (K2P2.1)  (Cahoy	  et	  al.	  2008).  In  a  heterologous  system,  TWIK-­‐‑1  shows  a  weakly  inward  
rectification,  whereas  TREK-­‐‑1  conducts  an  outwardly  rectifying  current  (Lesage	  et	  al.	  1996;	  Fink	  et	  al.	  1996).  These  two  channel  subtypes  are  believed  to  conduct  a  
large  proportion  of  the  overall  astrocytic  potassium  current,  and  to  be  mildly  
sensitive  to  blockage  by  barium  chloride  (Zhou	  et	  al.	  2009).    
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1.5.2  P2X  receptors    
  
ATP  is  a  universal  energy-­‐‑providing  molecule.  However,  in  the  central  nervous  
system  it  also  acts  as  a  signalling  molecule  –  both  a  neuro-­‐‑  and  gliotransmitter,  
with  it’s  own  set  of  receptors  (Abbracchio	  et	  al.	  2009).  ATP  can  be  both  released  
and  received  as  a  messenger  from  multiple  locations  in  the  brain,  and  both  
neuronal  and  glial  cells.  The  release  mechanisms  include  exocytosis  and  transport  
via  channels  and  pumps  (Verkhratsky	  et	  al.	  2012).  There  are  seven  subtypes  of  
ionotropic  purinoceptors:  P2X1-­‐‑P2X7;  they  form  functional  channels  out  of  three  
subunits.  Most  of  the  P2X  receptor  subunits  are  able  to  form  both  homo-­‐‑  and  
heteromeric  channels,  with  some  combinations  being  far  more  typical  than  
others(Jiang	  et	  al.	  2003).  Common  heteromers  include  P2X1/2,  P2X1/4,  P2X1/5,  P2X2/3,  
P2X2/6  and  P2X4/6  (North	  2002;	  Surprenant	  and	  North	  2009).  Since  the  currents  
conducted  by  the  seven  subunits  vary  to  a  large  degree,  existence  of  multiple  
patterns  for  heteromeric  channels  introduces  a  great  variation  in  the  functioning  of  
these  channels.  Figure  1.5  shows  the  desensitization  of  the  seven  homomeric  P2X  
receptors  in  rat  (North	  2002).  
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Figure  1.5:  Fast  (top)  and  slow  (bottom)  desensitization  compared  for  homomeric  rat  P2X  
receptors.    Fast  desensitization  is  only  noted  in  P2X1  and  P2X3  channel  subtypes,  following  a  brief  
application  (2s)  of  30  µμM  ATP  (except  P2X7,  where  1mM  was  used).  Slow  desensitization  was  
observed  in  P2X2  and  P2X4,  following  a  60s  application  of  ATP.  HEK293  cells  were  transfected  
with  1  µμg/ml  cDNA  48h  prior  to  the  recordings  being  made.  In  all  cases  a  single  application  
yielded  the  response  showing,  except  P2X7,  which  required  a  2min  application.  Figure  taken  from  
North  et  al.  (2002).    
Although  all  seven  P2X  subunits  were  found  in  astrocytes  on  a  transcriptional  
level  (Verkhrasky,	  Krishtal,	  and	  Burnstock	  2009),  when  acutely  isolated  cortical  
astrocytes  (from  mouse)  were  tested  for  the  mRNA  levels,  only  P2X1  and  P2X5  
subunits  were  identified  (Lalo	  et	  al.	  2008).  These  subunits  were  shown  to  form  
functional  heteromers,  which  were  extremely  sensitive  to  ATP  (KD  approximately  
50  nM)  and  have  intermediate  Ca2+  permeability  (PCa/Pmonovalent  –  2.2).  Activation  of  
these  heteromers  by  either  exogenous  or  synaptically  derived  ATP  can  trigger  
calcium  signals  (Palygin	  et	  al.	  2010).  The  expression  of  P2X1/5  channels  in  
astrocytes  varies  with  age,  reaching  it’s  peak  around  3-­‐‑6  months  old  mice  (Lalo,	  Palygin,	  et	  al.	  2011).  
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1.5.3  Other  relevant  astrocytic  channels  
  
NMDA  receptors  are  a  type  of  ionotropic  glutamate  receptor  that  is  very  abundant  
in  the  central  nervous  system.  The  name  of  this  channel  comes  from  the  selective  
agonist  N-­‐‑methyl-­‐‑D-­‐‑aspartate.  Functional  channels  are  formed  by  hetero-­‐‑
tetrameric  composition  of  GluN1  and  GluN2  subunit  types.  Properties  of  the  
subunit  types  are  different,  thus  introducing  an  increased  variation  in  regulation  
of  these  channels.  NMDARs  are  expressed  on  both  neurons  and  glial  cells  (Conti	  et	  al.	  1997).  One  of  the  hallmark  properties  of  neuronal  NMDARs  is  the  presence  of  
Mg+  ion  block  in  the  channel  pore,  thus  requiring  two  events  to  take  place  before  
the  channel  can  be  activated.  In  astrocytes  mRNA  for  both  NR1  and  NR2A/B  
subunits  were  detected  in  the  past  with  various  methods  (Conti	  et	  al.	  1997;	  Schipke	  et	  al.	  2001).  Recently,  it  was  shown  by  our  laboratory  that  astrocytes  express  
NMDA  receptors  that  are  devoid  of  this  magnesium  ion  block  and  that  these  
channels  can  mediate  the  transmission  from  glia  to  neurons  (Lalo	  et	  al.	  2006).  It  
was  then  also  shown  that  both  P2X1/5  and  NMDA  receptors  expressed  in  cortical  
astrocytes  are  permeable  to  calcium  (PCa/PK  was  2.2  and  3.1  respectively);  these  
influxes  of  calcium  are  consecutively  capable  of  triggering  Ca2+  signals  when  
stimulated  (Palygin	  et	  al.	  2010).    
  
Another  receptor  type  involved  in  this  project  is  the  astrocytic  PAR-­‐‑1  receptor.  
Protease-­‐‑activated  receptor  is  a  subfamily  of  related  GPCRs  that  are  highly  
expressed  on  platelets  and  are  vital  for  the  process  of  blood  clotting,  as  well  as  
being  involved  in  control  of  vascular  tone,  immune  response  (T-­‐‑cells)  and  many  
other.  Activation  of  PAR-­‐‑1  receptors  propagate  signals  via  many  G-­‐‑proteins,  
including  Gi,  Gq,  and  G12/13  and  can  lead  to  profound  consequences  in  the  cells,  
such  as  proliferation  (Traynelis	  and	  Trejo	  2007).  In  the  CNS  PAR-­‐‑1  receptors  are  
expressed  in  plural  cell  types,  but  the  highest  expression  was  found  in  glial  cells  (Junge	  et	  al.	  2004).  Activating  astrocytes  via  the  addition  of  agonist  to  PAR-­‐‑1  
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receptor  (e.g.  specific  peptide  agonist  TFLLR)  was  found  to  increase  the  exocytosis  
of  ATP  from  astrocytes,  thus  down-­‐‑regulating  the  inhibitory  synaptic  currents  in  
the  neocortex.    In  essence  this  means  that  by  activating  PAR-­‐‑1  receptors  in  
astrocytes  the  synaptic  plasticity  balance  shifts  towards  potentiation  (Lalo	  et	  al.	  2014).  
  
Having  discussed  several  types  of  channels,  their  similarities  and  differences  in  
structure,  cellular  localization  and  functions,  it  is  clear  that  despite  a  great  deal  of  
research  has  been  carried  out  there  are  still  many  areas  in  which  further  work  is  
needed.  Put  together  with  the  demand  for  more  investigations  into  the  age-­‐‑related  
changes  in  glial  cells,  especially  in  astrocytes,  exploring  the  functions  and  
potential  links  between  these  channels  may  yield  progress  in  the  understanding  of  
the  ageing  process  of  astrocytes.  Since  functions  of  astrocytes  include  
neuroprotection  as  well  as  signaling,  learning  about  the  ways  in  which  astrocytic  
functions  degenerate  with  time,  is  one  of  the  areas  of  neuroscience  where  more  
investigations  should  be  undertaken.    
1.6  Hypothesis    
  
Two  pools  of  astrocytic  functions  were  described  above:  the  signalling  and  
metabolic  functions.  These  functions  are  performed  by  the  same  set  of  glial  cells  
(although  there  likely  are  discrepancies  in  regional  location,  cell  subtypes  and  
subcellular  compartments  involved  in  each  of  the  functions).  An  emerging  field  of  
the  heterogeneity  of  glia  is  focusing  on  these  differences  (Matyash  and  
Kettenmann  2010).  Overall,  it  is  thought  that  a  single  astrocyte  should  be  able  to  
carry  out  multiple  functions  simultaneously  within  its  domain  (Bushong  et  al.  
2002).  It  is  therefore  possible  that  a  mechanism  of  linking  these  two  sets  of  
functions  exists.  Potassium  channels  would  make  a  perfect  candidate  for  this  role,  
due  to  their  abundant  expression  levels  and  involvement  in  both  types  of  
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processes:  Kir4.1  channels  have  been  implicated  in  the  process  of  potassium  
buffering  after  synaptic  activity  and  control  of  osmotic  balance.    
  
Figure  1.6:  A  schematic  of  the  hypothesis.  A  diagram  of  a  single  isolated  astrocytic  soma,  with  
typical  channels  found  displayed  on  the  cell  surface,  depicts  the  hypothesis.  Activation  of  certain  
astrocytic  channels  allows  the  calcium  influx  into  the  cell,  where  the  signal  can  increase  through  
transduction  pathway  via  the  IP3  channels  on  the  ER.  This  can  then  lead  to  a  local  change  in  the  
conductance  of  potassium  channels.  
Firstly,  the  current  densities  of  potassium  currents  in  astrocytes  from  the  
neocortex  were  to  be  determined;  the  changes  in  current  density  or  susceptibility  
to  blockers  during  the  process  of  non-­‐‑pathological  ageing  were  compared  to  those  
obtained  from  young  adult  mice  (to  exclude  developmental  changes).  Astrocytes  
were  isolated  from  the  slice  preparation  to  exclude  the  secondary  network  and  
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neuronal  effects.  Since  activation  of  astrocytes  can  be  achieved  by  overspill  of  
neurotransmitters  in  the  synaptic  and  extra  synaptic  spaces,  some  agonists  of  
iono-­‐‑  and  metabotropic  channels,  expressed  in  astrocytes  were  applied  to  acutely  
isolated  cortical  astrocytes  (see  Methods  and  Materials  chapter  for  details  of  
isolation).  Potassium  currents  before,  during  and  after  the  application  of  these  
agonists  were  measured  and  some  potassium  blockers  were  used  to  determine  
which  potassium  currents  were  affected,  if  any.  It  was  expected  that  activating  an  
astrocyte  would  result  in  the  up-­‐‑regulation  of  the  inwardly  rectifying  potassium  
channel  conductance.  Once  a  relationship,  if  any,  between  the  stimulated  
astrocytic  channels  (in  thus  study  agonists  to  P2X1/5,  NMDARs  and  PAR-­‐‑1  were  
used)  and  the  potassium  current  has  been  established  in  isolated  astrocytes,  it  was  
tested  if  the  same  mechanism  takes  place  in  slices.    Finally,  it  was  investigated  
whether  altering  this  relationship  in  slices  can  affect  one  of  the  astrocytic  functions  
–  control  of  concentration  of  ions  in  the  extracellular  space.  For  this  the  extent  of  
tissue  swelling  under  various  conditions  was  studied  in  young  adult  and  older  
mice,  to  account  for  any  age-­‐‑related  changes.  Some  LTP  (Long  Term  Potentiation)  
experiments  were  conducted  simultaneously  with  LT  (Light  Transmittance)  
experiments  to  test  the  signalling  function  of  astrocytes,  and  if  it  can  also  be  
affected  by  the  same  mechanism.    
  
Overall,  the  aim  of  this  study  was  to  explore  any  potential  links  between  various  
channels  expressed  in  neocortical  astrocytes  as  well  as  finding  out  how  these  links  
can  affect  both  signalling  and  potassium  buffering  functions  of  astrocytes.  
Collecting  these  data  will  help  understanding  the  role  of  astrocytes  and  how  they  
perform  their  roles  in  a  healthy  young  brain  versus  a  non-­‐‑pathologically  ageing  
brain.  Working  with  the  tissue  derived  from  mice  can  provide  an  insight  on  the  
processes  underlying  healthy  cognition  in  humans,  thus  hoping  to  improve  the  
current  understanding  of  normal  brain  functioning  as  well  as  bringing  closer  the  
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time  when  it  is  possible  to  prevent  senility  and  a  myriad  of  age-­‐‑related  conditions  
that  come  as  a  consequence.    
1.7  Nomenclature  statement    
  
In  this  study  the  potassium  channels  were  explored  based  on  their  functionality,  
as  oppose  to  expression.  Therefore,  the  following  jargon  was  used  to  refer  to  
specific  potassium  currents:    
• Generic  or  total  potassium  current  –  potassium  currents  recorded  upon  the  
stimulation  of  astrocyte  (with  a  series  of  depolarizing  voltage  steps  from  
holding  potential  of  -­‐‑80  mV)  
• Inwardly  rectifying  potassium  current  –  current  recorded  at  -­‐‑130  and  -­‐‑110  
mV  steps  (from  holding  potential  of  -­‐‑50mV),  where  the  dominant  
potassium  current  is  expected  to  be  the  conducted  via  inwardly  rectifying  
potassium  channels  (Kir4.1,  which  are  highly  expressed  in  astrocytes  
(Higashi  et  al.  2001))  
• Steady  state  voltage  gated  potassium  current  or  KD  –  slowly  inactivating  
delayed  rectifying  potassium  current  (Smart,  Bosma,  and  Tempel  1997)    
• Rapidly  inactivating  or  KA  current  –  transient  outward  potassium  current  
(Gordon,  Kocsis,  and  Waxman  1988)  
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Chapter  2:  Materials  and  Methods  
2.1  Solutions  and  Drugs  used  in  the  project  
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clamping  experiments.    
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40  µμM   Non-­‐‑specific  voltage-­‐‑




Αβ-­‐‑Methylene   10  µμM   Specific  P2X1  and  P2X3   Sigma  Aldrich  
                                                                                                 
1  See  Chapter  2.4  Vibrodissociation  










10  µμM   P2  receptors  agonist   Sigma  Aldrich  
biochemical  
(Dorset,  UK)  
























10  µμM   PAR-­‐‑1  selective  agonist   Tocris  
Bioscience  
(Bristol,  UK)  
Table  1:  Solutions  and  drugs  used  in  the  project.  
2.2  Animals    
  
Animal  work  was  approved  by  AWERB  and  carried  out  in  accordance  with  UK  
legislation  and  adhering  to  the  ‘3R  strategy’’.  Animals  used  were  GFAP-­‐‑EGFP+/+  
(Nolte  et  al.  2001)  and  their  littermates,  kept  in  Standard  Housing  conditions  
(1989).  Mice  were  divided  into  4  groups  based  on  their  age:    
  
Group  I   1-­‐‑3  months  PN  (Post  Natal)  
Group  II   6-­‐‑9  months  PN  
Group  III   9-­‐‑12  months  PN  
Group  IV   12-­‐‑24  months  PN  
  
The  groups  refer  to  these  ages  unless  otherwise  stated.    
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2.3  Slice  preparation  
  
Mice  were  anaesthetised  with  sufficient  IsoFluorane  to  induce  unconsciousness,  
followed  by  cardiac  arrest  and  death  (Schedule  1  procedure)(1989).  Upon  the  
confirmation  of  death  the  animals  were  decapitated  and  the  brain  was  removed  
rapidly  (typically  in  under  1  minute),  and  placed  in  the  ice-­‐‑cold  aCSF  (see  Table  1  
for  solution  details)  in  the  vibratome  chamber  for  slicing.  Coronal  slices  of  300  µμm  
thicknesses  were  cut  from  the  somato-­‐‑sensory  cortex  and  placed  into  recovery  
chamber  with  aCSF  gassed  with  95%  O2  and  5%  CO2  at  room  temperature  for  2-­‐‑2.5  
hours  to  recover  prior  to  the  experiments.    
2.4  Vibrodissociation  
  
For  experiments  with  isolated  astrocytes  and  neurons  a  technique  called  
vibrodissociation  (Vorobjev  1991)  was  used.  A  micro  capillary  ending  with  glass  
ball  200  µμm  in  diameter  was  moved  across  the  surface  of  the  neocortical  slice,  
vibrating  at  100  Hz  (lateral  displacement  20-­‐‑30  µμm).  This  process  mechanically  
dissociates  the  cells  out  of  the  slice,  leaving  them  viable.  The  benefit  of  using  this  
technique  compared  to  enzymatic  restriction  is  that  vibrodissociation  does  not  
cause  any  chemical  changes  to  the  cell  membranes,  leaving  them  intact.  This  
method  is  therefore  an  effective  tool  for  studying  cellular  mechanisms  in  the  brain  
by  taking  integral  cells  out  of  the  slice.  Figure  2.1  illustrates  the  set  up  of  the  
vibrodissociation  technique.  The  vibrating  ball  was  moved  across  the  slice  over  
layers  II/III  of  somatosensory  cortex  multiple  times  to  increase  the  number  of  
dissociated  cells.  The  slices  were  discarded  after  about  5  minutes  of  
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vibrodissociation.  
  
Figure  2.1:  Acute  vibrodissociation  set  up.  A  –  Microscope  and  micro  capillary  with  a  vibrating  
glass  ball  on  the  end,  B  -­‐‑  the  view  through  the  objective  (20X  magnification)  of  the  coronal  slice  
with  typical  position  of  glass  ball.  Scale  bar,  1  mm.    
2.5  Whole-­‐‑cell  patch  clamping  isolated  cells  
  
The  preparation  of  isolated  cells  was  kept  in  the  recording  chamber  for  the  cells  to  
settle  to  the  bottom  of  the  recording  chamber,  where  they  adhere  to  the  glass  
surface.  Unhealthy  cells  float  and  therefore  are  lost  during  the  perfusion.  
Electrophysiological  recordings  were  made  from  isolated  cells  suspended  in  the  
New  Ringer  solution  being  perfused  through  the  bath  chamber  (see  Figure  1  for  
composition)  at  1.5-­‐‑2  ml/min.  Patch  pipette  were  made  of  borosilicate  glass  
capillaries  of  1.5  mm  diameter  (World  Precision  Instruments,  USA),  pulled  with  a  
laser  micro  pipette  puller  (Sutton  Instrument  P-­‐‑2000).  Pipettes  were  differential  
sizes  for  neurons  (4-­‐‑5  MΩ)  and  astrocytes  (6-­‐‑8  MΩ)  and  filled  with  intracellular  
solution  (see  Figure  1  for  solution  composition).  The  AxoPatch200B  patch-­‐‑clamp  
amplifier  (Axon  Instruments,  USA)  was  used  to  observe  the  currents  and  those  
were  filtered  at  2  kHz  and  digitized  at  4  kHz.  To  control  the  experiments  the  data  
acquisition  board  PCI-­‐‑6229  (NI,  USA)  was  used.  Cells  with  input  resistance  of  500-­‐‑
A B  
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1100  MΩ  and  50-­‐‑150  MΩ  for  neurons  and  astrocytes  respectively,  with  less  than  
20%  variation  throughout  recordings,  were  used  for  the  analysis  (Pankratov  et  al.  
2007;  Pankratov  et  al.  2009).    
2.5.1  Cell  identification:  astrocytes  vs  neurons  
  
Astrocytes  and  neurons  were  distinguished  by  their  corresponding  morphology  
and  input  resistances.  Figure  2.2  shows  examples  of  the  typical  morphologies  
displayed  by  astrocytes  and  neurons  (A  and  B  respectively)  and  the  currents  
evoked  from  a  series  of  voltage  steps  (C  and  D).  Morphologically,  the  neuronal  
cell  body  is  much  larger  than  that  of  a  cortical  astrocyte.  Upon  the  isolation  
process  neurons  normally  keep  their  axons  intact,  whereas  astrocytes  tend  to  lose  
their  fine  projections  and  are  left  mostly  with  the  soma.    
  
Electrophysiologically,  the  main  difference  between  neurons  and  astrocytes  is  the  
inward  sodium  current,  which  is  absent  in  astrocytes  (Perea  and  Araque  2010).  
Astrocytes  can  also  be  distinguished  from  oligodendrocytes  for  the  same  reason  –  
oligodendrocytes  display  a  small  inward  sodium  current  (Fields  2008).  Compared  
to  published  data,  the  currents  recorded  in  isolated  astrocytes  are  smaller  than  
reported  values  (Bekar  2004).  This  is  most  likely  due  to  the  loss  of  fine  projections  
that  contain  a  high  number  of  channels,  and  thus  correspond  to  the  overall  
current.  Currents  recorded  from  slices,  however  were  similar  in  size  to  the  
published  values  (Pannicke  et  al.  2000).  
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Figure  2.2:  Isolated  neurones  and  astrocytes  have  distinctive  electrophysiological  and  
morphological  properties.  A-­‐‑  Isolated  astrocyte  (right)  and  neurone  (left),  B  –  typical  I/V  curves  
from  isolated  neurone  (black)  and  astrocyte  (blue),  C  –  typical  currents  of  astrocyte  and  neurones  
in  response  to  depolarising  voltage  steps  from  holding  potential  -­‐‑80  mV,  D  -­‐‑  Inward  sodium  
current  of  an  isolated  neurone.  
2.5.2  Patch  clamping  in  slice  
  
WinFlour  software  (Strathclyde  University,  UK)  was  used  to  record  the  currents  
from  layers  II/III  of  somatosensory  cortical  astrocytes  in  coronal  slices.  A  protocol  
with  9  consecutive  voltage  steps,  from  -­‐‑130  mV  to  +30  mV,  from  a  holding  
potential  of  -­‐‑50  mV,  was  used  to  record  both  the  inwardly  rectifying  potassium  
current,  which  is  most  prominent  at  the  lowest  2-­‐‑3  steps  of  this  protocol  and  the  
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of  current  at  the  highest  voltage  steps  of  this  protocol.  Another  protocol,  with  one  
voltage  step  from  the  holding  potential  of  -­‐‑80  mV  to  -­‐‑70  mV  was  used  for  
calculating  the  capacitance  and  for  controlling  the  health  of  the  patched  cell.  
2.5.3  Patch  clamping  isolated  cells  
  
For  isolated  cells  WinWCP  (Strathclyde  University,  UK)  was  used  to  record  from  
isolated  neurons  and  astrocytes.  Four  protocols  were  used  to  gather  electrical  
currents  from  cells.  
  
Firstly,  to  watch  the  health  of  the  experimental  cell,  a  single  10  mV  step  protocol  
(from  a  holding  potential  of  -­‐‑80  mV  to  -­‐‑70  mV)  was  recorded  throughout  the  
experiment.  The  capacitance  of  the  cell  and  input  resistance  was  calculated  at  the  
start  of  the  experiment.  As  stated  above,  the  cells  with  greater  variation  than  20%  
from  the  normal  range  (50-­‐‑150  MΩ  for  astrocytes  and  500-­‐‑1100  MΩ  for  neurons)  
were  not  used  for  data  analysis.  The  experimental  leak  was  also  estimated  from  
this  protocol;  any  experiments  with  abrupt  leak  changes  were  excluded  from  the  
data  collected.  
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Figure  2.3:  Voltage  protocol  used  in  the  study.  A  –  Protocol  to  record  sodium  current  in  neurones  
and  total  potassium  current  in  astrocytes.  B  –  Protocol  to  record  inwardly  rectifying  potassium  
current.  C  –  Protocol  with  a  pre  step  to  deactivate  inwardly  rectifying  potassium  current  and  
measure  voltage-­‐‑gated  current.    
Figure  2.3  illustrates  structure  of  protocols,  used  to  record  currents  in  this  study.  A  
series  of  voltage  steps  were  used  to  record  sodium  current  in  neurons  were  also  
utilised  to  test  for  the  absence  of  a  sodium  current  in  astrocytes:  the  holding  
potential  was  kept  at  -­‐‑80  mV,  to  keep  the  glial  cell  healthy,  and  12  voltage  steps  
were  recorded  from  -­‐‑70  mV  to  +40  mV.  The  current  recorded  at  the  highest  voltage  
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Thirdly,  a  protocol  that  recorded  both  inwardly  rectifying  and  voltage  gated  
potassium  currents  consisted  of  11  voltage  steps  from  -­‐‑130  mV  to  +70  mV  from  a  
holding  potential  of  -­‐‑50  mV.  At  lowest  voltage  steps  the  majority  of  the  current  is  
conducted  through  the  inwardly  rectifying  potassium  channels,  whereas  the  
highest  voltage  steps  display  mainly  the  voltage  sensitive  potassium  current.  To  
exclude  the  influence  of  the  inwardly  rectifying  potassium  channel,  another  
protocol  with  a  deactivating  pre-­‐‑step  was  devised.  The  holding  potential  was  -­‐‑80  
mV  and  again  12  voltage  steps  were  recorded  from  -­‐‑70  mV  to  +40  mV  but  with  a  -­‐‑
20  mV  pre-­‐‑step.    
2.6  Field  recording    
  
The  fEPSPs  were  measured  in  cortical  slices;  the  recording  electrode  was  placed  in  
layer  2/3  of  the  somatosensory  cortex.  A  thin  walled  glass  pipette  with  resistance  
of  1-­‐‑2  MΩ  was  filled  with  the  same  aCSF  used  for  perfusion  of  brain  slices.  To  
induce  fEPSPs,  the  concentric  bipolar  microelectrode  with  127  µμm  thick  core  
diameter  and  4  µμm  thick  tip  diameter  (World  Precision  Instruments,  USA)  was  
used  as  stimulation.  The  stimulating  electrode  was  placed  atop  layers  IV/V,  
parallel  to  the  recording  electrode.  A  constant  current  stimulator  isolator  (A.M.P.I.  
ISO-­‐‑Flex  Instrumentation  Canada  Inc.)  was  used.  In  order  to  measure  synaptic  
plasticity,  either  LTP  (Long  Term  Potentiation)  or  STP  (Short  Term  Potentiation)  
was  recorded.  Theta  Burst  Stimulation  (TBS)  was  applied  to  the  slice  to  produce  a  
change  in  synaptic  plasticity.  Each  TBS  is  made  of  ten  repetitions  of  High  
Frequency  Stimulation  (HFS)  trains  with  200  ms  intervals  between  bursts;  each  
burst  consisted  of  5  pulses  at  100  Hz.  Different  combinations  of  one,  two  or  five  
TBS  were  applied  to  slices  to  induce  synaptic  plasticity.  Before  the  onset  of  TBS,  a  
control  fEPSPs  were  recorded  for  approximately  10-­‐‑15  minutes  to  establish  a  
steady  baseline  with  stimulation  that  caused  a  response  of  30-­‐‑50%  of  maximal  
intensity.    
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To  analyse  recordings,  the  slope  of  the  post-­‐‑synaptic  component  of  the  fEPSP  was  
calculated  as  a  difference  in  amplitude  between  t1  and  t2  (see  Figure  2.3B).  Slope  
values  were  then  normalised  to  t0  –  the  last  slope  measurement  prior  to  TBS  
stimulation.  Figure  2.4  shows  the  region  of  the  recording  where  the  post-­‐‑synaptic  
slope  was  measured.  The  slopes  were  then  presented  as  percentage  of  baseline  (t0)  
fEPSP.    
  
Figure  2.4:  Slope  analysis  of  a  fEPSP  (panel  A).  Typical  trace  recorded  during  field  recording  
experiments.  Slope  of  post-­‐‑synaptic  component  is  measured  between  points  t1  and  t2,  shown  on  
panel  B;  note  the  artefact  of  the  recording  is  clipped.  
2.7  Light  Transmittance  (LT)  experiments  
  
The  coronal  slices  were  placed  into  the  recording  chamber,  where  they  were  
perfused  at  with  KREBS  aCSF  (see  Table  1  for  details  on  composition)  at  2.5-­‐‑3.5  
ml/min  rate  and  whilst  being  oxygenated  with  95%  O2  and  5%  CO2.  
Simultaneously  with  field  recording,  the  video  frames  of  light  trans  illuminated  
slice  were  obtained  at  0.3  Hz  for  short  experiments  (20  minutes  long)  and  at  0.1  Hz  
for  long  experiments  (20  minutes  with  0.3  Hz  frequency  followed  by  50  minutes  at  
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University,  UK),  whilst  the  corresponding  LT  data  was  analysed  using  ImageJ  
software  (National  Institutes  of  Health,  NIH).    
  
Figure  2.5:  Experimental  set  up  for  LT  experiments.  A  coronal  slice  of  somatosensory  cortex  with  
recording  (box  A)  and  stimulating  (box  B)  electrodes  positioned  in  layers  II/III  and  IV/V,  
respectively.  Box  C  shows  control  region  of  slice,  used  to  monitor  health  of  tissue  and  signal  
quality  of  recordings.  
2.8  Data  analysis  
2.8.1  Whole  cell  recordings  
  
Cells  accepted  for  analysis  had  to  pass  two  criteria:  cell  input  resistance  should  be  
within  the  respective  ranges  and  vary  less  than  by  20%  throughout  the  experiment  
(input  resistance  for  neurons  500-­‐‑1100  MΩ  and  50-­‐‑150  MΩ  for  astrocytes).    
  
Capacitances  of  astrocytes  were  calculated  from  a  10  mV  step  from  holding  
potential  -­‐‑80  mV  to  -­‐‑70  mV  by  multiplying  the  artefact  of  the  recording  by  the  
τ(decay).  Since  the  soma  of  the  astrocytic  cell  is  close  to  round  in  shape,  and  
following  vibrodissociation  the  cell  body  takes  up  a  more  round  form,  this  was  a  




         48  
close  approximation  to  the  true  size  of  the  cell  patched.  Current  densities  of  
astrocytes  were  also  calculated  for  different  age  groups  to  look  for  any  potential  
changes  that  take  place  in  cortical  astrocytes  during  the  process  of  ageing.  These  
results  can  be  found  in  Chapter  3.    
  
To  find  the  effect  of  the  drugs  a  ratio  was  calculated,  where  the  current  under  the  
drug  application  was  divided  by  the  average  of  current  in  control  and  washout  
parts  of  recording.  The  same  process  was  undertaken  for  all  drugs  used.  For  
experiments  where  potassium  current  blockers  were  added  prior  to  the  
application  of  the  drug,  the  average  between  the  currents  measured  under  the  
blocker  and  after  the  washout  of  the  drug  (still  under  the  influence  of  the  
potassium  current  blocker)  was  used  as  control  for  analysis.  Examples  of  
representative  recordings  with  three  currents:  control,  current  under  the  
application  of  the  drug  and  the  washout  current,  were  constructed  as  well  as  
single  ratios  of  currents  (described  above)  plotted  as  bar  charts.  This  was  done  for  
every  experimental  condition  to  build  a  full  representative  illustration  of  the  data  
gathered  throughout  the  project.    
2.8.2  Field  recording  
  
In  order  to  analyze  synaptic  plasticity,  alterations  in  the  slope  of  the  fEPSPs  were  
compared  throughout  the  recording.  To  compare  the  changes  in  the  slope  of  the  
fEPSP,  a  time  zero  (T0)  was  defined  as  the  last  point  before  the  TBS  was  given  to  
the  slice.  The  average  current  from  T-­‐‑5–T0  was  used  as  100%  value  against  which  
the  consecutive  fEPSPs  were  measured.  Figure  2.5  illustrates  a  typical  fEPSP  
recorded  in  the  coronal  slice  with  stimulation  located  in  layer  IV/V  and  post-­‐‑
synaptic  response  recorded  in  layer  II/III  of  the  somatosensory  cortex.  As  stated  
above,  STP  and  LTP  were  calculated  at  20-­‐‑30  and  50-­‐‑60  minutes  respectively.  
Experiments  were  represented  as  both  typical  examples  of  time  courses  and  
average  single  value  for  STP  and/or  LTP  in  bar  charts.    
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2.8.3  Light  Transmittance  (LT)  experiments  
  
Regions  of  interest  (ROI)  were  chosen  to  calculate  any  differences  in  the  light  
transmittance  of  the  brain  slice.  A  typical  selection  of  ROIs  is  shown  on  Figure  2.5:  
one  control  area  to  measure  background  noise,  and  two  ROIs  near  the  recording  
electrode  to  measure  the  change  in  light  transmittance  due  to  activity  of  the  tissue.  
A  time  zero  (T0)  was  defined  as  the  last  time  point  before  the  TBS  was  given  to  the  
slice.  Similarly  to  the  fEPSP  analysis,  the  average  of  5  time  points  before  the  T0  was  
set  as  the  100%  of  the  response.  The  following  points  were  represented  as  Tt/T0  
ratio.  Similarly  to  the  field  recordings,  LT  experiments  were  plotted  against  the  
time  to  show  typical  time  courses  of  the  experiments  and  the  highest  peaks  (ratios  
of  Tt/T0)  during  the  activity  of  the  tissue  were  plotted  in  bar  charts  for  each  of  the  
experimental  conditions.    
  
All  data  are  presented  as  Mean±SEM  unless  otherwise  stated.  
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Chapter  3  –  Age  differences  in  astrocytes  
Electrophysiological  characteristics  of  cortical  astrocytes  with  specific  focus  on  
Potassium  currents  
  
3.1  Aim  and  hypothesis  of  the  chapter  
  
The  aim  of  this  part  of  the  project  was  to  gain  an  insight  into  the  
electrophysiological  changes  that  occur  in  astrocytes  with  age.  There  are  
multitudes  of  subtypes  of  glial  cells  in  the  brain,  all  with  their  specific  
electrophysiological  characteristics  and  functions  (Matyash  and  Kettenmann  2010;  
Rose  and  Kirchhoff  2015;  Oberheim,  Goldman,  and  Nedergaard  2011).  It  is  
therefore  vital  to  study  the  individual  types  of  astrocytes,  to  avoid  the  differences  
in  subtypes  of  glial  cells  in  the  brain  based  on  their  location  (in  this  case  layer  II/III  
of  somatosensory  cortex).  Cortical  astrocytes  were  chosen  because  of  their  
abundance  and  well-­‐‑studied  functions:  participating  in  the  plasticity  of  the  brain  
as  well  as  keeping  certain  metabolic  characteristics  constant  (Kimelberg  and  
Nedergaard  2010).    
  
To  find  out  if  there  is  any  electrophysiological  differences  between  the  young  
adult  mice  of  group  I  (1-­‐‑3  months  postnatal).    This  includes  comparing  the  size  of  
the  cell  bodies  of  astrocytes,  the  current  densities  for  total  potassium  current,  
inwardly  rectifying  and  voltage-­‐‑gated  potassium  currents;  and  the  proportions  of  
the  current  that  is  blocked  by  the  addition  of  specific  potassium  current  blockers:  
4-­‐‑aminopyridine  (4-­‐‑AP)  and  barium  (Ba).  Two  methods  were  used  for  this  latter  
test:  a  combined  effect  of  addition  both  of  the  blockers  and  addition  of  the  
blockers  separately  in  different  experiments.  The  null  hypothesis  was  that  there  is  
no  difference  between  any  of  the  above-­‐‑mentioned  characteristics  of  the  
astrocytes  in  groups  I  and  III  (1-­‐‑3  and  9-­‐‑12  months  postnatal).  If  the  null  
hypothesis  was  correct,  the  conclusion  to  follow  should  be  that  the  age  introduces  
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no  change  in  the  electrophysiological  properties  of  cortical  astrocytes  in  the  
somatosensory  cortex  of  mice.    
3.2  Capacitance  of  cortical  astrocytes  
  
The  capacitances  of  the  astrocytes  were  calculated  from  the  tau  decay  (Τdec)  and  
the  artefact  height  of  the  +10  mV  step  from  holding  potential  of  -­‐‑80  mV.  This  is  a  
characteristic,  proportional  to  the  size  of  the  spherical  cell  body  of  the  astrocytes,  
that  remains  after  the  Vibrodissociation  process  (see  Methods  chapter  for  details)  
(Vorobjev  1991).  It  is  assumed  that  proportion  of  cellular  extensions  lost  during  
the  dissociation  process  is  similar  in  both  Group  I  and  Group  III  and  that  
therefore,  the  isolation  method  does  not  introduce  any  differences  in  cell  size.    
  
Capacitances  were  plotted  for  young  adult  and  old  mice,  as  distributions  and  
linear  regression  of  capacitances  and  current  density,  as  can  be  seen  on  Figure  3.1  
(panels  B  and  D,  respectively).  There  is  a  clear  right  shift  that  is  consistent  with  
large  sample  size  and  small  error,  which  leads  to  believe  that  there  is  a  tendency  
for  the  capacitance  of  the  cell  to  increase  with  age.  From  the  frequency  distribution  
(see  Figure  3.1)  of  capacitance  it  can  be  seen  that  there  is  a  shift  in  the  distribution  
towards  the  increase  when  comparing  astrocytes  from  old  mice  to  those  of  young  
adult  mice.  This  positive  shift  in  the  capacitances  of  the  astrocytic  cells  with  
regards  to  age  signifies  a  shift  in  the  cell  size.  Since  the  capacitance  is  a  measure  of  
the  ability  to  hold  the  electrical  charge,  in  a  round  body  it  is  proportional  to  the  
size  of  this  body.  Therefore  the  positive  shift  in  the  capacitances  distribution  
displays  the  positive  shift  in  the  cell  body  sizes  of  the  astrocytes  of  old  mice.  Since  
there  is  no  sharp  increase  in  the  numbers  of  cells  with  the  highest  capacitances;  
instead  the  shift  appears  rather  gradual  and  small  changes  appear  on  majority  of  
cells,  not  a  handful  of  extremely  large  cells.  These  data  supports  the  idea  that  
astrocytes  increase  in  size  with  age  (Schipper  1998).  This  could  be  potentially  due  
to  increased  number  of  reactive  astrocytes  in  age  group  III  (9-­‐‑12  months)  that  
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corresponds  with  enhanced  production  of  GFAP  (Hayakawa,  Kato,  and  Araki  
2007).    
  
A  weak  positive  correlation  was  found  between  current  density  and  capacitance  
size  (panel  D,  Figure  3.1).  The  R  numbers  were  0.39  and  0.41  for  groups  I  and  III  
respectively.  This  shows  a  correlation  between  the  size  of  the  capacitance  –  which  
in  itself  is  a  measure  of  volume  of  isolated  astrocytic  soma  and  the  current  density  
that  is  measured  in  each  cell.  An  existing  correlation  allows  some  assumptions  
about  the  size  of  the  cells  to  be  made  from  measuring  the  current  density.  
However,  because  this  correlation  is  weak,  current  density  cannot  substitute  the  
classic  I/V  measurement.  Therefore,  the  data  for  current/voltage  relationship  is  
presented  as  current  and  not  current  density,  thus  providing  a  better  
representation  of  current  measured.    
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Figure  3.1:  Cell  capacitance  significantly  increases  with  age.    A  –  Probability  distribution  of  cell  
capacitances  of  astrocytes  from  young  adult  and  old  mice  (1-­‐‑3  months  and  9-­‐‑12  months  old,  
respectively).  B  –  Relative  distribution  of  cell  capacitances  in  young  (red)  and  old  (purple)  mice.  C-­‐‑  
Representative  isolated  cells  from  group  I  (left)  and  group  III  (right).  D  –  Current/cell  capacitances  
linear  regression  relationships  in  groups  I  and  III  (voltage  step  +30mV).    Cell  capacitances  of  young  
mice  was  significantly  lower  than  old  mice  (p<0.01).  
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3.3  Current  densities  of  cortical  astrocytes    
  
Current  densities  were  calculated  for  young  adult  and  old  mice.  This  was  done  by  
normalising  the  current  evoked  at  +40  mV  from  -­‐‑80  mV  holding  potential,  at  -­‐‑130  
mV  step  from  holding  potential  -­‐‑50  mV  and  +40  mV  from  holding  -­‐‑80  mV  with  a  
deactivating  pre-­‐‑step  of  -­‐‑20  mV  (both  the  steady  state  and  the  rapidly  
desensitizing  potassium  current).  These  current  densities  are  corresponding  to  
total  potassium  current,  inwardly  rectifying  and  steady  state  and  rapidly  
deactivating  voltage-­‐‑dependent  potassium  currents  respectively.  Measuring  the  
current  density  can  help  take  into  the  account  the  size  of  the  astrocytic  cell  body  
and  thus  provides  a  better  electrophysiological  description  of  the  astrocyte.  This  
measurement  can  help  in  investigating  whether  the  astrocytic  cells  experience  and  
increase  or  decrease  in  number  of  potassium  channels  present  on  the  cellular  
membranes,  as  the  mouse  grows  older.  The  limitation  of  this  measurement  is  that  
only  the  channels  present  on  the  membrane  of  the  cell  body  were  measured,  as  
finer  astrocytic  projections  were  lost  during  the  cell  isolation  process.  The  results  
were  differential,  and  are  illustrated  and  described  below.    
3.3.1  Total  potassium  current  densities    
 
To  compare  total  or  combined  potassium  current  produced  by  the  cortical  
astrocytes  in  young  adult  and  old  mice,  a  current  was  evoked  by  a  voltage  step  
from  holding  potential  of  -­‐‑80mV  to  +40  mV,  thus  imitating  a  stimulation  of  the  
glial  cell.  Astrocytes  do  not  exhibit  voltage-­‐‑dependent  sodium  channels  and  
therefore  the  entire  current  that  is  evoked  is  attributed  to  the  opening  of  the  
potassium  channels  present  in  the  surface  of  the  cell  body  of  the  isolated  glial  cell.  
The  findings  below  are  presented  as  current  density,  which  as  explained  above  is  
the  amount  of  current  conducted  per  unit  of  capacitance.  Figure  3.2  shows  the  
distributions  and  the  mean  current  densities  of  two  pools  of  astrocytes:  from  
young  adult  and  old  mice.  It  is  clear  that  there  is  a  shift  to  the  right  from  the  
young  to  old  mice,  with  an  increased  number  of  cells  with  very  high  current  
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densities.  A  handful  of  cells  with  current  densities  of  100  pA/pF  or  above  appear  
in  Group  III  that  were  not  present  in  Group  I.  As  well  as  a  few  cells  with  very  high  
current  densities,  the  proportion  of  cells  with  the  lowest  densities  is  significantly  
diminished  in  the  older  group  of  cells.  Therefore,  not  only  the  clear  shift  for  an  
increased  current  density  at  +40mV  is  apparent  but  also  the  appearance  of  some  
cells  with  very  high  current  densities.  The  cells  with  extremely  high  current  
densities  could  potentially  be  those  astrocytes  that  have  been  activated  and  are  
part  of  the  reactive  gliosis  of  the  brain  –  an  event  that  can  take  place  in  older  brain  
tissue  (Hablitz  et  al.  2000).  The  mean  current  density  almost  doubles  going  from  
young  adult  to  old  mice.    
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Figure  3.2:  Current  density  of  total  potassium  current  decreases  with  age.  A  –  Current/voltage  
relationship  of  cells  from  young  (black)  and  old  (navy)  mice.  B  –  Representative  traces  from  cell  
derived  from  mice  group  I  and  III  (1-­‐‑3  and  9-­‐‑12  months  old,  black  and  navy,  respectively),  
recorded  in  response  to  a  set  of  depolarising  voltage  steps  from  holding  potential  -­‐‑80mV.  The  
average  current  density  was  calculated  to  be  25.9±1.0  pA/pF  and  42.5±3.2  pA/pF  for  astrocytes  from  
young  adult  and  old  mice  respectively.  Two  sample  t  test  showed  that  the  average  current  density  
is  greater  in  the  old  astrocytic  cells  than  in  young  adult  (p=0.1*10⌃-­‐‑6  when  current  densities  for  total  
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3.3.2  Inwardly  rectifying  potassium  current  densities  
  
  In  order  to  compare  the  inwardly  rectifying  potassium  current  of  old  and  young  
adult  astrocytic  cells  of  mice,  the  following  protocol  was  used:  a  series  of  voltage  
steps  from  -­‐‑130  mV  to  +70  mV  with  holding  potential  of  -­‐‑50  mV  was  recorded.  The  
inwardly  rectifying  potassium  current  is  conducted  mainly  through  the  Kir4.1  
potassium  channel  subtype  (Verkhratsky  and  Steinhäuser  2000;  Higashi  et  al.  
2001).  This  subtype  has  an  equilibrium  potential  of  -­‐‑90  mV,  thus  making  the  two  
lowest  voltage  steps,  -­‐‑130  mV  and  -­‐‑110  mV  displays  predominantly  the  current  
conducted  by  Kir  channel  in  astrocytes  (Butt  and  Kalsi  2006).  As  can  be  seen  from  
Figure  3.3,  there  is  no  significant  shift  in  the  distribution  of  the  current  densities  
due  to  age  of  the  animal  used.  Mean  current  density  also  does  not  change  between  
young  adult  and  old  mice.  Thus,  it  can  be  concluded  that  there  is  no  significant  
change  in  the  current  density  of  the  inwardly  rectifying  potassium  current  due  to  
the  process  of  ageing.      
  
Currents  evoked  on  depolarising  voltage  steps  (-­‐‑30  mV  and  above)  show  a  higher  
current  density  in  older  mice.  As  can  be  seen  from  Figure  3.3,  the  current/voltage  
relationship  is  different  between  two  groups.  For  example,  the  mean  current  
density  of  the  +70  mV  step  of  old  mice  is  much  greater  than  that  of  the  young  
adult  mice,  34  pA/pF  against  20  pA/pF.  Since  the  repolarising  voltage  steps  do  not  
display  such  a  pattern,  this  change  therefore  arises  from  other  potassium  channel  
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Figure  3.3:  Current  densities  of  inwardly  rectifying  potassium  current  do  not  change  with  age.    
A  –  Current/voltage  relationships  of  cells  from  young  (black)  and  old  (navy)  mice.  B  –  
Representative  traces  from  cell  derived  from  mice  group  I  and  III  (1-­‐‑3  and  9-­‐‑12  months  old,  black  
and  navy,  respectively),  recorded  in  response  to  a  set  of  repolarising  and  depolarising  voltage  
steps  from  holding  potential  -­‐‑50  mV.  The  two-­‐‑sample  student  t-­‐‑test  found  no  significant  difference  
between  the  current  density  of  the  inwardly  rectifying  potassium  channel  in  young  and  the  old  
astrocytes  (p=0.8).  At  repolarising  voltage  steps  the  difference  between  current  densities  of  young  
and  old  mice  is  significant  (p=4.1*10⌃-­‐‑9).    
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3.3.3  Voltage  gated  potassium  current  densities  
  
A  third  protocol,  with  a  deactivating  pre  step  of  -­‐‑20  mV  was  recorded.  This  was  
done  to  exclude  other  potassium  currents  except  for  the  voltage  gated  potassium  
currents.  The  currents  evoked  had  two  segments:  the  rapidly  desensitizing  
potassium  current,  measured  at  the  start  of  the  recording  and  immediately  after  
the  artefact  (Tokimasa  and  Nishimura  2013);  and  the  steady  state  potassium  
current  (slowly  inactivating  potassium  current),  measured  across  the  second  half  
of  the  evoked  current  (Bordey  and  Sontheimer  1999).  Figure  3.4  below  shows  the  
steady  state  and  rapidly  desensitizing  potassium  current  densities  respectively.  
The  current  densities  for  the  steady  state  potassium  current  display  a  similar  
positive  shift  as  the  total  potassium  currents.  The  proportion  of  cells  with  very  low  
current  density  is  halved  in  the  astrocytes  of  old  mice  when  compared  to  young  
adult  mice.  The  frequency  of  cells  with  higher  current  densities  is  increased  in  the  
old  astrocytes  as  well.  Also  the  mean  current  density  is  higher  by  approximately  
40%  in  old  astrocytic  cells  (96  pA/pF  in  young  adult  astrocytes  compared  to  152  
pA/pF  in  old  astrocytic  cells).    
  
When  the  current  densities  were  calculated  for  the  rapidly  inactivating  part  of  the  
current,  a  different  distribution  was  acquired.  In  astrocytes  of  young  adult  mice  
there  were  very  few  cells  with  the  lowest  current  density,  whereas  in  the  steady  
state  segment  of  the  current  this  was  a  frequent  density.  This  shows  that  overall;  in  
the  young  astrocytes  the  rapidly  desensitizing  potassium  current  displays  greater  
current  density  than  the  steady  state  potassium  current.  There  were  a  higher  
number  of  cells  that  exhibit  a  rather  large  current  density  of  100  pA/pF  and  above  
for  the  rapidly  desensitizing  compared  to  the  steady  state  potassium  current.  
However,  there  is  still  a  clear  shift  for  the  increase  of  the  current  density  for  the  
rapidly  desensitizing  potassium  current  from  the  cortical  astrocytes  from  young  
adult  mice  to  old  mice.  The  number  of  cells  that  have  the  lowest  current  density  
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decreases,  and  the  cells  with  higher  current  densities  become  more  abundant.  The  
mean  current  density  was  calculated  to  be  111pA/pF  for  the  astrocytes  from  young  
adult  mice  and  167  pA/pF  for  the  astrocytes  isolated  from  the  slices  of  old  mice.    
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Figure  3.4:  Current  densities  of  steady  state  and  rapidly  inactivating  voltage  gated  potassium  
current  are  higher  in  astrocytes  isolated  from  old  mice.  A  –  Current/voltage  relationship  in  young  
(black)  and  old  (navy)  astrocytic  cells.  B  –  Representative  traces  from  cell  derived  from  mice  group  
I  and  III  (1-­‐‑3  and  9-­‐‑12  months  old,  black  and  navy,  respectively),  recorded  in  response  to  a  set  of    
depolarising  voltage  steps  from  holding  potential  -­‐‑80  mV  with  a  deactivating  pre-­‐‑step  of  -­‐‑20  mV.  
Young  adult  cells  have  the  average  steady  state  current  density  94.7±6.2  pA/pF  compared  to  the  
average  current  density  151.7±20.9  pA/pF  for  astrocytes  of  old  mice.  Rapidly  inactivating  current  
density  is  110.8±6.1  pA/pF  and  167.5±20.8  pA/pF  for  young  and  old  mice,  respectively.  Two-­‐‑sample  
student  t  test  showed  that  current  densities  are  significantly  greater  in  older  mice  for  both  current  
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3.3.4  Conclusions  for  comparing  capacitances  and  current  densities  of  astrocytes    
 
The  data  presented  above  illustrates  the  difference  in  capacitance  and  current  
densities  of  acutely  isolated  cortical  astrocytes  of  young  mature  and  old  mice.  It  
was  shown  that  the  mean  capacitance  increases  with  age,  thus  complying  with  the  
notion  that  astrocytes  increase  in  size,  but  not  numbers  during  the  process  of  
ageing  (Amenta  et  al.  1998;  Finch  2003).  Total  potassium  current  as  well  as  both  
delayed  rectifier  (also  referred  to  as  steady  state  potassium  current)  and  rapidly  
desensitizing  potassium  current  all  increase  their  respective  current  densities  by  
41%,  37%  and  34%  respectively.  When  measuring  the  current  densities  of  
astrocytes  of  young  adult  and  old  mice,  it  was  found  that  inwardly  rectifying  
potassium  current  it  the  only  subtype  of  potassium  currents  that  does  not  increase  
in  its’  density  with  age.  These  differential  age-­‐‑related  changes  in  the  current  
density  of  potassium  currents  
3.4  Blocking  differential  potassium  currents  with  4-­‐‑aminopyridine  and  
barium  
  
To  investigate  the  average  electrophysiological  profile  of  cortical  astrocytes  a  
number  of  potassium  channel  blockers  was  used;  namely  4-­‐‑aminopyridine  and  
barium,  at  40  and  100  µμM  concentrations  respectively  (Bordey  and  Sontheimer  
1999;  Hibino  et  al.  2010).  Two  methods  were  implemented:  in  some  experiments  
either  of  the  blocker  was  used  and  the  total  amount  of  current  blocked  was  added  
up  from  multiple  recordings,  whereas  in  other  experiments  both  of  the  blockers  
were  used  in  the  same  recording  in  increments.    
  
The  proportions  of  the  total  potassium  current  of  astrocytes  may  change  with  age,  
which  could  give  rise  to  consequent  greater  alterations  or  disturbances  of  the  
astrocytic  function.  Any  alterations  of  the  proportions  of  potassium  current  due  to  
age  demonstrate  the  changes  in  either  the  quantity  or  quality  of  the  potassium  
channel  subtypes.  As  has  already  been  shown,  the  current  densities  of  potassium  
         63  
channel  subtypes  do  indeed  change  as  a  result  of  age,  and  more  importantly  
change  they  change  differentially;  that  leads  to  expectations  of  more  prominent  
changes  in  the  potassium  channel  subtypes  fractions  in  the  total  potassium  current  
measured  in  the  isolated  astrocytes.    
3.4.1  Individual  blockers  for  separate  experiments  
 
Recordings  were  conducted  in  a  following  manner:  for  each  cell  the  control  
current  was  recorded  before  the  addition  of  the  blocker  and  its’  consecutive  
washout.  All  of  the  results  are  presented  as  percentage  ratios  of  the  potassium  
current  inhibited  by  the  addition  of  the  blocker  over  the  average  current  (average  
between  the  control  and  washout  currents).  Similarly  to  current  densities,  multiple  
ratios  were  calculated  for  different  current  subtypes  and  for  multiple  voltage  
steps,  i.e.  two  highest  and  two  lowest  steps  of  the  recording  protocol.    
3.4.1.1  Proportion  of  total  potassium  current  sensitive  to  4-­‐‑aminopyridine  blocker  
in  young  and  old  mice  
  
The  fractions  of  the  potassium  current  in  astrocytes  from  young  adult  and  old  
mice  that  is  susceptible  to  blockage  by  a  non-­‐‑selective  voltage-­‐‑dependent  blocker  
called  4-­‐‑aminopyrimidine  at  40  µμM  was  calculated.  This  blocker  is  widely  used  in  
research  as  an  anti-­‐‑convulsant  as  it  aids  the  generation  of  seizures  in  animal  
models  of  epilepsy  (Avoli  and  Jefferys  2016;  Frenguelli  and  Wall  2016).  This  
blocker  inhibits  both  Kv1.1  and  Kv1.2  potassium  channel  subtypes  at  the  
concentration  used  (Bordey  and  Sontheimer  1999).  By  comparing  the  fractions  of  
the  overall  current  that  can  be  blocked  by  the  bath  addition  of  4-­‐‑aminopyridine  in  
different  age  groups,  one  can  find  out  whether  the  composition  of  the  potassium  
current  produced  by  the  astrocytes  alters  depending  on  age.  The  data  were  
collected  for  all  three  protocols  used  in  the  electrophysiological  recordings  of  
isolated  astrocytes,  and  are  presented  below  as  bar  charts  of  the  current  that  was  
sensitive  to  the  4-­‐‑aminopyridine  block  (as  percentage  of  the  overall  current  of  the  
experiment).    
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Figure  3.5  illustrates  the  proportion  of  total  potassium  current  that  is  sensitive  to  
4-­‐‑aminopyridine.  The  fraction  appears  to  be  fairly  similar  in  lowest  and  highest  
voltage  steps  of  the  recording  protocol;  it  fluctuates  around  the  25  per  cent  mark  
of  the  total  potassium  current,  with  the  lowest  being  23.5  per  cent  and  the  highest  
29.4  per  cent.  When  comparing  the  different  age  groups  to  each  other  there  
appears  to  be  little  difference  between  proportions  of  the  current  that  is  sensitive  
to  this  blocker.  Taken  together  with  the  results  obtained  for  the  current  density  of  
the  total  potassium  current,  it  seems  that  although  the  current  density  of  the  total  
potassium  current  increases  with  age  by  41  per  cent  (for  +40  mV  step  in  this  
protocol  with  holding  potential  -­‐‑80  mV),  the  fraction  of  the  current  that  is  sensitive  
to  voltage-­‐‑gated  potassium  current  blocker  does  not  change.  It  is  therefore  
possible  to  suggest  that  the  increase  in  the  current  density  does  not  take  place  due  
to  voltage-­‐‑gated  potassium  channel  subtypes.    
  
A  similar  result  illustrated  on  Figure  3.6  was  obtained  with  the  second  
experimental  protocol,  which  consisted  of  11  voltage  steps  from  (-­‐‑130  mV  to  +70  
mV)  the  rest  potential  of  -­‐‑50  mV.  The  proportion  of  the  current  blocked  by  4-­‐‑
aminopyridine  was  within  the  range  established  from  the  data  from  the  protocol  
recording  the  total  potassium  current,  i.e.  23.5-­‐‑29.4  per  cent  of  the  total  current  
was  blocked  by  the  addition  of  40  µμM  4-­‐‑aminopyridine.  At  lower  voltage  steps,  
where  the  inwardly  rectifying  potassium  current  is  most  prominent,  there  is  no  
change  in  proportion  of  current  that  is  susceptible  to  4-­‐‑aminopyridine.    
  
Figures  3.7  and  3.8  show  the  fractions  of  the  overall  potassium  current  that  are  
blocked  by  4-­‐‑aminopyridine  in  steady  state  and  rapidly  desensitizing  potassium  
currents  respectively.  The  data  for  both  Figures  was  gathered  in  a  single  protocol,  
with  a  deactivating  -­‐‑20  mV  pre  step  and  a  series  of  voltage  steps  from  holding  
potential  of  -­‐‑80  mV.  None  of  the  voltage  steps  display  a  significant  change  due  to  
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age  in  the  proportion  of  the  potassium  current  that  is  susceptible  to  4-­‐‑
aminopyridine,  as  tested  with  the  two-­‐‑sample  t  test.  However,  in  the  steady  state  
current,  at  high  voltage  steps  there  seems  to  be  a  trend  for  a  decrease  in  the  4-­‐‑
aminopyridine  sensitive  current.    
  
Altogether  the  comparison  of  the  effect  of  4-­‐‑aminopyridine  on  potassium  currents  
in  astrocytes  from  different  age  groups  shows  no  significant  alteration  due  to  age.  
This  means  that  the  functioning  of  the  voltage-­‐‑gated  potassium  currents  remains  
the  same  throughout  the  lifespan  of  mice,  granted  the  lack  of  development  of  any  
pathological  conditions.    
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Figure  3.5:  Fractions  of  the  4-­‐‑AP  sensitive  currents  in  total  potassium  current  do  not  change  with  
age.  The  ratios  of  4-­‐‑AP  sensitive  currents  were  29.3±3.1  and  25.6±2.4  per  cent  of  control  currents  (in  
Group  I  at  -­‐‑70  mV  and  -­‐‑60  mV  voltage  steps)  and  23.7±2.6  and  24.1±2.5  per  cent  (in  Group  III  at  -­‐‑70  
mV  and  -­‐‑60  mV  steps);  two  highest  voltage  steps  of  astrocytes  from  Group  I  show  28.8±5.3  and  
25.4±4.4  per  cent  of  the  current  are  susceptible  to  4-­‐‑aminopyridine;  26.6±5.0  and  25.0±4.3  (Group  
III).  Two-­‐‑sample  t-­‐‑test  showed  no  significant  differences  between  two  age  groups.    
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Figure  3.6:  Fractions  of  the  4-­‐‑AP  sensitive  currents  in  inwardly  rectifying  and  total  potassium  
current  do  not  change  with  age.  The  ratios  of  4-­‐‑AP  sensitive  current  portion  in  inwardly  rectifying  
potassium  current  display  a  trend  towards  decreasing  in  astrocytes  of  old  mice.  For  the  total  
potassium  current  (two  highest  voltage  steps)  the  ratio  of  4-­‐‑AP  sensitive  current  was  20.5±4.1  and  
24.8±5.3  %  in  Group  I  and  19.9±5.0  and  27.0±4.6  per  cent  range  of  total  potassium  current.  At  two  
lowest  voltage  steps  the  ratios  measured  in  young  astrocytes  were  26.6±4.6  and  26.3±4.0,  and  in  
Group  III  the  corresponding  voltage  steps  yielded  26.9±4.5  and  25.8±4.0  per  cent  of  the  control  
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Figure  3.7:  Fractions  of  the  4-­‐‑AP  sensitive  currents  in  steady  state  potassium  current  do  not  
change  with  age.  The  ratios  of  4-­‐‑AP  sensitive  current  portion  in  steady  state  or  delayed  rectifier  
potassium  current  display  a  trend  towards  decreasing  in  astrocytes  of  old  mice.  The  4-­‐‑
aminopyridine  sensitive  current  in  Group  I  were  30.2±4.2,  30.2±3.9,  26.8±4.8  and  20.6±4.6  per  cent  
for  the  voltage  steps  from  -­‐‑70  mV  to  +40  mV.  Group  III  displayed  the  following  proportions  of  
current:  30.6±4.2,  30.2±3.7,  25.5±4.9  and  19.2±4.4  per  cent  of  control  current.  Two-­‐‑sample  t-­‐‑test  
showed  no  significant  differences  between  two  age  groups.  
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Figure  3.8:  Fractions  of  the  4-­‐‑AP  sensitive  currents  in  rapidly  inactivating  potassium  current  do  
not  change  with  age.  The  ratios  of  4-­‐‑AP  sensitive  current  portion  in  rapidly  inactivating  potassium  
current  display  very  little  difference  between  the  two  groups  of  cells.  The  ratios  of  4-­‐‑AP  sensitive  
current  for  Group  I  were  26.8±3.8,  21.4±3.0,  26.8±4.6  and  20.2±4.5  per  cent  of  the  total  potassium  
current.  Group  III  displayed  the  following  proportions  of  4-­‐‑aminopyridine  sensitive  current:  
26.8±3.8,  21.9,  24.2±4.6  and  21.3±4.8  per  cent  for  voltage  steps  in  order  of  increase.  Two-­‐‑sample  t-­‐‑
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3.4.1.2  Proportion  of  total  potassium  current  sensitive  to  Barium  blocker  in  young  
and  old  mice  
 
The  second  blocker  used  was  barium  chloride,  used  at  100  µμM  concentration  to  
block  the  inwardly  rectifying  potassium  current  (Hibino  et  al.  2010).  Inwardly  
rectifying  potassium  current  is  mainly  conducted  via  the  Kir4.1  potassium  channel  
subunit  in  the  glial  cells  (Higashi  et  al.  2001;  Seifert  et  al.  2009).  This  potassium  
current  subtype  helps  astrocytes  carry  out  one  of  their  main  functions:  
homeostatic  control  of  the  concentration  of  potassium  ions  in  the  CSF.  However,  
Kir4.1  channels  are  located  in  highest  density  near  the  areas  of  greatest  K+  
perturbations:  perisynaptic  feet  and  at  the  tripartite  synapses  (Higashi  et  al.  2001).  
During  this  project  the  fraction  of  the  overall  potassium  current  that  is  sensitive  to  
blockage  by  bath  addition  of  barium  chloride  dihydride  was  measured  in  isolated  
astrocytes  form  young  adult  and  old  mice.    
  
For  consistency,  the  effect  of  Barium  was  measure  at  the  same  voltage  steps  as  the  
effect  of  4-­‐‑aminopyridine  for  three  experimental  protocols  used.  Figures  3.9-­‐‑3.12  
present  the  data  collected.  Overall,  it  is  clear  that  the  proportion  of  the  potassium  
current  that  is  conducted  via  barium-­‐‑sensitive  channels  is  approximately  double  
than  that  of  the  4-­‐‑aminopyridine  sensitive  channel  types,  constituting  up  to  40%  of  
the  total  potassium  current.    
  
When  measuring  the  total  potassium  current,  the  proportion  of  the  current  
sensitive  to  block  by  barium  chloride  in  young  adult  mice  is  greater  at  lower  
voltage  steps  than  at  higher,  40  and  42  %  against  33  and  34  %  respectively  (see  
Figure  3.9).  Similarly,  group  III  displays  the  same  pattern  appears:  at  lowest  
voltage  steps  barium  chloride  blocks  30-­‐‑31%  and  only  22-­‐‑23%  at  high  voltage  
steps.  There  is  also  a  tendency  for  decrease  in  the  amount  of  current  blocked  by  
barium  chloride  in  group  III.  However,  the  comparison  of  two  age  groups,  as  
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calculated  by  the  two-­‐‑sample  t  test  shows  that  no  significant  differences  were  
found  between  the  astrocytes  from  young  adult  and  old  mice.  
    
The  second  protocol  was  recorded  to  allow  measuring  the  effect  of  barium  
chloride  on  inwardly  rectifying  potassium  current  separately  (holding  potential  -­‐‑
50  mV  with  11  voltage  steps  from  -­‐‑130  mV  to  +70  mV).  The  ranges  of  the  blocking  
effect  of  barium  chloride  are  45  -­‐‑  46  %  in  lowest  and  34  –  35%  in  highest  voltage  
steps  of  the  protocol  in  young  adult  mice,  whereas  for  astrocytes  from  old  mice  
exhibit  the  19  –  20  %  in  low  and  only  10  -­‐‑12  %  in  high  voltage  steps  (see  Figure  
3.10).  There  is  a  much  greater  proportion  of  the  overall  current  in  young  adult  
astrocytes  that  is  barium-­‐‑sensitive,  than  in  cells  from  old  mice.  These  data  show  
that  when  comparing  Group  I  and  III,  young  astrocytes  display  double  or  even  
more  of  the  current  that  can  be  blocked  by  barium.  
    
The  last  protocol  was  constructed  to  record  only  the  voltage-­‐‑gated  potassium  
currents  (holding  potential  -­‐‑80  mV  with  a  deactivating  pre-­‐‑step  of  -­‐‑20  mV  and  12  
voltage  steps  starting  from  -­‐‑70  up  to  +40  mV).  Overall,  the  amount  of  Barium-­‐‑
sensitive  current  is  much  lower  in  this  dataset,  than  it  is  in  protocols  that  measure  
total  and  inwardly  rectifying  potassium  currents.  When  looking  at  voltage-­‐‑gated  
potassium  current,  a  similar  proportion  of  the  rapidly  desensitizing  and  steady  
state  currents  are  blocked  by  the  bath  addition  of  barium  chloride.  In  the  steady  
state  current  the  ranges  of  the  barium-­‐‑sensitive  currents  are  19  –  21  per  cent  and  14  
–  23  per  cent  in  astrocytes  from  young  adult  and  old  mice  respectively  (see  Figure  
3.11).  Barium  block  appears  to  be  consistent  throughout  the  voltage  steps  and  does  
not  significantly  vary  with  age  (as  measured  using  the  two-­‐‑sample  t  test).  In  the  
rapidly  desensitizing  portion  of  the  current  the  ranges  of  the  Barium  blockage  
were  as  follows  (see  Figure  3.12):  16  -­‐‑19  per  cent  in  young  adult  and  22  –  25  per  
cent  in  astrocytes  from  old  mice.  Similarly  to  the  steady  state  current,  the  effect  of  
Barium  was  universal  across  all  voltage  steps  here,  as  expected  for  a  protocol  that  
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measures  a  single  type  of  potassium  current.  However,  in  astrocytes  from  old  
mice  the  proportion  of  rapidly  desensitizing  potassium  current  that  is  blocked  by  
the  addition  of  barium  chloride  was  higher  than  that  of  the  young  adult  cells,  
although  the  two-­‐‑sample  t  test  showed  no  significant  difference.  This  lack  of  
significance  can  be  explained  by  the  high  error  in  the  experiments  with  the  
astrocytes  from  old  mice.    
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Figure  3.9:  Fractions  of  the  barium  chloride  sensitive  currents  in  total  potassium  current  do  not  
change  with  age.  Proportion  of  the  overall  current  that  is  susceptible  to  Barium  in  young  adult  and  
old  mice  were  40.1±3.5,  41.2±3.0,  32.9±2.5  and  33.9±2.6  and  per  cent  in  young  mice  and  30.0±8.4,  
30.4±6.9,  22.2±5.8  and  21.5±6.9  per  cent  in  old  mice  respectively,  with  higher  fractions  of  the  current  
consistently  blocked  at  lowest  voltage  steps.  The  ratios  of  barium  chloride  -­‐‑  sensitive  current  
portion  in  total  potassium  current  appear  to  be  greater  in  the  first  group  of  astrocytes,  i.e.  
astrocytes  from  young  adult  mice.  
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Figure  3.10:  Fractions  of  the  barium  chloride  sensitive  currents  in  inwardly  rectifying  and  total  
potassium  current  decrease  in  older  mice.  Barium-­‐‑sensitive  currents  in  young  adult  mice  were  
42.8±3.8  and  42.9±3.4  for  inwardly  rectifying  potassium  current.  In  Group  III  the  inwardly  
rectifying  potassium  currents  were  19.3±4.9  and  18.5±7.2  per  cent,  (p=0.003  and  p=0.01  at  -­‐‑130  mV  
and  -­‐‑110  mV  steps  as  calculated  with  two-­‐‑sample  t  test).  At  higher  voltage  steps  barium  chloride  
sensitive  currents  were  34.7±3.0  and  32.8±3.1  in  Group  I  and  in  old  mice  10.0±4.8  and  11.4±5.6  per  
cent  respectively  (p=0.001  and  p=0.007  at  +50  mV  and  +70  mV  as  calculated  with  a  two-­‐‑sample  t  
test).  The  amount  of  Barium-­‐‑sensitive  current  shows  a  clear  decrease  in  Group  III  in  comparison  
with  Group  I.  Two-­‐‑sample  t  test  showed  a  significant  difference  between  young  adult  and  old  
mice;  *  shows  p<0.01  as  calculated  with  two-­‐‑sample  t  test.  
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Figure  3.11:  Fractions  of  the  barium  chloride  sensitive  currents  in  steady  state  potassium  current  
do  not  change  with  age.  The  proportion  of  barium  chloride-­‐‑sensitive  current  in  steady  state  
voltage-­‐‑gated  currents  in  young  adult  mice  was  22.6±2.6,  21.6±2.8,  19.8±2.2  and  21.0±2.2  per  cent  of  
control  current;  in  old  mice  16.7±3.7,  26.0±7.6,  14.5±3.8  and  15.3±3.6  per  cent  of  control.  The  amount  
of  barium-­‐‑sensitive  current  shows  a  small  decrease  in  Group  III  with  the  exception  of  -­‐‑60  mV  
voltage  step.  Two-­‐‑sample  t  test  showed  no  significant  difference  between  young  adult  and  old  
mice.  
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Figure  3.12:  Fractions  of  the  barium  chloride  sensitive  currents  in  rapidly  desensitizing  
potassium  current  do  not  change  with  age.  Rapidly  desensitizing  voltage-­‐‑gated  current  has  a  
Barium-­‐‑sensitive  fraction.  In  young  adult  mice  the  barium-­‐‑sensitive  fractions  were  22.6±2.6,  
21.6±2.8,  19.8±2.2  and  21.0±2.2  per  cent,  and  in  old  mice  16.7±3.7,  26.0±7.6,  14.5±3.8  and  15.3±3.6  per  
cent.    The  amount  of  Barium-­‐‑sensitive  current  shows  a  small  increase  in  Group  III,  however,  the  
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3.4.2  Combined  effect  of  blockers  
 
An  alternative  set  of  data  was  collected,  using  a  mix  of  both  blockers,  in  order  to  
measure  the  effect  of  bath  addition  of  both  4-­‐‑aminopyridine  and  barium  chloride.  
This  was  done  to  investigate  whether  the  individual  blockers  can  affect  more  than  
one  subtype  of  potassium  current  or  if  there  is  any  interference  between  their  
actions  that  can  lead  to  different  results.    
  
Figures  3.13-­‐‑16  below  show  the  combined  effect  of  both  blockers  applied  in  a  
single  experiment.  Similarly  to  data  collection  for  individual  blocker  addition  
experiments,  three  protocols  were  used  for  combined  blocker  effect.  In  young  
adult  mice  the  highest  voltage  steps  exhibit  higher  amount  of  current  blocked  by  
the  addition  of  40  µμM  of  4-­‐‑aminopyridine  and  100  µμM  barium  chloride.  This  is  not  
the  case  in  Group  III,  which  corresponds  to  astrocytes  isolated  from  old  mice.  
Despite  this  trend,  there  is  no  significant  difference  between  the  amounts  of  
current  blocked  at  different  voltage  steps  as  checked  by  the  two-­‐‑sample  t  test.  
Similarly,  when  comparing  the  groups  of  astrocytes  to  each  other,  there  is  a  trend  
for  increased  amount  of  current  that  is  sensitive  to  combined  blockers  effect.  This  
difference  was  not  found  significant  with  a  two-­‐‑sample  t  test  (see  Figure  3.13).    
  
The  second  protocol  illustrates  the  effect  of  the  combined  blockers  addition  on  
inwardly  rectifying  and  total  potassium  currents  (see  Figure  3.14).  Here,  the  
fractions  of  the  total  current  blocked  by  the  addition  of  both  blockers  fell  in  the  38  
–  41.2  per  cent  and  48.6  –  60.8  per  cent  in  astrocytes  from  young  adult  and  old  
mice  respectively.  Group  I  shows  fairly  consistent  effect  on  both  high  and  low  
voltage  steps,  whereas  in  Group  III  the  effect  of  the  addition  of  both  4-­‐‑
aminopyridine  and  barium  chloride  is  clearly  more  prominent  on  high  voltage  
steps  of  the  protocol.  However,  the  difference  between  the  proportions  of  the  
current  blocked  by  two  blockers  at  high  voltage  steps  is  not  significantly  different  
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to  that  of  the  lowest  voltage  steps.  When  comparing  the  results  from  two  groups  
to  each  other,  at  higher  voltage  steps  the  difference  between  young  adult  and  old  
mice  is  significant  with  p<0.01,  unlike  the  results  for  the  lowest  two  voltage  steps.    
  
The  last  protocol  was  used  to  collect  data  for  voltage  gated  potassium  currents:  the  
steady  state  and  the  rapidly  desensitizing  components  of  it.  In  the  steady  state  
part  of  the  current  the  effect  of  the  addition  of  combined  blockers  produces  a  
consistent  effect  throughout  all  voltage  steps:  the  fractions  that  are  blockers-­‐‑
sensitive  reside  in  32.9  –  33.6  per  cent  range  of  the  overall  current  in  young  adult  
mice.  There  is  a  greater  degree  of  variability  in  the  data  for  Group  III:  the  range  of  
the  susceptible  current  is  37.9  –  47.2  per  cent  of  the  total  current.  When  the  results  
for  two  age  groups  were  compared  using  two-­‐‑sample  t  test  that  there  is  no  
significant  differences  between  the  proportion  of  the  current  that  is  inhibited  by  
the  addition  of  both  4-­‐‑aminopyridine  and  barium  chloride.    
  
Rapidly  desensitizing  voltage-­‐‑gated  potassium  currents  were  compared  in  
isolated  astrocytes  from  young  adult  and  old  mice.  Similarly  to  the  steady  state  
current,  astrocytes  in  Group  I  display  a  consistent  amount  of  current  that  is  
inhibited  by  the  addition  of  two  blockers  –  data  fall  into  the  following  range  29.4  –  
32.3  per  cent.  Also  similar  to  the  steady  state  data,  astrocytes  from  Group  III  have  
a  great  range  of  variability:  39.7  –  48.5  per  cent  of  the  total  current.  The  
comparison  of  the  two  age  groups  against  each  other  show  that  there  is  a  trend  for  
the  increase  in  the  proportion  of  current  that  is  sensitive  to  blockers  mix,  however  
the  difference  is  not  significant  on  all  voltage  steps;  two  of  the  voltage  steps,  -­‐‑70  
and  +30  mV,  are  significantly  different  (p<0.01),  whereas  -­‐‑60  mV  and  +40  mV  are  
not  significant  (p>0.01).    
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Figure  3.13:  Fraction  of  current  sensitive  to  combined  blockers  in  total  potassium  current  does  
not  change  with  age.  Proportions  of  the  overall  current  that  is  susceptible  to  both  blockers  in  
young  adult  mice  40.9±5.5,  37.7±4.5,  42.5±5.4  and  43.7±5.4  per  cent  of  control  at  voltage  steps  in  
order  of  increase.  In  Group  III  the  following  fractions  of  current  that  are  sensitive  to  both  blockers  
were  measured:  55.1±8.5,  54.5±9.4,  50.1±8.3  and  51.7±8.0  per  cent  at  respective  voltage  steps.  The  
fraction  of  current  sensitive  to  both  blockers  is  greater  in  group  III,  but  this  difference  is  not  
significant  as  calculated  with  two-­‐‑sample  t  test.  
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Figure  3.14:  Fraction  of  current  sensitive  to  combined  blockers  in  total  and  inwardly  rectifying  
potassium  current  does  not  change  with  age.  Proportions  of  the  overall  current  that  is  susceptible  
to  both  blockers  in  young  adult  mice  were  41.3±5.9,  40.6±6.3,  38.3±6.5  and  37.9±5.9  per  cent  of  
control.  In  Group  III  the  proportions  of  the  respective  voltage  steps  were  50.3±8.5,  48.9±9.8,  61.3±3.4  
and  53.9±5.8  per  cent.  The  fraction  of  current  sensitive  to  both  blockers  is  greater  in  Group  III,  but  
this  difference  is  not  significant  at  lowest  voltage  steps,  where  inwardly  rectifying  potassium  
current  is  the  predominant  current.  At  high  voltage  steps,  however,  the  difference  was  significant  
with  p<0.05  (p=0.01  and  p=0.02  when  comparing  Group  I  and  Group  III  at  +50  and  +70  mV  as  
calculated  with  two-­‐‑sample  t  test).    
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Figure  3.15:  Fraction  of  current  sensitive  to  combined  blockers  in  steady  state  potassium  current  
does  not  change  with  age.  Proportion  of  the  overall  current  that  is  susceptible  to  both  blockers  in  
young  adult  and  old  mice  varies  within  32.9  –  33.6  per  cent  and  37.9  –  47.2  per  cent,  respectively.  
The  fraction  of  current  sensitive  to  both  blockers  is  greater  in  group  III,  but  this  difference  is  not  
significant  with  the  two-­‐‑sample  t  test.  
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Figure  3.16:  Fraction  of  current  sensitive  to  combined  blockers  in  rapidly  desensitizing  
potassium  current  increases  with  age.  Proportion  of  the  overall  current  that  is  susceptible  to  both  
blockers  in  young  adult  and  old  mice  varies  within  29.4  –  32.3  per  cent  and  39.7  –  48.5  per  cent  
respectively.  The  fraction  of  current  sensitive  to  both  blockers  is  greater  in  group  III,  but  this  
difference  is  significant  on  some  of  the  voltage  steps  (-­‐‑70  mV  and  +30  mV),  as  measured  with  the  
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3.5  Conclusions  
  
This  chapter  set  out  to  investigate  the  changes  that  occur  in  electrophysiological  
profiles  of  cortical  astrocytes  from  somatosensory  cortex  during  the  process  of  
non-­‐‑pathological  ageing.  Table  2  summarises  the  results,  covered  in  this  chapter.    
   Potassium  
current    
Change/effect  
in  aged  mice  
Cell  capacitance      ↑  
Current  density   Total   ↑  
   Kir   -­‐‑  
   KD   ↑  
   KA   ↑  
4-­‐‑aminopyridine  block   Total   -­‐‑  
   Kir   -­‐‑  
   KD   -­‐‑  
   KA   -­‐‑  
Barium  chloride  block   Total   -­‐‑  
   Kir   ↓  
   KD   -­‐‑  
   KA   -­‐‑  
Combined  block   Total   -­‐‑  
   Kir   -­‐‑  
   KD   -­‐‑  
   KA   ↑  
Table  2:  Summary  of  effects,  described  in  Chapter  3.      
Firstly,  the  size  of  the  cell  somas  was  compared  between  the  two  age  groups.  It  
was  found  to  be  significantly  greater  in  older  mice.  Since  it  is  known  that  there  is  
an  increase  in  the  GFAP  production  around  the  40  -­‐‑  44  weeks  old  mice  (Amenta  et  
al.  1998)  so  the  increased  capacitance  in  Group  III  was  expected.    Current  densities  
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on  average  were  higher  in  isolated  cells  from  Group  III,  when  measured  with  all  
but  one  electrophysiological  protocol.  The  exceptions  were  the  data  collected  for  
the  lowest  voltage  steps  of  the  protocol  for  recording  inwardly  rectifying  
potassium  currents.  There  was  no  significant  change  in  the  current  density  of  
inwardly  rectifying  potassium  current  between  young  mature  and  old  mice.  It  is  
possible  that  this  lack  of  increase  in  the  current  density  can  lead  to  astrocytes  
being  unable  to  effectively  remove  extracellular  potassium  following  action  
potential  (Rossi  2015;  Finch  2003).  However,  it  can  also  be  a  consequence  of  ageing  
as  opposed  to  a  cause.    
  
The  proportions  of  currents  were  described  by  their  blocker-­‐‑sensitivities.  
Proportion  of  current  sensitive  to  both  4-­‐‑aminopyridine  and  barium  were  
measured  in  separate  experiments  and  some  experiments  were  performed  using  
both  blockers  together.  All  experiments  using  40  µμM  of  4-­‐‑aminopyridine  showed  
no  significant  difference  in  the  proportion  of  the  overall  current  susceptible  to  
blocker  between  young  mature  and  old  mice.  When  taken  together  with  the  data  
collected  for  current  density,  it  can  be  concluded  that  the  since  the  current  density  
rises  but  the  proportion  of  4-­‐‑aminopyridine  sensitive  current  remains  the  same,  
there  is  in  fact  an  increase  in  the  proportion  of  4-­‐‑aminopyridine  sensitive  current  
from  young  mature  to  old  mice.    
  
When  a  blocker  for  inwardly  rectifying  potassium  current  –  barium  chloride,  was  
applied  the  isolated  astrocytes  from  young  mature  mice  showed  a  greater  
inhibition  of  the  total  current  than  astrocyte  isolated  from  old  mice.  The  
proportion  of  the  current  that  was  barium  chloride  -­‐‑  sensitive  at  100  µμM  was  
reduced  by  50  per  cent  or  more.  It  appears  that  the  inwardly  rectifying  potassium  
channels  expression  or  functioning  reduces  with  non-­‐‑pathological  ageing.  These  
data  point  to  similar  processes,  underlying  non-­‐‑pathological  ageing  and  various  
pathological  settings,  for  instance  ischemia-­‐‑like  conditions  (Pannicke  et  al.  2000).  
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However,  this  reduction  was  only  seen  at  the  protocol  aimed  for  recording  the  
inwardly  rectifying  potassium  current;  the  trend  was  similar  in  other  protocols,  
but  high  error  bars  coupled  with  only  a  small  fraction  of  this  current  type  at  other  
protocols.    
  
When  a  cocktail  of  both  blockers  at  the  same  concentrations  was  used,  the  data  
appeared  in  disagreement  with  the  previous  experiments.  The  overall  trend  
displayed  an  increase  in  the  proportion  of  current,  which  was  sensitive  to  both  of  
the  blockers.  Some  of  the  protocols  (namely  the  protocol  for  recording  total  
potassium  current,  negative  voltage  steps  of  protocol  for  recording  the  inwardly  
rectifying  potassium  current  and  protocol  for  recording  the  voltage-­‐‑gated  
potassium  current)  showed  no  significant  difference,  whereas  the  proportion  of  
the  total  current  blocked  by  the  mixture  of  both  blockers  increased  in  some  voltage  
steps,  including  the  most  positive  voltage  steps  in  the  protocol  for  recording  
inwardly  rectifying  potassium  current  and  some  of  the  voltage  steps,  at  which  the  
rapidly  desensitizing  potassium  current  was  measured.  It  also  appeared  that  in  
young  mature  mice  the  proportion  of  the  current  blocked  by  the  addition  of  both  
4-­‐‑aminopyridine  and  barium  chloride  together  was  smaller  than  what  was  
expected  from  the  experiments  where  the  blockers  were  applied  separately.  The  
proportion  of  the  total  current  that  should  be  blocked  by  the  blocker  cocktail  was  
69  per  cent  for  -­‐‑70  mV  (from  holding  potential  -­‐‑80  mV)  but  instead  it  was  only  40  
per  cent.  Therefore  it  is  possible  that  the  simultaneous  blockage  of  multiple  
potassium  channels  leads  to  increased  build  up  of  potassium  ions  inside  the  
patched  cells  and  an  increased  conductance  via  the  leaky  potassium  channel  types,  
unaffected  by  the  blockers  used  (L.  Y.  Kucheryavykh  et  al.  2009;  Zhou  et  al.  2009).    
  
In  conclusion,  it  has  been  shown  that  in  non-­‐‑pathological  ageing  prominent  
changes  in  cortical  astrocyte  take  place.  The  capacitance  of  the  cells  increase,  
showing  that  on  average  astrocytes  increase  in  size,  potentially  signifying  that  the  
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proportion  of  reactive  astrocytes  increases.  Current  densities  of  voltage-­‐‑dependent  
potassium  currents  (total,  KD  and  KA  or  slowly  deactivating  and  rapidly  
desensitizing  potassium  current  types)  increase  with  age,  whereas  the  current  
density  of  inwardly  rectifying  potassium  current  does  not.  The  fractions  of  the  
overall  current  that  are  sensitive  to  4-­‐‑aminopyridine  blocked  (specific  blocker  for  
voltage  gated  potassium  currents  at  the  concentration  used)  (Tse  et  al.  1992).  The  
Barium-­‐‑sensitive  fraction  of  the  current  was  significantly  diminished  in  old  mice.  
These  changes  shift  the  overall  balance  from  the  healthy  state  towards  more  
reactive  and  hyperpolarised  astrocytes,  similar  to  those  brought  about  by  age-­‐‑
related  diseases,  such  as  Alzheimer  disease.    
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Chapter  4  –  Autocrine  current  interactions    
Interaction  of  P2X,  NMDARs  and  PAR  –  1  channels  and  potassium  currents  
of  astrocytes  and  neurons  
4.1  Aim  and  Hypothesis  
  
The  aim  of  this  chapter  was  to  explore  a  potential  link  between  one  or  possibly  
more  channel  types  of  astrocytes  and  the  potassium  currents  and  to  identify  what  
types  of  currents  are  involved,  if  any.  Firstly,  isolated  neurons  and  astrocytes  were  
compared  in  their  responses  to  bath  addition  of  10  µμM  ATP  or  αβ  –  methylene  
ATP  (analogue  of  ATP)  in  the  presence  or  absence  of  intracellular  Calcium.  It  was  
determined  that  neuronal  and  astrocytic  responses  were  different,  thus  limiting  
the  mechanism  in  question  to  astrocytes  only.  Multiple  drugs  were  used  to  
determine  which  channels  are  involved  in  this  mechanism.  Secondly,  the  effect  of  
the  addition  of  10  µμM  αβ  –  methylene  ATP  or  NMDA  under  the  presence  of  
Calcium  chelator  EGTA  was  measured.  As  mentioned  previously,  this  study  
focused  primarily  on  the  functionality  of  the  potassium  currents,  thus  the  
following  jargon  was  used:  total  potassium  current  refers  the  full,  non-­‐‑filtered  
current  conducted  by  the  patched  cell;  inwardly  rectifying  potassium  current  was  
current  measured  at  two  lowest  voltage  steps  (repolarising  step  from  -­‐‑50  mV  of  
holding  potential  to  -­‐‑130  mV  and  -­‐‑110  mV  to  induce  inward  potassium  current).  
Voltage-­‐‑gated  potassium  currents  were  split  by  their  components:  the  steady  state  
(KD)  current,  measured  between  50-­‐‑150  ms  of  voltage  step  stimulation;  the  rapidly  
inactivating  (KA)  potassium  current  refers  to  sharp  peak  at  the  start  of  the  voltage  
step  stimulation.  The  facilitation  effect  on  potassium  currents  was  further  
investigated,  with  the  addition  of  certain  potassium  channel  blockers  to  find  what  
types  of  potassium  channels  may  be  affected.  Lastly,  it  was  tested  whether  this  
effect  takes  place  in  patched  astrocytes  in  slice.  The  null  hypothesis  in  this  chapter  
was  as  follows:  the  bath  addition  of  the  agonists  to  P2X1/5,  NMDARs  and  PAR-­‐‑1  
receptors  should  produce  no  changes  in  the  potassium  current  measured.  The  
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data  are  presented  as  examples  of  typical  currents  and  bar  charts  ±  experimental  
errors.  The  mean  was  calculated  as  follows:    
  
Mean  =  [K+  current  under  the  drug]  /  average  [K+  in  
control  and  washout  conditions]  *100%  
  
Experimental  error  was  calculated  as  SEM  (standard  error  of  mean).  Two  sample  
or  one-­‐‑sample  t  tests  were  used  to  calculate  significance  of  the  experimental  data.      
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4.2  Results    
4.2.1  Effect  of  addition  of  ATP  or  αβ-­‐‑methylene  ATP  on  isolated  neurons    
  
In  order  to  examine  whether  this  mechanism  is  present  in  astrocytes  only,  it  was  
first  tested  on  neurons.  Isolated  neurons  were  patched  (under  the  addition  of  TTX  
to  block  the  sodium  current)  and  their  responses  to  the  addition  of  ATP  or  αβ-­‐‑
methylene  ATP  was  measured  by  recording  a  protocol  where  holding  potential  
was  -­‐‑50  mV  and  a  series  of  voltage  steps  from  -­‐‑130  mV  to  +70  mV  was  measured.    
The  addition  of  ATP  was  done  in  two  different  conditions:  with  or  without  the  
presence  of  intracellular  Calcium  (Cai).  In  the  presence  of  Calcium,  the  
concentration  of  EGTA  used  in  the  patch  pipette  was  0.1  µμM,  which  allows  
fluctuations  of  free  calcium  inside  the  cell.  In  experiments  where  the  patch  pipette  
contained  10  µμM  of  EGTA,  any  unbound  intracellular  calcium  ions  were  chelated  
by  the  EGTA.  This  therefore  disturbed  any  potential  calcium  signals  from  
transducing  from  outside  of  the  cell.  Neither  of  these  conditions  yielded  any  
significant  increase  in  the  potassium  currents  of  isolated  neurons,  with  ATP  
addition  under  the  presence  of  intracellular  Calcium  produced  an  average  of  
97.1±15.3  and  104.5±24.3  per  cent  at  -­‐‑130  and  +70  mV  respectively  (see  figure  4.1).  
The  addition  of  ATP  under  the  10  µμM  of  EGTA  also  did  not  raise  the  current  
significantly  at  either  -­‐‑130  mV  or  +70  mV,  with  average  values  being  94.1±8.7  and  
95±8  per  cent  respectively.    
  
Under  the  addition  of  αβ-­‐‑methylene  ATP  the  potassium  current  also  did  not  
increase,  generating  83.6±5.2  and  96.6±5.4  per  cent  of  the  control  current  in  the  
lowest  and  highest  voltage  steps  of  the  protocol.  The  current  in  the  lowest  voltage  
step  appears  to  diminish  slightly,  however  this  effect  can  be  accounted  for  by  the  
rundown  of  some  of  the  experiments.    
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Overall,  it  was  shown  that  agonists  to  P2X  receptors  were  not  able  to  induce  an  
increase  in  the  potassium  current  of  the  isolated  neurons,  and  therefore  it  was  
concluded  that  they  do  not  have  a  similar  mechanism  to  that  of  astrocytes  for  
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Figure  4.1:  Potassium  currents  in  isolated  neurons  are  not  altered  upon  application  of  P2X  
channel  agonists.  A  –  Representative  traces  of  recordings  (note  the  scale  change),  B  –  Average  I/V  
relationship  graphs  for  all  sets  of  experiments,  C-­‐‑  The  average  effect  of  drug  applications.  Under  
the  absence  of  intracellular  Calcium  (achieved  by  the  addition  of  Calcium  chelator  10  µμM  EGTA  
into  the  patch  pipette)  the  current  under  the  ATP  was  94.1±8.7  and  95±8  per  cent  of  the  control  
current  at  -­‐‑130  and  +70mV  steps  respectively.  The  addition  of  ATP  under  the  presence  of  
intracellular  Calcium  (0.1  µμM  of  EGTA  in  the  patch  pipette),  the  current  recorded  was  97.1±15.3  
and  104.53±24.3  per  cent  of  control  respectively.  It  was  measured  that  the  addition  of  10  µμM  αβ-­‐‑
methylene  ATP  caused  the  current  to  be  85  and  96  per  cent  of  control  in  -­‐‑130  and  +70mV  steps.  The  
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4.2.2  Effect  of  ATP/ATP  under  the  presence  of  barium  chloride  on  isolated  
astrocytes    
  
Similarly  to  neurons,  astrocytes  were  tested  for  a  response  to  a  bath  addition  of  
ATP  0.1  µμM  EGTA.  Astrocytes  were  isolated  using  the  vibrodissociation  technique  
(see  Chapter  2:  Methods  and  Material)  from  slices  of  young  adult  mice  1-­‐‑3  months  
postnatal.  As  can  be  seen  from  Figure  4.2,  unlike  neurons,  astrocytes  have  a  
response  to  the  addition  of  ATP.  At  -­‐‑130  mV  step  the  average  astrocytic  potassium  
current  was  106.4±14.4  per  cent  of  the  control  current.  Student  t  test  showed  that  at  
this  voltage  step  the  application  of  ATP  does  not  significantly  change  the  current  
from  control.  At  -­‐‑130  mV  step  the  conductance  is  dominated  by  inwardly  
rectifying  potassium  current.  Therefore  it  appears  that  the  inwardly  rectifying  
potassium  current  is  unaffected  by  the  addition  of  ATP  extracellularly.  When  
comparing  this  result  with  the  data  collected  for  the  same  voltage  step  but  under  
the  influence  of  barium  chloride  blocker,  there  is  a  slight  increase  in  the  effect  of  
ATP  addition.  The  mean  current  ratio  reaches  109.7±2.8  per  cent  of  control  current  
when  the  ATP  is  added  after  the  addition  of  barium  chloride  extracellularly.  Since  
barium  chloride  is  a  specific  blocker  for  inwardly  rectifying  potassium  current,  it  
shows  that  when  the  inwardly  rectifying  potassium  current  is  removed  from  the  
overall  potassium  current,  the  extracellular  addition  of  ATP  increases  the  current  
by  9.6±12.5  per  cent.  However,  the  one  sample  t  test  used  determined  that  at  -­‐‑
130mV  the  addition  of  ATP  under  the  influence  of  barium  chloride  does  not  cause  
a  significantly  different  current  (p=0.05).      
  
At  high  voltage  step  (+30mV  shown  on  Figure  4.2)  the  majority  of  the  current  is  
conducted  via  the  voltage  gated  potassium  channels.  The  addition  of  ATP  
produced  a  9.8±12.5  per  cent  increase,  compared  to  the  control  current,  thus  not  
increasing  the  current  by  a  significant  amount,  as  calculated  by  the  student  t  test.  
However,  when  barium  chloride  was  applied  prior  to  bath  addition  of  ATP,  the  
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current  recorded  was  23.5±12.8  per  cent  higher  than  the  control  current,  and  this  
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Figure  4.2:  Application  of  ATP  on  isolated  astrocytes  increases  the  outward  potassium  
conductance.  A  –  Representative  traces  of  recordings,  B  –  Average  I/V  relationship  graphs,  C-­‐‑  The  
average  effect  of  drug  applications.  The  changes  in  potassium  currents  upon  activation  with  10  µμM  
ATP  and  ATP  under  the  presence  of  100  µμM  barium  chloride  were  measured.  The  average  current  
recorded  from  isolated  astrocytes  under  the  10  µμM  ATP  was  106.4±14.4  and  109.7±2.8  per  cent  of  
the  control  current  at  -­‐‑130  and  +70mV  steps  respectively.  The  addition  of  ATP  under  the  presence  
of  inwardly  rectifying  potassium  current  blocker  barium  chloride  yielded  a  mean  current  of  
109.8±12.5  and  123.5±12.8  per  cent  of  control  current  at  -­‐‑130mV  and  +30mV  steps  respectively.  It  
was  measured  that  the  addition  of  10  µμM  ATP  under  the  presence  and  absence  of  barium  chloride  
caused  a  significant  difference  at  +30mV  (p=0.006  and  p=0.04  respectively),  but  not  at  -­‐‑130mV  step;  
**  shows  p<0.01,  *  shows  p<0.05  as  measured  with  one-­‐‑sample  t  test.    
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4.2.3  Effect  of  addition  of  αβ-­‐‑methylene  ATP  to  isolated  astrocytes  under  the  
presence  or  absence  of  intracellular  Calcium  
 
In  order  to  investigate  the  nature  of  this  mechanism,  it  was  decided  to  test  
whether  this  mechanism  is  Ca-­‐‑dependent.  Calcium  signalling  is  the  major  type  of  
signal  transduction  in  astrocytes  (Corner-­‐‑Bell  et  al.  1990).  Two  conditions  were  
used:  with  low  (0.1  µμM)  and  high  (10  µμM)  EGTA  concentrations.  If  removing  
intracellular  Calcium  ions  blocks  this  facilitation  of  potassium  current,  then  
calcium  can  the  link  between  the  P2X  and  potassium  channels.  Three  protocols  
were  recorded.    
  
Firstly,  total  potassium  currents  were  measured  by  a  series  of  voltage  steps  from  -­‐‑
70  to  +40  mV  from  holding  potential  of  -­‐‑80  mV.  Figure  4.3  illustrates  the  typical  
currents  recorded  with  this  protocol  for  the  +40  mV  voltage  step  as  well  as  the  
average  current  ratios  ±  SEM.  Under  the  presence  of  intracellular  Calcium  ions  the  
facilitation  of  the  current  upon  the  addition  of  αβ-­‐‑methylene  ATP  is  
approximately  20%.  A  mean  increase  in  current  was  15.9±3.7  and  21.8±4.7  per  cent  
compared  to  the  control  current  in  -­‐‑70  mV  and  +40  mV  respectively.  When  a  high  
concentration  of  EGTA  (10  µμM)  was  used  in  the  patch  pipette,  there  was  no  
increase  in  the  current  when  the  drug  was  added  to  the  chamber.  Instead  the  
experimental  currents  were  92.2±3.9  and  91.2±4.7  per  cent  of  control  at  -­‐‑70  and  +40  
mV  respectively.  A  two-­‐‑sample  t  test  was  utilised  to  assess  whether  the  change  in  
the  current  was  significant:  for  experiments  with  intracellular  calcium  both  
voltage  steps  produced  a  significant  change  in  the  current  with  p<0.01.    
  
To  test  the  inwardly  rectifying  potassium  channel,  the  second  protocol  was  
recorded:  with  holding  potential  of  -­‐‑50  mV  and  11  voltage  steps  from  -­‐‑130  mV  to  
+70  mV.  At  the  lowest  two  voltage  steps  the  predominant  current  type  is  inwardly  
rectifying  potassium  current.  Figure  4.4  shows  the  data  for  this  protocol.  At  -­‐‑130  
mV  voltage  step  the  ratio  of  current  was  104.8±3.0  and  97.7±3.9  per  cent  under  the  
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presence  and  absence  of  intracellular  Calcium  ions  respectively.  There  is  a  slight  
increase  in  the  presence  of  Calcium,  however  it  is  not  significant.  The  inwardly  
rectifying  potassium  current  does  not  increase  with  the  addition  of  extracellular  
αβ-­‐‑methylene  ATP.  The  effect  on  high  voltage  step  is  different:  the  current  under  
the  drug  application  is  116.7±3.7  under  0.1  µμM  EGTA  and  91.2±4.7  per  cent  of  the  
control  current.    
  
Third  protocol  was  recorded  with  a  deactivating  pre  step  of  -­‐‑20mV  and  12  voltage  
steps  from  -­‐‑70mV  to  +40  mV.  Two  current  components  were  considered  
separately:  the  steady  state  and  the  rapidly  desensitizing  currents  (Figures  4.5).  
Under  the  low  concentration  of  EGTA  the  current  was  118.8±3.7  and  116.9±4.8  per  
cent  of  the  control  current  at  -­‐‑70  and  +40  mV  respectively.  Both  display  a  
significantly  greater  current  than  the  control,  as  tested  with  the  one-­‐‑sample  t  test.  
When  high  concentration  of  EGTA  was  used  for  patching  pipette,  the  
experimental  currents  were  92.2±6.0  and  96.7±4.1  per  cent  of  the  control  current.  
Removing  intracellular  Calcium  ions  abolishes  this  facilitation  effect  from  the  bath  
application  of  αβ-­‐‑methylene  ATP.    
  
Similar  results  were  obtained  for  the  rapidly  desensitizing  voltage  gated  
potassium  current  (Figure  4.5).  Under  low  concentration  of  EGTA  the  
experimental  currents  were  111.9±3.2  and  112.6±2.6  per  cent  of  the  control  current  
at  -­‐‑70  and  +40mV.  Both  ratios  are  significantly  higher  than  control  currents.  When  
the  Calcium  chelator  is  present  in  high  concentration  this  effect  is  negated,  
producing  only  90.9±6.2  and  93.9±3.8  per  cent  of  the  control  current.    
  
Taken  together  these  data  clearly  suggest  that  there  is  a  facilitation  effect  on  the  
potassium  current  that  appears  following  the  application  of  10  µμM  of  αβ-­‐‑
methylene  ATP.  It  ranges  from  a  modest  111.9±3.2  to  121.8±4.7  per  cent  when  
compared  to  control  current.  This  effect  is  prominent  on  all  voltage  steps,  except  
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those  where  inwardly  rectifying  potassium  is  the  predominant  current  subtype.  
The  addition  of  high  EGTA  to  the  patch  pipette  completely  abolishes  this  increase,  
and  even  lowers  the  current  by  3  –  13  per  cent  of  control  current.      
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Figure  4.3:  Total  potassium  current  is  facilitated  by  αβ-­‐‑methylene  ATP.  A  –  Representative  traces  
of  recordings,  B  –  Average  I/V  relationship  graphs,  C  -­‐‑  The  average  effect  of  drug  applications.  The  
changes  in  potassium  currents  upon  activation  with  10  µμM  αβ-­‐‑methylene  ATP  in  cells  with  0.1  µμM  
of  EGTA  and  10  µμM  EGTA  in  the  patch  pipette  were  measured.  The  average  current  recorded  from  
isolated  astrocytes  activated  by  10  µμM  αβ-­‐‑methylene  ATP  in  the  presence  of  intracellular  Calcium  
was  115.9±3.7  and  121.8±4.7  per  cent  of  the  control  current  at  -­‐‑70  and  +40  mV  steps  respectively.  As  
calculated  with  one-­‐‑sample  t  test  the  effect  of  the  addition  the  analogue  of  ATP  is  significantly  
different  from  the  control  current  (p=0.0004  and  p=0.00007  as  calculated  with  one-­‐‑sample  t  test).  
The  addition  of  αβ-­‐‑methylene  ATP  under  the  presence  of  Calcium  chelator  EGTA  yielded  a  mean  
current  of  92.2±3.9  and  91.2±4.7  per  cent  of  control  current  at  -­‐‑70mV  and  +40mV  steps  respectively,  
failing  to  increase  the  potassium  current;  **  shows  p<0.01  with  two-­‐‑sample  t  test  (comparing  
current  ratios  under  high  and  low  EGTA  concentrations).  Note  scale  change.    
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Figure  4.2:  Inwardly  rectifying  potassium  current  is  not  facilitated  by  αβ-­‐‑methylene  ATP  in  the  
presence  or  absence  of  intracellular  Calcium.  A  –  Representative  traces  of  recordings,  B  –  Average  
I/V  relationship  graphs,  C  -­‐‑  The  average  effect  of  drug  applications.  The  changes  in  potassium  
currents  upon  addition  of  10  µμM  αβ-­‐‑methylene  ATP  in  cells  with  0.1  µμM  of  EGTA  and  10  µμM  
EGTA  in  the  patch  pipette  were  measured.  The  average  current  recorded  from  isolated  astrocytes  
activated  by  10  µμM  αβ-­‐‑methylene  ATP  in  the  presence  of  intracellular  Calcium  was  104.8±3  and  
116.7±3.7  per  cent  of  the  control  current  at  -­‐‑130  and  +70  mV  steps  respectively.  As  calculated  with  
one-­‐‑sample  t  test,  the  effect  of  the  addition  of  the  analogue  of  ATP  was  significant  at  high  voltage  
steps  (p=0.0002),  but  not  at  -­‐‑130mV,  where  the  inwardly  rectifying  potassium  channel  dominates  
the  current.  The  addition  of  αβ-­‐‑methylene  ATP  under  the  presence  of  Calcium  chelator  EGTA  
yielded  a  mean  current  of  97.7±3.9  and  91.2±4.7  per  cent  of  control  current  at  -­‐‑130mV  and  +70mV  
steps  respectively,  failing  to  increase  the  potassium  current;  **  shows  p<0.01  with  two-­‐‑sample  t  test  
(p=0.0002,  comparing  current  ratios  under  high  and  low  EGTA  concentrations).  Note  scale  change.  
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Figure  4.3:  Steady  state  (KD)  and  rapidly  inactivating  (KA)  potassium  currents  is  facilitated  by  
αβ-­‐‑methylene  ATP  in  the  presence  of  intracellular  Ca2+.  A  –  Representative  traces  of  recordings,  B  
–  Average  I/V  relationship  graphs,  C  -­‐‑  The  average  effect  of  drug  applications.  The  changes  in  
potassium  currents  upon  addition  of  10  µμM  αβ-­‐‑methylene  ATP  in  cells  with  0.1  µμM  of  EGTA  and  
10  µμM  EGTA  in  the  patch  pipette  were  measured.  The  average  current  recorded  from  isolated  
astrocytes  activated  by  10  µμM  αβ-­‐‑methylene  ATP  in  the  presence  of  intracellular  Calcium  was  
118.8±3.7  and  116.9±4.8  per  cent  (steady  state)  and  111.9±3.2  and  112.6±2.6  per  cent  (rapidly  
inactivating)  of  the  control  current  at  -­‐‑70  and  +40  mV  steps  respectively.  As  calculated  with  one-­‐‑
sample  t  test  both  the  steady  state  and  rapidly  inactivating  currents  under  the  addition  of  the  
analogue  of  ATP  are  significantly  greater  than  the  control  under  the  presence  of  intracellular  
Calcium  (steady  state:  p=0.00008  and  p=0.0007  at  low  and  high  voltage  steps;  rapidly  inactivating:  
p=  0.01  and  p=0.002  respectively).  **  shows  p<0.05  with  two-­‐‑sample  t  test  (p=  0.001  and  p=0.002,  
comparing  current  ratios  under  high  and  low  EGTA  concentrations).  Note  scale  change.  
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4.2.4  Effect  of  addition  of  NMDA  under  the  presence  or  absence  of  intracellular  
Calcium  in  isolated  astrocytes  
 
It  was  determined  that  there  was  a  facilitation  effect  on  the  potassium  current  
upon  the  bath  addition  of  10  µμM  of  αβ-­‐‑methylene  ATP.  This  effect  was  found  to  
be  Ca-­‐‑dependent,  since  it  was  abolished  by  the  removal  of  intracellular  Calcium  
by  10  µμM  EGTA.  It  was  decided  to  test  whether  more  than  one  channel  type  can  
be  used  for  this  Calcium  influx  into  the  astrocytic  cell.  Since  NMDA  receptors  in  
glial  cells  are  permeable  to  Calcium,  it  was  hypothesised  that  activating  NMDARs  
should  elicit  the  same  effect  as  the  activation  of  P2X  receptors.    
  
To  activate  NMDARs  10  µμM  of  N-­‐‑methyl-­‐‑D-­‐‑aspartate  (NMDA)  was  applied  to  the  
recording  chamber.  Two  conditions  were  used:  under  the  presence  of  intracellular  
Calcium  ions,  and  in  their  absence.  Different  concentrations  of  Calcium  chelator  
EGTA,  0.1  and  10  µμM  were  used  to  make  up  the  respective  conditions.  In  parallel  
with  the  αβ-­‐‑methylene  ATP  experiments,  three  protocols  were  recorded  to  review  
the  effect  of  the  addition  of  NMDA  on  different  subtypes  of  potassium  currents.  
Figures  7-­‐‑10  show  the  data  collected  for  these  experiments:  typical  experimental  
currents  observed  and  averages,  presented  as  mean  ±  SEM.  One  sample  t  test  was  
used  to  compare  the  effect  observed  with  the  control  current  and  two-­‐‑sample  t  test  
was  utilised  for  comparing  the  experimental  current  ratios  under  the  low  and  high  
EGTA  concentrations.    
  
Figure  4.6  illustrates  the  data  collected  for  the  first  protocol:  12  voltage  steps  
starting  from  -­‐‑70  mV  from  the  -­‐‑80  mV  holding  potential.  As  can  be  seen,  under  the  
low  EGTA  concentration,  the  addition  of  10  µμM  NMDA  produces  122.6±5.6  and  
123.7±5.3  per  cent  of  control  current  at  the  -­‐‑70  and  +40  mV  steps  respectively.  This  
facilitation  effect  is  significantly  different  from  the  control  currents  and  from  the  
98.2±4.4  and  99.4±4.9  per  cent  found  under  10  µμM  of  EGTA,  as  calculated  with  
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one-­‐‑sample  and  two-­‐‑sample  t  tests  respectively.  Therefore  it  appears  that  
activation  of  NMDARs  starts  the  same  Ca2+  transduction  pathway  as  the  activation  
of  P2X  receptors  in  astrocytes,  whereby  a  transient  increase  in  the  intracellular  
calcium  can  activate  the  IP3  channels,  located  on  the  ER,  which  in  turn  opens  
internal  calcium  stores.    
  
Inwardly  rectifying  potassium  current  was  addressed  in  the  second  protocol  
recorded:  holding  potential  of  -­‐‑50  mV  and  11  voltage  steps  from  -­‐‑130  to  +70  mV.  
At  two  lowest  voltage  steps,  -­‐‑130  and  -­‐‑110  mV  the  inwardly  rectifying  potassium  
channel  conductance  prevails  in  the  current.  As  can  be  seen  from  Figure  4.7,  there  
is  a  minor  increase  in  current  at  -­‐‑130mV  (102.8±3.3  compared  to  100  %  control),  
however  this  increase  is  not  significant.  At  +70mV  step,  however,  this  facilitation  
effect  seems  to  re-­‐‑appear  under  the  low  concentration  of  EGTA  (0.1  µμM)  –  
producing  126.2±5.7  per  cent  of  the  control  current.  When  the  high  concentration  
of  Calcium  chelator  was  used  the  experimental  current  ratios  were  96.5±5.0  and  
97.8±4.4  per  cent  of  the  control  currents.  There  is  no  significant  difference  between  
the  two  conditions  at  -­‐‑130mV  step,  but  the  28%  difference  between  the  current  
ratios  at  +70mV  is  significant  with  p<0.01.  This  means  that  the  addition  of  Calcium  
chelator  abolishes  the  facilitation  effect  due  to  the  addition  of  NMDA.    
  
A  third  protocol  was  recorded,  to  measure  the  voltage-­‐‑gated  potassium  currents  
more  closely.  The  deactivating  pre  step  of  -­‐‑20  mV  precedes  12  voltage  steps  from  
holding  potential  of  -­‐‑80  mV  starting  from  -­‐‑70  mV.  Figure  4.8  shows  the  data  
collected  for  the  steady  state  and  rapidly  desensitizing  potassium  current  
components  to  this  protocol.  Similarly  to  the  total  potassium  current,  the  
recordings  with  low  concentrations  of  EGTA  displayed  the  increase  following  the  
addition  of  the  extracellular  NMDA.  The  steady  state  current  had  a  121.6±7.6  and  
117.0±3.7  per  cent  of  control  currents  for  the  -­‐‑70  and  +40  mV  steps  respectively.  
When  the  intracellular  Calcium  was  mopped  up  by  the  high  concentration  of  
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EGTA  this  effect  did  not  take  place;  steady  state  current  yielded  97.6±3.4  and  
98.1±3.9  per  cent  of  the  control  current  at  lowest  and  highest  voltage  steps  
respectively.  A  very  similar  trend  was  exhibited  by  the  data  for  the  rapidly  
desensitizing  potassium  current.  Under  the  presence  of  intracellular  Calcium  the  
lowest  and  highest  voltage  steps  show  116.6±5.2  and  112.1±4.1  per  cent  of  control,  
and  only  98.1±3.4  and  99.0±3.5  per  cent  when  the  10  µμM  of  EGTA  was  added  to  
the  patch  pipette.    
  
These  data  demonstrated  reliably  that  the  effect  of  the  addition  of  10  µμM  of  
NMDA  to  the  recording  chamber  is  akin  to  the  effect,  produced  by  the  addition  of  
the  analogue  of  ATP.  Both  of  these  drugs  are  activators  of  ionotropic  channels  that  
are  Calcium  permeable  in  astrocytes.  This  leads  us  to  believe  that  the  activation  of  
P2X  or  NMDARs  allows  an  influx  of  Calcium  ions  inside  the  astrocyte  soma,  
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Figure  4.6:  Total  potassium  current  is  facilitated  by  NMDA  in  the  presence  of  intracellular  Ca2+.  
A  –  Representative  traces  of  recordings,  B  –  Average  I/V  relationship  graphs,  C  -­‐‑  The  average  effect  
of  drug  applications.  The  changes  in  potassium  currents  upon  activation  with  10  µμM  NMDA  in  
cells  with  0.1  µμM  of  EGTA  and  10  µμM  EGTA  in  the  patch  pipette  were  measured.  The  average  
current  recorded  from  isolated  astrocytes  activated  by  10  µμM  NMDA  in  the  presence  of  
intracellular  Calcium  was  122.6±5.6  and  123.7±5.3  per  cent  of  the  control  current  at  -­‐‑70  and  +40  mV  
steps  respectively.  As  calculated  with  one-­‐‑sample  t  test  the  effect  of  the  addition  of  NMDA  was  
significantly  different  from  the  control  current  (p=0.004  and  p=0.0002  at  low  and  high  voltage  steps  
respectively).  The  addition  of  NMDA  under  the  presence  of  Calcium  chelator  EGTA  yielded  a  
mean  current  of  98.2±4.4  and  99.4±4.9  per  cent  of  control  current  at  -­‐‑70mV  and  +40  mV  steps  
respectively,  failing  to  increase  the  potassium  current;  **  shows  p<0.01  with  two-­‐‑sample  t  test  
(p=0.003  and  p=0.001  at  low  and  high  voltage  steps,  comparing  current  ratios  under  high  and  low  
EGTA  concentrations).  Note  scale  change.  
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Figure  4.7:  Inwardly  rectifying  potassium  current  is  not  facilitated  by  NMDA  in  the  presence  of  
intracellular  Ca2+.  A  –  Representative  traces  of  recordings,  B  –  Average  I/V  relationship  graphs,  C  -­‐‑  
The  average  effect  of  drug  applications.  The  changes  in  potassium  currents  upon  activation  with  10  
µμM  NMDA  in  cells  with  0.1  µμM  of  EGTA  and  10  µμM  EGTA  in  the  patch  pipette  were  measured.  
The  average  current  recorded  from  isolated  astrocytes  activated  by  10  NMDA  in  the  presence  of  
intracellular  Calcium  was  102.8±3.3  and  126.2±5.7  per  cent  of  the  control  current  at  -­‐‑130  and  +70  
mV  steps  respectively.  As  calculated  with  one-­‐‑sample  t  test,  the  effect  of  the  addition  of  NMDA  is  
significant  at  high  voltage  step,  but  not  at  -­‐‑130  mV  (p=0.0001  for  +70  mV  step).  The  addition  of  
NMDA  under  the  presence  of  Calcium  chelator  EGTA  yielded  a  mean  current  of  96.5±5  and  
97.8±4.4  per  cent  of  control  current  at  -­‐‑130  and  +70  mV  steps  respectively,  failing  to  increase  the  
potassium  current;  **  shows  p<0.01  with  two-­‐‑sample  t  test  (p=0.003  at  +70  mV,  comparing  current  
ratios  under  high  and  low  EGTA  concentrations).  Note  scale  change.  
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Figure  4.8:  Steady  state  (KD)  and  rapidly  inactivating  (KA)  potassium  current  are  facilitated  by  
NMDA  in  the  presence  of  intracellular  Ca2+.  A  –  Representative  traces  of  recordings,  B  –  Average  
I/V  relationship  graphs,  C  -­‐‑  The  average  effect  of  drug  applications.  The  changes  in  potassium  
currents  upon  activation  with  10  µμM  NMDA  in  cells  with  0.1  µμM  of  EGTA  and  10  µμM  EGTA  in  the  
patch  pipette  were  measured.  The  average  current  recorded  from  isolated  astrocytes  activated  by  
10  µμM  NMDA  in  the  presence  of  intracellular  Calcium  was  121.6±7.6  and  117.0±3.7  per  cent  of  the  
control  steady  state  current  at  -­‐‑70  and  +40  mV  steps  respectively.  The  average  rapidly  inactivating  
current  recorded  from  isolated  astrocytes  activated  by  10  µμM  NMDA  in  the  presence  of  
intracellular  Calcium  was  116.6±5.2  and  112.1±4.1  per  cent  of  the  control  current  at  -­‐‑70  and  +40  mV  
steps  respectively.  The  addition  of  NMDA  under  the  10  µμM  EGTA  yielded  a  mean  steady  state  
current  of  97.6±3.4  and  98.1±3.9  per  cent  and  mean  rapidly  inactivating  current  of  98.1±3.4  and  
99.0±3.5  per  cent  of  control  current  at  -­‐‑70  and  +40  mV  steps  respectively,  failing  to  increase  either  
steady  state  or  rapidly  inactivating  potassium  currents.  As  calculated  with  one-­‐‑sample  t  test  the  
effect  of  the  addition  of  NMDA  is  significant  for  both  currents  under  the  presence  of  intracellular  
Calcium  (Steady  state:  p=0.008  and  p=0.001  for  -­‐‑70  and  +40  mV;  rapidly  inactivating:  p=0.005  and  
p=0.007  at  -­‐‑70  and  +40  mV  respectively);  **  shows  p<0.01  with  two-­‐‑sample  t  test  (comparing  current  
ratios  under  high  and  low  EGTA  concentrations).  Note  scale  change.  
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4.2.5  Age-­‐‑related  changes  in  the  link  between  activation  of  NMDARs  and  
potassium  currents  of  astrocytes    
 
The  effect  of  ageing  on  this  facilitation  of  potassium  current  by  the  addition  of  
NMDA  to  the  aCSF  was  investigated.  Astrocytes  were  isolated  from  mice  of  
Group  III  (9-­‐‑12  months  old)  and  patch-­‐‑clamped,  with  three  protocols  being  
recorded  for  the  control  current,  current  under  the  application  of  NMDA  and  the  
washout  current  under  the  presence  of  intracellular  Calcium  ions.  Figure  4.9  
shows  the  data  collected  for  these  cells.    
  
As  calculated  with  one-­‐‑sample  t  test  the  effect  of  the  addition  of  NMDA  in  
astrocytes  from  old  mice  diminishes  compared  to  their  young  counter  parts.  The  
total  potassium  current  was  increased  by  the  addition  of  NMDA  at  the  lowest  
voltage  steps,  producing  a  mean  current  ratio  of  117.2±9.2  per  cent  of  the  control  
current  at  -­‐‑70  mV.  However,  this  increase  diminished  towards  the  highest  voltage  
steps;  +40  mV  step  had  an  average  current  ratio  of  100.7±2.7  per  cent  of  control  
current.      
  
The  protocol  for  recording  inwardly  rectifying  potassium  current  collected  the  
data  that  was  very  akin  to  corresponding  data  collected  from  young  adult  mice.  At  
the  lowest  voltage  step,  -­‐‑130  mV,  the  current  ratio  is  105.8±3.3,  showing  only  a  
small  insignificant  increase,  whereas  at  +70  mV  the  current  reaches  120.0±6.7  per  
cent  of  the  control  current  upon  the  addition  of  the  NMDA.    
  
Voltage-­‐‑gated  potassium  currents,  both  steady  state  and  rapidly  desensitizing  
kinds,  seem  to  be  less  susceptible  to  this  facilitation  effect  in  astrocyte  from  Group  
III  mice.  Steady  state  current  type  reaches  109.9±7.2  per  cent  at  -­‐‑70  mV  and  only  
104.7±4.0  per  cent  of  control  currents  and  rapidly  desensitizing  potassium  current  
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shows  a  smaller  effect  of  NMDA  still:  105.8±3.6  and  101.5±1.3  per  cent  
respectively.    
  
The  data  presented  on  Figure  4.9  displays  that  the  facilitation  that  activation  of  
NMDARs  causes  in  young  adult  mice  is  less  prominent  in  astrocytes  from  older  
mice.  Specifically,  the  voltage-­‐‑gated  potassium  currents  seem  to  be  less  responsive  
to  the  addition  of  10  µμM  of  NMDA.    
  
        109  
 
Figure  4.9:  Facilitation  of  potassium  currents  by  NMDA  is  less  pronounced  in  old  mice.  A  –  
Representative  traces  of  recordings,  B  –  Average  I/V  relationship  graphs,  C  -­‐‑  The  average  effect  of  
drug  applications.  The  changes  in  potassium  currents  upon  activation  with  10  µμM  NMDA  in  
astrocytes  from  old  mice  (9-­‐‑12  months  PN)  were  measured.  The  average  current  recorded  from  
isolated  astrocytes  activated  by  10  µμM  NMDA  was  117.2±9.2  and  100.7±2.7  per  cent  of  the  control  
current  at  -­‐‑70  and  +40  mV  in  total  potassium  current.  The  inwardly  rectifying  current  was  105.8±3.3  
and  120.0±6.7  per  cent  of  control  at  -­‐‑130  and  +70  mV  voltage  steps  respectively.  The  average  steady  
state  current  recorded  from  isolated  astrocytes  activated  by  10  µμM  NMDA  was  109.9±7.2  and  
104.7±4.0  per  cent  of  the  control  current  at  -­‐‑70  and  +40  mV  of  total  potassium  current;  rapidly  
desensitizing  current  produced  current  ratios  of  105.8±3.6  and  101.5±1.3  at  corresponding  voltage  
steps.  As  calculated  with  one-­‐‑sample  t  test  the  effect  of  the  addition  of  NMDA  in  astrocytes  from  
old  mice  diminishes  compared  to  their  young  counter  parts,  so  only  the  lowest  voltage  step  for  the  
steady  state  current  produces  a  significant  (p<0.05)  increase  when  compared  to  control  current;  *  
shows  p<0.05  with  one-­‐‑sample  t  test  (p  =  0.052  and  p=0.01  for  -­‐‑70  mV  and  +70  mV  of  total  and  
inwardly  rectifying  potassium  currents  respectively).  Note  scale  change.    
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4.2.6  Distinguishing  between  affected  potassium  currents  by  the  bath  addition  
of  αβ-­‐‑methylene  ATP  under  4-­‐‑aminopyridine  or  barium  chloride    
  
To  further  investigate  the  nature  of  this  facilitation  mechanism,  two  potassium  
channel  blockers  were  used  to  determine  whether  there  is  a  specific  subtype  of  
potassium  channel  that  is  affected  by  the  extracellular  addition  of  αβ-­‐‑methylene  
ATP.  The  blockers  used  were  4-­‐‑aminopyridine  and  barium  chloride,  at  40  and  100  
µμM  concentrations  respectively.    
  
4-­‐‑aminopyridine  is  a  voltage-­‐‑gated  potassium  channel  blocker,  which  is  often  
used  for  evoking  epileptogenesis  (Frenguelli  and  Wall  2016).  Barium  chloride  is  a  
specific  inwardly  rectifying  potassium  channel  blocker.  The  barium  ion  resides  in  
the  pore  of  the  channel,  thus  prohibiting  its’  conductive  properties(Seifert  et  al.  
2009).  Since  the  hypothesis  at  work  is  that  adding  the  αβ-­‐‑methylene  ATP  affects  
the  conduction  of  voltage-­‐‑gated  potassium  currents,  then  blocking  the  inwardly  
rectifying  potassium  current  should  yield  a  greater  increase  in  this  facilitation  
effect.  It  is  even  possible  that  blocking  the  inwardly  rectifying  potassium  current  
can  cause  this  effect  to  appear  at  -­‐‑130  mV  step,  despite  not  being  prominent  in  
other  experimental  conditions.    
  
The  electrophysiological  protocols  used  were  identical  to  those  in  the  previous  
experiments.  When  the  current  ratios  were  calculated  in  experiments  with  the  
addition  of  the  blockers,  the  current  under  the  blocker  was  used  as  a  control.  This  
was  done  specifically  to  avoid  confusion  between  the  effect  of  the  blocker  on  the  
control  current  and  the  effect  of  the  addition  of  the  αβ-­‐‑methylene  ATP  on  top  of  
the  blocker.    
  
Figures  4.10  –  4.12  illustrate  the  data  collected  for  these  experiments,  presented  as  
mean  ±  SEM  in  bar  charts  and  displaying  typical  examples  of  currents  observed  
during  these  recordings.  Firstly,  the  total  potassium  current  was  measured  (see  
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Figure  4.10),  and  the  differences  in  them  due  to  addition  of  αβ-­‐‑methylene  ATP  
under  the  influence  of  4-­‐‑aminopyridine  or  barium  chloride.  In  control  condition,  
where  10  µμM  αβ-­‐‑methylene  ATP  was  added  without  the  presence  of  any  blockers,  
the  mean  current  ratios  were  122.6±5.6  and  123.7±5.3  per  cent  of  the  control  
current  at  -­‐‑70  and  +40  mV  steps  respectively.  The  addition  of  αβ-­‐‑methylene  ATP  
after  the  application  of  4-­‐‑aminopyridine  yielded  the  current  ratios  of  only  
104.8±5.0  and  102.2±4.1  for  the  corresponding  voltage  steps.  This  means  that  the  
addition  of  4-­‐‑aminopyridine  effectively  blocks  the  facilitation  effect  of  the  addition  
of  αβ-­‐‑methylene  ATP  to  the  aCSF.  Therefore,  the  currents  affected  by  this  effect  
are  sensitive  to  4-­‐‑aminopyridine,  which  is  a  known  voltage-­‐‑gated  potassium  
channel  blocker.  When  barium  chloride  was  added  to  the  bath  prior  to  the  
addition  of  αβ-­‐‑methylene  ATP,  the  experimental  current  ratios  reached  133.1±17.2  
and  117.3±7.7  per  cent  of  control  currents  at  -­‐‑70  mV  and  +40  mV  respectively.  Both  
sets  of  current  ratios  from  control  condition  and  under  the  influence  of  barium  
chloride  were  significantly  different  from  their  respectively  control  currents  (as  
calculated  with  one-­‐‑sample  t  test,  p<0.01),  and  also  significantly  different  from  the  
data  collected  for  experiments  under  the  influence  of  4-­‐‑aminopyridine  blocker  (as  
calculated  with  two-­‐‑sample  t  test,  p<0.01).    
  
The  data  for  the  protocol,  recording  inwardly  rectifying  potassium  current  
(holding  potential  -­‐‑50  mV  with  11  voltage  steps  from  -­‐‑130  to  +70  mV)  are  
presented  on  Figure  4.11.  The  current  ratios  recorded  in  the  control  condition  were  
102.8±3.3  and  126.2±5.7  per  cent  of  the  control  current  at  -­‐‑130  mV  and  +70  mV  
respectively.  Current  ratios  recorded  under  the  presence  of  4-­‐‑aminopyridine  
showed  a  mean  of  104.0±5.3  and  104.1±4.2  for  the  same  voltage  steps,  thus  not  
introducing  any  changes  at  -­‐‑130  mV  but  completely  abolishing  the  facilitation  of  
current  at  +70  mV.  Application  of  barium  chloride  prior  to  the  addition  of  αβ-­‐‑
methylene  ATP  yielded  109.0±3.8  and  114.7±3.8  per  cent  of  control  currents.  At  130  
mV  only  the  experiments  where  barium  chloride  was  added  demonstrate  a  
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significantly  increased  current  upon  the  addition  of  αβ-­‐‑methylene  ATP  (as  
calculated  with  one-­‐‑sample  t  test,  p<0.01).  This  means  that  when  the  inwardly  
rectifying  potassium  current  is  blocker,  the  potassium  current  elevates  upon  
application  of  10  µμM  αβ-­‐‑methylene  ATP.  At  highest  voltage  step,  the  trend  is  
similar  to  the  data  collected  with  the  previous  protocol.  The  addition  of  4-­‐‑
aminopyridine  blocks  the  effect  of  the  addition  of  αβ-­‐‑methylene  ATP,  whereas  
barium  chloride  does  not.    
  
Thirdly,  the  data  obtained  through  protocol  for  considering  voltage-­‐‑gated  
potassium  current  are  presented  on  Figure  4.12.  Two  distinct  components,  the  
steady  state  and  rapidly  desensitizing  potassium  currents  were  studied  separately.  
The  control  conditions  for  steady  state  voltage-­‐‑gated  potassium  current  yielded  
121.6±7.6  and  117.0±4.4  per  cent  of  control  currents  at  -­‐‑70  and  +40  mV  steps  
respectively.  When  4-­‐‑aminopyridine  was  applied  prior  to  the  addition  of  αβ-­‐‑
methylene  ATP,  mean  current  ratios  of  114.1±6.6  and  102.8±6.1  per  cent  were  
recorded.  Finally,  in  experiments  with  addition  of  barium  chloride,  the  following  
current  ratios  were  recorded  for  -­‐‑70  and  +40  mV:  122.5±4.5  and  111.1±3.9  per  cent  
respectively.  The  addition  of  4-­‐‑aminopyridine  blocked  the  facilitation  of  
potassium  current  at  +40  mV,  but  only  reduced  it  at  -­‐‑70  mV.  Barium  chloride,  
however,  did  not  decrease  the  effect  shown  in  control  condition.  At  -­‐‑70  mV  all  
experimental  conditions  displayed  an  increase  in  current  upon  the  addition  of  αβ-­‐‑
methylene  ATP  (one-­‐‑sample  t  test,  p<0.05),  whereas  at  +40  mV  only  the  control  
and  experiments  under  barium  chloride  are  significantly  different  from  their  
control  current  ratios.    
  
The  data  for  rapidly  desensitizing  potassium  current  appeared  more  similar  to  the  
data  for  the  total  potassium  current.  In  control  experiments  the  addition  of  αβ-­‐‑
methylene  ATP  evoked  116.6±5.2  and  112.1±4.1  per  cent  of  control  currents,  at  -­‐‑70  
and  +40  mV  respectively.  The  experiments  where  4-­‐‑aminopyridine  was  added  
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prior  to  αβ-­‐‑methylene  ATP  application  these  voltage  steps  displayed  108.7±1.9  
and  105.3±2.8  per  cent  of  control  current  ratios  only.  Addition  of  barium  chloride  
yielded  120.5±5.7  and  111.0±3.5  per  cent  of  control  current  ratios  at  corresponding  
voltage  steps.  Both  conditions,  the  control  experiments  and  with  addition  of  
barium  chloride,  were  significantly  different  from  the  current  ratios  calculated  for  
the  experiments  with  the  addition  of  4-­‐‑aminopyridine  (as  calculated  with  two-­‐‑
sample  t  test,  p<0.05).    
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Figure  4.10:  Facilitation  of  total  potassium  current  by  αβ-­‐‑methylene  ATP  is  blocked  by  4-­‐‑
aminopyridine  but  not  barium  chloride.  A  –  Representative  traces  of  recordings,  B  –  Average  I/V  
relationship  graphs,  C  -­‐‑  The  average  effect  of  drug  applications.  The  changes  in  potassium  currents  
upon  activation  with  10  µμM  αβ-­‐‑methylene  ATP  in  cells  under  the  application  of  40  µμM  4-­‐‑
aminopyridine  and  100  µμM  barium  chloride  in  the  aCSF  were  measured.  As  calculated  with  two-­‐‑
sample  t  test  both  conditions,  control  and  under  the  influence  of  barium,  yielded  significantly  
greater  currents  than  experiments  with  the  application  of  4-­‐‑aminopyridine;  **  shows  p<0.05  with  
two-­‐‑sample  t  test  (p=0.02  and  p=0.005  at  -­‐‑70  and  +40  mV  when  comparing  current  ratios  in  control  
and  4-­‐‑aminopyridine  conditions  p=0.04  (at  +40  mV  step)  for  barium  chloride  and  4-­‐‑aminopyridine  
experimental  conditions);  *  shows  p<0.05  as  measured  with  one-­‐‑sample  t  test  (p=0.03  at  -­‐‑70  mV  
steps  in  experiments  with  addition  of  barium  chloride).  
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Figure  4.11:  Facilitation  of  inwardly  rectifying  potassium  currents  by  αβ-­‐‑methylene  ATP  is  
blocked  by  4-­‐‑AP  but  not  barium  chloride.  A  –  Representative  traces  of  recordings,  B  –  Average  
I/V  relationship  graphs,  C  -­‐‑  The  average  effect  of  drug  applications.  The  changes  in  potassium  
currents  upon  activation  with  10  µμM  NMDA  in  cells  under  the  application  of  40  µμM  4-­‐‑
aminopyridine  and  100  µμM  barium  chloride  in  the  aCSF  were  measured.  As  calculated  with  two-­‐‑
sample  t  test  both  conditions,  control  and  under  the  influence  of  barium,  produced  significantly  
greater  currents  than  those  in  the  experiments  with  4-­‐‑aminopyridine.  At  -­‐‑130  mV  the  addition  of  
barium  chloride  allowed  the  increase  of  the  current;  *  shows  p<0.05  with  two-­‐‑sample  t  test  
(comparing  control  and  barium  chloride  to  4-­‐‑aminopyridine  conditions  respectively).  Note  scale  
change.  
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Figure  4.12:  Facilitation  of  steady  state  (KD)  and  rapidly  inactivating  (KA)  voltage-­‐‑gated  
potassium  currents  by  αβ-­‐‑methylene  ATP  is  blocked  by  4-­‐‑aminopyridine  but  not  barium  
chloride.  A  –  Representative  traces  of  recordings,  B  –  Average  I/V  relationship  graphs,  C  -­‐‑  The  
average  effect  of  drug  applications.  The  changes  in  potassium  currents  upon  activation  with  10  µμM  
αβ-­‐‑methylene  ATP  in  cells  under  the  application  of  40  µμM  4-­‐‑aminopyridine  and  100  µμM  barium  
chloride  in  the  aCSF  were  measured.  As  calculated  with  two-­‐‑sample  t  test  at  +40  mV  step  both,  KD  
and  KA,  currents  were  significantly  higher  in  experiments  with  application  of  barium  chloride;  **  
shows  p<0.05  with  two-­‐‑sample  t  test  (steady  state  current:  p=0.04  when  comparing  current  ratios  in  
control  and  experiments  with  barium  chloride  with  experiments  with  4-­‐‑aminopyridine.  Rapidly  
inactivating  current:  p=0.04  p=0.02  respectively);  *  shows  p<0.05  as  calculated  with  the  one-­‐‑sample  
t  test  (p=0.0008  and  p=0.011  experiments  with  barium  chloride).    
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4.2.7  Distinguishing  between  potassium  currents  affected  by  the  addition  of  
NMDA  under  4-­‐‑aminopyridine  or  barium  chloride  
 
An  identical  set  of  experimental  conditions  was  set  up  for  testing  whether  the  bath  
addition  of  10  µμM  αβ-­‐‑methylene  ATP  produced  a  similar  set  of  data,  as  did  the  
experiments  that  used  NMDA  as  an  activator  of  the  autocrine  mechanism  that  
links  NMDARs  and  P2X  receptors  in  astrocytes  with  voltage-­‐‑gated  potassium  
channels.  Three  protocols  were  recorded,  with  four  potassium  current  subtypes  
being  measured.  The  data  is  presented  below  in  Figures  4.13  –  4.15  as  mean  ±  SEM  
and  examples  of  typical  currents  observed  during  the  recordings.  
 
Total  potassium  current  was  considered  in  the  first  protocol:  12  voltage  steps,  
starting  from  -­‐‑70  to  +40  mV,  from  holding  potential  of  -­‐‑80  mV.  Figure  4.13  displays  
the  data  collected  for  this  protocol  from  three  experimental  conditions.  Control  
experiments  show  110.4±4.1  and  120.5±4.7  per  cent  current  ratios  from  control  
current  at  -­‐‑70  and  +40  mV  steps.  Addition  of  4-­‐‑aminopyridine  prior  to  the  
application  of  NMDA  achieved  full  block  of  the  actions  of  NMDA:  102.8±6.1  and  
98.8±3.4  per  cent  of  control  currents.  When  barium  chloride  was  used  in  place  of  4-­‐‑
Aminopyridine,  the  facilitation  effect  of  NMDA  not  only  was  not  blocked,  but  
instead  it  increased  further.  The  mean  current  ratios  were  122.1±4.7  and  120.8±9.5  
per  cent  of  control  currents  at  low  and  high  voltage  steps  respectively.  These  data  
follow  the  same  pattern  as  the  data  collected  for  the  experiments  with  the  addition  
of  αβ-­‐‑methylene  ATP.    
  
Second  protocol  considers  both  inwardly  rectifying  and  total  potassium  currents  
(see  Figure  4.14).  In  control  condition  the  addition  of  NMDA  caused  the  current  to  
be  104.7±5.8  and  113.3±3.4  per  cent  of  control  currents  for  -­‐‑130  and  +70  mV  
respectively.  The  addition  of  4-­‐‑aminopyridine  before  the  application  of  NMDA  
did  not  introduce  prominent  change  at  -­‐‑130  mV  step  (108.5±9.5),  however  at  +70  
mV  the  increase  was  completely  abolished,  with  the  current  staying  at  100.6±4.0  
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per  cent  of  control.  Finally,  barium  chloride  did  not  inhibit  the  increase  that  is  
caused  by  the  addition  of  NMDA.  The  current  ratios  measured  in  experiment  with  
barium  chloride  were  110.3±3.4  and  110.6±3.6  per  cent  at  low  and  high  voltage  
steps  respectively.  Again,  similarly  to  data  for  experiments  with  αβ-­‐‑methylene  
ATP,  at  -­‐‑130  mV  step,  the  addition  of  barium  chloride  allowed  the  facilitation  
effect  to  be  seen.  At  high  voltage  step  in  this  protocol,  the  data  show  very  similar  
trend  to  the  protocol  above.    
  
The  third  protocol,  for  reflecting  the  trends  in  voltage-­‐‑gated  potassium  currents,  
was  recorded.  The  steady  state  and  rapidly  desensitizing  components  of  the  
currents  measured  by  this  protocol  are  considered  separately,  but  are  presented  
on  together  on  Figure  4.15.  
  
The  steady  state  current  reaches  112.5±3.4  and  115.3±4.2  per  cent  of  control  
currents,  when  recorded  without  any  blockers  added.  The  addition  of  4-­‐‑
aminopyridine  before  the  application  of  NMDA  fully  blocked  any  increase  in  
current,  with  98.8±6.6  and  101.4±3.2  per  cent  of  control  currents  at  -­‐‑70  and  +40  mV  
respectively.  When  barium  chloride  was  used  in  place  of  4-­‐‑Aminopyridine,  the  
effect  of  the  addition  of  NMDA  became  more  prominent:  132.3±14.1  and  121.4±9.6  
per  cent  at  corresponding  voltage  steps.  These  data  show  that  the  addition  of  
barium  chloride  exaggerates  the  mechanism  in  question,  whereas  4-­‐‑
aminopyridine  diminishes  the  effect  of  NMDA.  From  this  one  can  derive  that  the  
potassium  channels  that  are  affected  by  this  mechanism  are  of  voltage-­‐‑gated  
variety,  since  blocking  them  inhibits  this  mechanism.    
  
The  patterns  presented  by  rapidly  inactivating  potassium  current  are  similar  to  
that  of  the  steady  state  potassium  current.  Such,  the  control  experiments  show  the  
facilitation  of  current  to  110.5±3.0  and  112.6±2.6  per  cent  at  -­‐‑70  and  +40  mV  
respectively.  The  addition  of  4-­‐‑aminopyridine  removes  this  intensification  effect  
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and  only  yields  99.8±2.4  and  102.8±2.9  per  cent  at  corresponding  voltage  steps.  The  
addition  of  barium  chloride,  however,  causes  the  opposite.  The  current  ratios  
increase  to  120.7±9.7  and  117.0±9.9  per  cent  respectively  under  the  influence  of  
barium  chloride.    
  
Taken  together,  the  data  gathered  for  the  effect  of  the  addition  of  NMDA  display  
patterns  comparable  with  those  of  experiments  where  αβ-­‐‑methylene  ATP  was  
used  in  place  of  NMDA.  This  means  that  the  mechanism  at  work  is  a  common  one  
for  both  of  these  drugs  and  the  corresponding  channels  (NMDARs  and  P2X1/5  










     
        120  
  
Figure  4.13:  Facilitation  of  total  potassium  current  by  NMDA  is  blocked  by  4-­‐‑aminopyridine  but  
not  barium  chloride.  A  –  Representative  traces  of  recordings,  B  –  Average  I/V  relationship  graphs,  
C  -­‐‑  The  average  effect  of  drug  applications.  The  changes  in  potassium  currents  upon  activation  
with  10  µμM  NMDA  in  cells  under  the  application  of  40  µμM  4-­‐‑aminopyridine  and  100  µμM  barium  
chloride  in  the  aCSF  were  measured.  As  calculated  with  two-­‐‑sample  t  test  the  currents  measured  in  
both  conditions,  control  and  under  the  influence  of  barium,  were  significantly  greater  than  those  
from  experiments  with  4-­‐‑aminopyridine;  *  shows  p<0.05  with  two-­‐‑sample  t  test  (comparing  current  
ratios  in  different  experimental  conditions).  
  
-80 -60 -40 -20 0 20 40
200
300







































































        121  
  
  
Figure  4.14:  Facilitation  of  inwardly  rectifying  potassium  current  by  NMDA  is  blocked  by  4-­‐‑
aminopyridine  but  not  barium  chloride.  A  –  Representative  traces  of  recordings,  B  –  Average  I/V  
relationship  graphs,  C  -­‐‑  The  average  effect  of  drug  applications.  The  changes  in  potassium  currents  
upon  activation  with  10  µμM  NMDA  in  cells  under  the  application  of  40  µμM  4-­‐‑aminopyridine  and  
100  µμM  barium  chloride  in  the  aCSF  were  measured.  As  calculated  with  two-­‐‑sample  t  test  the  
currents  measured  in  both  conditions,  control  and  under  the  influence  of  barium,  were  
significantly  greater  than  those  from  experiments  with  the  application  of  4-­‐‑aminopyridine  at  high  
voltage  step.  At  -­‐‑130  mV  the  addition  of  barium  chloride  allowed  the  facilitation  effect  to  take  
place;  **  shows  p<0.05  with  two-­‐‑sample  t  test  (comparing  current  ratios  in  different  experimental  
conditions).  Note  scale  change.  
  














































































        122  
  
Figure  4.15:  Facilitation  of  steady  state  (KD)  and  rapidly  inactivating  (KA)  voltage-­‐‑gated  
potassium  currents  by  NMDA  is  blocked  by  4-­‐‑aminopyridine  but  not  barium  chloride.  A  –  
Representative  traces  of  recordings,  B  –  Average  I/V  relationship  graphs,  C  -­‐‑  The  average  effect  of  
drug  applications.  The  changes  in  potassium  currents  upon  activation  with  10  µμM  NMDA  in  cells  
under  the  application  of  40  µμM  4-­‐‑aminopyridine  and  100  µμM  barium  chloride  in  the  aCSF  were  
measured.  As  calculated  with  two-­‐‑sample  t  test  the  currents  measured  in  both  conditions,  control  
and  barium  chloride  experiments,  were  significantly  greater  than  that  from  experiments  with  4-­‐‑
aminopyridine;  *  shows  P<0.05  as  calculated  with  one  sample  t  test;  **  shows  p<0.05  with  two-­‐‑
sample  t  test.  Note  scale  change.  
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4.2.8  Distinguishing  between  potassium  currents  affected  by  the  addition  of  
TFLLR  under  4-­‐‑aminopyridine  or  barium  chloride  
 
From  the  data  described  in  sections  4.3.1-­‐‑4.3.6,  it  has  been  shown  that  there  is  a  
cellular  mechanism  that  links  the  ionotropic  channels,  namely  P2X  and  NMDARs,  
and  potassium  channels  in  the  astrocytic  soma.    It  was  determined  that  the  
voltage-­‐‑gated  potassium  current  subtype  is  affected  by  the  activation  of  either  of  
these  channels.  Upon  activation  of  P2X  or  NMDARs  with  their  agonists  the  
channels  open  and  permit  an  influx  of  ions,  some  of  which  will  be  Ca2+  ions.  This  
Calcium-­‐‑driven  message  will  reach  the  inside  of  the  cell,  where  it  can  affect  
multiple  players  and  elicit  a  subsequent  response,  in  this  case  the  elevation  of  
voltage-­‐‑gated  potassium  current  by  10-­‐‑30  percent.  The  increase  in  the  potassium  
out  flux  can  raise  the  extracellular  concentration  of  K+  ions  in  nearby  projections  of  
other  astrocytes  and  trigger  responses  from  other  glial  cells.  An  increase  in  the  
intracellular  Calcium  can  itself  trigger  a  vast  number  of  molecular  cascades,  thus  
making  this  a  mechanism  of  high  functional  importance.    
  
If  the  activation  of  ionotropic  receptors  can  propagate  the  Calcium  messenger  
inside  the  cell,  can  a  stimulation  of  a  metabotropic  receptor  that  raises  the  
intracellular  concentration  of  Calcium,  elicit  a  similar  response,  causing  an  
increase  in  potassium  current?    
  
PAR-­‐‑1  is  a  G-­‐‑protein  coupled  receptor  that  is  also  known  as  coagulation  factor  II  
(thrombin)  receptor.  It  is  present  in  many  types  of  cells,  including  astrocytes  and  
neurons.  In  astrocytes  it  is  expressed  specifically  in  sell  body  and  astrocytic  
endfeet,  which  enwrap  capillaries  in  the  brain.  Activating  PAR-­‐‑1  receptor  
increases  intracellular  Ca2+  concentration  (Junge  et  al.  2004).  This  made  PAR-­‐‑1  
receptor  a  perfect  testing  candidate  for  testing  whether  the  mechanism  in  question  
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has  a  GPCR  connection.  A  short  peptide,  TFLLR-­‐‑NH2  (TFLLR),  derived  from  
PAR-­‐‑1  receptor  acts  was  used  as  a  selective  agonist.    
  
The  experimental  set  up  was  identical  to  experiments  with  NMDA  and  αβ-­‐‑
methylene  ATP,  with  three  protocols  being  recorded.  The  data  collected  for  
experiments  with  TFLLR  are  presented  on  Figures  4.16-­‐‑4.18  below.    
  
Overall,  the  pattern  displayed  by  the  total  potassium  current  is  akin  to  that  shown  
by  the  experiments  with  αβ-­‐‑methylene  ATP  and  NMDA.  At  control  conditions,  
the  addition  of  10  µμM  TFLLR  caused  a  slight  rise  of  potassium  current,  105.6±7.8  
and  114.6±4.5  per  cent  at  -­‐‑70  and  +40  mV.    The  addition  of  4-­‐‑aminopyridine  
reversed  this  effect,  yielding  90.2±5.3  and  91.1±3.7  per  cent  of  control  current  
ratios.  In  experiments  where  barium  chloride  was  applied  prior  to  the  addition  of  
TFLLR,  the  current  ratios  reached  125.9±7.9  and  114.7±2.9  per  cent  of  control  
currents.  Once  again,  the  addition  of  4-­‐‑aminopyridine  before  the  application  of  
TFLLR  blocks  any  increase  in  the  potassium  current,  whereas  the  addition  of  
barium  chloride  only  exaggerates  the  effect  of  TFLLR.    
  
The  protocol,  studying  both  total  and  inwardly  rectifying  potassium  current  also  
showed  similar  trends  as  the  experiments  with  the  addition  of  ionotropic  receptor  
agonists.  Figure  4.17  illustrates  the  data  obtained.  In  control  conditions,  the  mean  
current  ratios  upon  the  addition  of  TFLLR  were  106.6±4.5  and  111.1±4.0  per  cent.  
At  -­‐‑130  mV  there  is  no  prominent  increase  in  the  potassium  current  following  the  
addition  of  TFLLR.  Adding  4-­‐‑aminopyridine  resulted  in  decrease  of  the  current  
ratios:  88.9±3.8  and  102.1±6.7  per  cent  were  achieved  at  -­‐‑130  and  +70  mV  
respectively.  At  corresponding  voltage  steps,  the  addition  of  barium  chloride  
caused  an  increase  in  the  potassium  current  after  the  addition  of  TFLLR  up  to  
119.4±7.4  and  121.2±6.6  per  cent  respectively.  In  this  protocol  application  of  
barium  chloride  prior  to  TFLLR  aids  the  increase  of  the  potassium  current.    
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Data  collected  for  the  third  protocol,  consisting  of  two  current  components,  is  
presented  on  Figures  4.18,  with  steady  state  and  rapidly  desensitizing  currents  
respectively.  In  control  conditions,  the  steady  state  voltage-­‐‑gated  potassium  
current  reached  113.5±6.8  and  108.9±3.7  upon  the  addition  of  TFLLR,  very  similar  
to  that  of  rapidly  desensitizing  potassium  current:  110.4±6.5  and  109.0±3.2  per  cent  
of  control  current  ratios  at  -­‐‑70  and  +40  mV  steps  respectively.  The  addition  of  4-­‐‑
aminopyridine  rectified  this  facilitation  effect  of  TFLLR:  92.4±6.3  and  90.1±4.7  per  
cent  for  the  steady  state  and  91.0±7.9  and  88.7±4.4  per  cent  for  the  rapidly  
desensitizing  potassium  currents  at  corresponding  voltage  steps.  When  barium  
chloride  was  added  instead  of  4-­‐‑aminopyridine,  the  facilitation  effect  of  the  
application  of  TFLLR  was  completely  restored  and  even  enhanced.  The  steady  
state  current  achieved  115.2±4.0  and  111.1±2.9  per  cent  and  the  rapidly  
desensitizing  potassium  current  116.7±3.7  and  112.2±3.0  per  cent  of  control  
currents  at  -­‐‑70  and  +40  mV  respectively.    
  
Overall,  these  data  show  that  activation  of  PAR  -­‐‑1  channel  elicits  the  same  effect  as  
the  activation  of  ionotropic  NMDA  and  P2X  receptors  in  isolated  astrocytes.  
Therefore,  it  can  be  assumed  that  the  mechanism  responsible  for  link  between  
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Figure  4.16:  Facilitation  of  total  potassium  current  by  TFLLR  is  blocked  by  4-­‐‑aminopyridine  but  
not  barium  chloride.  A  –  Representative  traces  of  recordings,  B  –  Average  I/V  relationship  graphs,  
C  -­‐‑  The  average  effect  of  drug  applications.  The  changes  in  potassium  currents  upon  activation  
with  10  µμM  TFLLR  in  cells  under  the  application  of  40  µμM  4-­‐‑aminopyridine  and  100  µμM  barium  
chloride  in  the  aCSF  were  measured.  As  calculated  with  two-­‐‑sample  t  test  the  currents  measured  in  
both  conditions,  control  and  under  the  influence  of  barium,  were  significantly  greater  than  that  
from  experiments  with  4-­‐‑aminopyridine;  **  shows  p<0.01  with  two-­‐‑sample  t  test  (comparing  
current  ratios  in  different  experimental  conditions).  
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Figure  4.17:  Facilitation  of  inwardly  rectifying  potassium  current  by  TFLLR  is  blocked  by  4-­‐‑
aminopyridine  but  not  barium  chloride.  A  –  Representative  traces  of  recordings,  B  –  Average  I/V  
relationship  graphs,  C  -­‐‑  The  average  effect  of  drug  applications.  The  changes  in  potassium  currents  
upon  activation  with  10  µμM  TFLLR  in  cells  under  the  application  of  40  µμM  4-­‐‑aminopyridine  and  
100  µμM  barium  chloride  in  the  aCSF  were  measured.  As  calculated  with  two-­‐‑sample  t  test  the  
currents  from  both  conditions,  control  and  under  the  influence  of  Barium,  were  significantly  
greater  than  those  from  experiments  with  4-­‐‑aminopyridine  at  low  voltage  steps.  At  +70  mV  the  
addition  of  barium  chloride  allowed  the  increase  of  the  current;  **  shows  p<0.01  with  two-­‐‑sample  t  
test  (comparing  current  ratios  in  different  experimental  conditions);  *  shows  p<0.01  as  calculated  
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Figure  4.18:  Facilitation  of  steady  state  (KD)  and  rapidly  inactivating  (KA)  voltage-­‐‑gated  
potassium  currents  by  TFLLR  is  blocked  by  4-­‐‑aminopyridine  but  not  barium  chloride.  A  –  
Representative  traces  of  recordings,  B  –  Average  I/V  relationship  graphs,  C  -­‐‑  The  average  effect  of  
drug  applications.  The  changes  in  potassium  currents  upon  activation  with  10  µμM  TFLLR  in  cells  
under  the  application  of  40  µμM  4-­‐‑aminopyridine  and  100  µμM  barium  chloride  in  the  aCSF  were  
measured.  As  calculated  with  two-­‐‑sample  t  test  the  currents  from  both  control  and  barium  chloride  
experiments  were  significantly  greater  than  those  recorded  in  experiments  with  4-­‐‑aminopyridine;  
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4.2.9  The  effect  of  addition  of  αβ-­‐‑methylene  ATP  in  astrocytes  in  slices  
  
The  cells  were  patched  in  slices  in  order  to  test,  whether  this  mechanism  is  viable  
in  the  presence  of  other  cells,  and  in  intact  astrocytes  in  situ,  with  all  the  
projections  of  the  patched  astrocyte  (including  perisynaptic  branchlets  and  
endfeet)  are  linked  to  the  entire  synaptic  network  in  a  more  or  less  intact  manner.  
Figures  4.19  and  4.20  display  the  data  collected  for  whole-­‐‑cell  patched  astrocytes  
in  slices.    
  
Firstly,  some  cells  were  patched  in  slice  and  their  potassium  currents  were  
recorded  overtime  to  examine  the  spontaneous  fluctuations.  These  experiments  
were  used  as  control  time  courses  (Figure  4.19).  For  experimental  conditions,  10  
µμM  αβ-­‐‑methylene  ATP  was  applied  during  some  recordings  (marked  with  a  blue  
and  purple  lines)  and  in  other  recordings  100  µμM  barium  chloride  was  added  to  
the  aCSF  prior  to  application  of  αβ-­‐‑methylene  ATP.  The  facilitation  effect  is  still  
present  in  these  experiments.  Upon  the  activation  of  the  P2X  receptors  with  the  
addition  of  αβ-­‐‑methylene  ATP,  the  current  ratio  grew  up  to  138.3±14.6  per  cent.  
When  compared  with  control  experiments,  the  difference  was  significant  
(p=0.11*10⌃  (-­‐‑9)  as  calculated  with  the  two-­‐‑sample  t  test.  In  experiments  with  the  
addition  of  the  drug  under  the  influence  of  barium  chloride  blocker  the  maximal  
current  ratio  was  135.8±14.2  (p=0.14*10⌃  (-­‐‑6)  per  cent  of  the  control  current  as  
calculated  with  the  two-­‐‑sample  t  test).  These  data  show  that  the  described  effect  of  
facilitation  of  current  by  the  activation  P2X  receptors  is  relevant  in  the  context  of  
the  entire  slice.  It  can  therefore  be  assumed  that  this  mechanism  takes  place  in  the  
living  brain  of  rodents.    
  
Figure  4.20  shows  the  data  collected  for  the  astrocytes  patched  in  slice  in  the  same  
format  as  the  data  presented  above.  It  compared  the  control  experiments,  where  
no  drugs  were  added  (green  on  Figure  4.20)  and  two  sets  of  experiments  with  the  
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addition  of  αβ-­‐‑methylene  ATP,  with  and  without  the  prior  treatments  with  the  
barium  chloride  blocker.  The  protocol  for  total  and  inwardly  rectifying  potassium  
current  was  recorded.  In  control  experiments  the  current  ratios  were  101.2±2.7  and    
100.0±1.6  per  cent  at  corresponding  time  points  as  application  of  drug  in  other  
experimental  conditions.  The  addition  of  αβ-­‐‑methylene  ATP  increased  the  current  
in  both,  high  and  low,  voltage  steps;  the  current  ratios  recorded  were  126.2±11.3  
and  122.6±7.3  per  cent  at  -­‐‑130  and  +30  mV  steps  respectively.  The  addition  of  
barium  chloride  prior  to  the  application  of  αβ-­‐‑methylene  ATP  did  not  block  this  
increase,  yielding  114.0±6.4  and  121.4±7.1  per  cent  of  control  current  at  
corresponding  voltage  steps.  These  data  show  that  the  facilitation  effect,  originally  
demonstrated  in  isolated  astrocytes,  is  still  present  in  patched  astrocytes  in  slices.  
When  working  in  slices  in  situ,  the  application  of  agonists,  such  as  αβ-­‐‑methylene  
ATP,  the  network  effects  can  provide  secondary  effects.  For  instance,  the  
application  of  an  analogue  of  ATP  would  activate  both  P2  and  P1  receptors  in  
neurons,  which  can  have  downstream  effects.  These  include  increased  neuronal  
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Figure  4.19:  Time  course  of  whole-­‐‑cell  patched  clamped  astrocytes  in  slices.  A  time  course  of  
voltage  steps  was  measured  every  30  seconds  (resting  potential  -­‐‑50mV  with  voltage  steps  from  -­‐‑
130mV  to  +30mV),  with  application  of  αβ-­‐‑methylene  ATP  and  addition  of  barium  chloride  and  
subsequent  application  of  αβ-­‐‑methylene  ATP.  At  its  peak,  the  addition  of  µμM  αβ-­‐‑methylene  ATP  
increases  the  current  by  38.3±14.6  per  cent  (p=1.17*10⌃(-­‐‑8)  significantly  different  as  measured  with  
two-­‐‑sample  t  test).  Upon  the  washout  of  the  drug  the  effect  was  reversible.  When  barium  chloride  
is  added  prior  to  the  application  of  αβ-­‐‑methylene  ATP,  the  maximal  current  was  135.8±14.2  per  
cent  (p=1.37*10⌃(-­‐‑5)  when  comparing  current  ratios  recorded  in  experiments  with  the  addition  of  
αβ-­‐‑methylene  ATP  under  the  presence  of  barium  chloride  and  control  conditions);  *  shows  p<0.05  
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Figure  4.20:  αβ-­‐‑methylene  ATP  facilitates  potassium  conductance  in  whole-­‐‑cell  patched  
clamped  astrocytes  in  slice.  The  changes  in  potassium  currents  upon  activation  with  10  µμM  αβ-­‐‑
methylene  ATP  in  cells  under  the  application  of  100  µμM  barium  chloride  in  the  aCSF  were  
measured.  The  average  currents  recorded  from  isolated  astrocytes  activated  by  10  µμM  αβ-­‐‑
methylene  ATP  in  the  control  conditions  were  126.2±11.3  and  122.6±7.3  per  cent  of  the  control  
current  at  -­‐‑130  and  +30mV  steps  respectively.  The  addition  of  αβ-­‐‑methylene  ATP  under  the  
presence  of  barium  chloride  yielded  a  mean  current  of  114.0±6.4  and  121.4±7.1  per  cent  of  control  
current  at  -­‐‑130mV  and  +30mV  steps  respectively,  fully  prohibiting  the  increase  the  potassium  
current.  The  control  experiments  without  any  drugs  added  evoked  mean  current  ratios  of  101.2±2.7  
and  100.0±1.6  per  cent  of  the  control  current  at  corresponding  voltage  steps.  As  calculated  with  
two-­‐‑sample  t  test  control  and  barium  chloride  experiments  were  significantly  different  from  
experiments  with  the  application  of  4-­‐‑aminopyridine;  **  shows  p<0.05  with  two-­‐‑sample  t  test.  Note  
scale  change.  
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4.3  Conclusions    
  
This  chapter  set  out  to  overview  the  data  collected  from  isolated  neurons  and  
astrocytes  and  astrocytes  patched  in  slice.  The  null  hypothesis  stated  that  the  
addition  of  agonists  for  the  following  channels:  P2X,  NMDARs  and  PAR-­‐‑1;  does  
not  alter  the  potassium  currents  conducted  by  astrocytic  cells.    
  
Firstly,  it  was  determined  that  in  isolated  neurons  the  addition  of  αβ-­‐‑methylene  
ATP  does  not  in  fact  alter  the  outward  potassium  current  recorded.  Therefore  the  
null  hypothesis  is  correct  for  neurons.  When  the  same  experiments  were  
completed  with  isolated  astrocytes,  the  effect  was  present  (see  sections  4.3.2).  This  
link  between  P2X  and  potassium  currents  is  a  mechanism  unique  to  astrocytes.    
  
The  nature  of  this  mechanism  was  closely  studied  in  isolated  astrocytes.  It  was  
found  that  this  facilitation  effect  is  Ca-­‐‑dependent,  as  it  was  banished  completely  
by  the  addition  of  EGTA  –  a  Calcium  chelator.  This  means  that  upon  the  activation  
of  P2X  receptors,  a  small  amount  of  Calcium  ions  enter  the  sell  and  initiate  a  
Calcium  cascade  that  causes  an  increase  in  potassium  current  conductance  as  a  
result.  Another  agonist  of  a  different  type  of  ionotropic  ion  channel  was  used  –  
NMDA  –  to  activate  NMDARs.  This  was  done  because  it  is  known  that  the  
astrocytic  subtypes  of  NMDARs  are  Ca-­‐‑permeable  (Palygin  et  al.  2010),  therefore  
it  was  assumed  that  it  can  be  linked  to  the  same  molecular  cascade.  Indeed,  the  
activation  of  NMDARs  with  their  selective  agonist  NMDA  caused  the  same  effect  
in  the  presence  of  intracellular  Calcium.  The  removal  of  Calcium  completely  
abolished  the  increase  of  the  potassium  current,  thus  showing  that  this  molecular  
cascade  involves  the  glutamate  receptor.    
  
Some  experiments  with  NMDA  were  also  done  in  astrocytes  isolated  from  mice  of  
age  group  III  (9-­‐‑12  months  post-­‐‑natal;  for  more  details  see  Chapter  2).  This  
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facilitation  effect  diminishes  with  age,  and  is  seen  in  higher  voltage  steps,  but  not  
on  lower  voltage  steps  (see  section  4.3.5).  This  can  be  due  to  potential  change  in  
the  subunit  composition  or  a  post-­‐‑translational  modification  of  NMDA  receptors,  
making  these  receptors  less  permeable  to  Ca2+  ions  and  thus  putting  an  end  to  the  
influx  of  Calcium  ions  into  the  cell.  Alternatively,  it  could  be  a  different  disruption  
of  this  mechanism  downstream  of  NMDARs.  
  
Further  experiments  were  conducted  to  see  which  specific  subtypes  of  potassium  
channels  are  involved  in  this  mechanism.  Since  there  are  a  large  number  of  
potassium  channel  types  (Hibino  et  al.  2010),  and  multiple  ones  are  expressed  in  
glial  cells  (Vit  et  al.  2008;  Pannicke  et  al.  2000;  Butt  and  Kalsi  2006).To  determine  
whether  the  mechanism  described  is  affecting  one  or  more  subtypes  of  potassium  
channels,  two  blockers  were  used:  4-­‐‑aminopyridine  (voltage-­‐‑gated  potassium  
current  blocker)  and  barium  chloride  (inwardly  rectifying  potassium  current).  
Experiments  using  either  NMDA  or  αβ-­‐‑methylene  ATP  were  conducted  with  the  
addition  of  one  of  the  blockers  prior  to  the  application  of  the  agonists.  The  
patterns  of  data  collected  for  two  types  of  channels  were  very  similar:  the  addition  
of  4-­‐‑aminopyridine  blocked  the  increase  of  the  potassium  current  upon  the  
application  of  agonists,  whereas  the  addition  of  barium  chloride  did  not.  In  some  
cases,  the  application  of  barium  chloride  blocker  at  the  voltage  steps,  where  the  
inwardly  rectifying  potassium  current  dominates,  introduced  this  facilitation  of  
the  current  (see  sections  4.3.5-­‐‑4.3.6).    
  
It  was  hypothesised  that  if  the  activation  of  ionotropic  receptors  can  cause  an  
influx  of  Calcium  into  the  cell  and  a  consequent  increase  in  the  potassium  current,  
then  it  is  possible  that  activation  of  a  metabotropic  receptor  that  is  part  of  the  
cascade  should  cause  the  same  result.  PAR-­‐‑1  receptor  was  chosen  as  a  
metabotropic  receptor,  because  it  is  present  in  astrocytes,  especially  on  the  soma  
and  the  endfeet  enwrapping  the  blood  vessels  (Junge  et  al.  2004).  The  activation  of  
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PAR-­‐‑1  receptor  initiates  astrocytic  Ca2+  signalling  (Lalo  et  al.  2014).  As  section  
4.3.7  demonstrates,  the  application  of  TFLLR  –  an  agonist  of  PAR-­‐‑1  receptor  
evoked  the  same  response  as  the  agonists  of  ionotropic  receptors.  Under  the  
addition  of  TFLLR  without  the  influence  of  the  blockers,  the  potassium  current  
increases.  This  increase  was  blocked  by  the  addition  of  4-­‐‑aminopyridine,  but  not  
of  barium  chloride.  Therefore  it  can  be  assumed  that  both  ionotropic  and  
metabotropic  channels  (P2X,  NMDARs  and  PAR-­‐‑1)  are  part  of  the  same  molecular  
mechanism,  that  connects  the  agonists  from  the  aCSF  and  the  outward  potassium  
currents,  elicited  by  the  astrocytic  cell.    
  
Lastly,  section  4.3.8  covers  the  data  collected  during  patching  the  astrocytes  in  
slices.  The  effect  is  persistent  as  long  as  the  agonist  is  present  at  the  aCSF.  The  
facilitation  effect  takes  place  in  slices  as  well  as  in  isolated  cells.  However,  unlike  
in  isolated  cell,  the  increase  in  potassium  current  appears  at  -­‐‑130  mV  voltage  step  
(where  current  is  mainly  conducted  via  the  inwardly  rectifying  potassium  
channel).  
  
Overall,  the  data  presented  in  this  chapter  suggest  that  there  is  a  molecular  
mechanism  that  links  the  P2X,  NMDARs  and  PAR-­‐‑1  receptors  on  one  hand  and  
voltage-­‐‑gated  potassium  current  on  the  other.  It  has  been  shown  that  this  
mechanism  is  Calcium-­‐‑dependent,  and  involves  voltage-­‐‑gated  potassium  currents,  
but  not  inwardly  rectifying  potassium  currents.  This  mechanism  provides  a  link  
between  ionotropic  and  metabotropic  receptors,  expressed  in  astrocytes  and  the  
outward  potassium  current.  There  is  no  relationship  between  the  activation  of  
astrocyte  (by  influx  of  Calcium  ions)  and  the  inwardly  rectifying  potassium  
current.  Therefore  it  could  be  proposed  that  the  neurotransmitters,  spilled  at  the  
synapse  activate  astrocyte  and  cause  an  increased  of  outward  potassium  current.  
Alternatively,  the  extracellular  potassium  concentration  could  be  driven  up  by  
neuronal  activity.  It  is  possible  that  the  increased  outward  potassium  current  
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triggers  the  potassium  buffering  process,  but  more  experiments  are  needed  before  
any  conclusions  can  be  drawn.  This  mechanism  could  be  an  assistant  method  of  
recruiting  nearby  astrocytic  branches,  by  increasing  the  outward  potassium  
conductance,  which  would  initiate  the  process  of  potassium  buffering  in  these  
astrocytic  projections.  
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Chapter  5  –  Light  transmission  and  tissue  
swelling  
Astrocytes  participation  in  potassium  buffering  measured  as  changes  in  Light  
Transmittance  
5.1  Aim  and  hypothesis  
  
The  aim  of  this  chapter  is  to  put  the  mechanism,  described  in  Chapter  4  into  a  
physiological  context,  e.g.  ex  vivo  brain  slice.  Activation  of  a  number  of  astrocytic  
channels  was  shown  to  increase  the  outward,  but  not  inward  potassium  currents.  
However,  does  this  mechanism  take  place  in  an  intact  slice;  and  if  so,  what  is  the  
significance  of  this  autocrine  regulation  for  the  signalling  and  potassium  buffering  
processes  of  the  cortex?    
  
It  was  assumed,  that  potassium  currents  should  best  be  studied  via  considering  
their  involvement  in  tissue  swelling  and  potassium  buffering  (Kofuji  and  
Newman  2004;  Song  and  Gunnarson  2012;  Anděrová  et  al.  2014;  Chvátal,  
Anděrová,  and  Syková  2004).  A  method  chosen  for  this  chapter  was  experiments  
where  light  transmittance  of  the  tissue  slices  was  measured  (Kreisman  et  al.  1995).  
It  is  known  that  the  when  using  light  microscope  for  electrophysiological  
recordings,  the  tissue  slice  refracts  the  light  in  a  certain  pattern.  Changes  in  
relative  proportions  of  extra-­‐‑cellular  matrix  and  somas  will  affect  this  refractory  
pattern.  This  can  be  measured  by  taking  a  series  of  pictures  and  consecutive  
comparison  of  those  (see  Chapter  2  for  more  details).  The  current  scientific  
doctrine  agrees  that  during  the  process  of  potassium  buffering  astrocytes  take  up  
the  extracellular  potassium  and  water  molecules,  simultaneously  or  otherwise  
(Kofuji  and  Newman  2004;  Nagelhus,  Mathiisen,  and  Ottersen  2004).  This  in  turn  
causes  the  shrinkage  of  the  extracellular  space,  which  can  be  measured  by  the  light  
transmittance  experiments  as  an  increase  in  the  signal.    
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A  set  of  experiments  was  performed,  using  stimulation  of  different  strengths  to  
study  how  the  activity  of  slices  influences  the  tissue  swelling.  A  number  of  agents  
were  used  to  activate  or  block  the  mechanism,  described  previously  and  any  
changes  in  the  light  transmittance  signals  of  the  slices.  The  tissue  slices  were  
derived  from  young  adult  (1-­‐‑3  months  postnatal)  and  older  mice  (5-­‐‑8  months  
postnatal).  This  was  done  in  order  to  test  whether  the  light  transmittance  signals  
and  their  alterations  due  to  activity  would  be  different  in  slices  from  distinct  age  
groups.  For  some  of  the  experiments  data  collected  through  field  recordings  were  
compared  to  light  transmittance  data,  to  provide  comparison  between  data  
collected  by  the  laboratory  previous  and  in  due  course  of  this  project.    
5.2  Application  of  hypo-­‐‑osmotic  aCSF    
  
To  ensure  that  the  data  that  can  be  gathered  by  this  method  can  be  compared  to  
the  published  values,  certain  control  experiments  were  performed.  Firstly,  the  
addition  of  hypo-­‐‑osmotic  aCSF  was  tested  for  its  effect  on  the  transmittance  of  
light  in  the  brain  slice.  Similarly  to  Stroman  et  al.  (2008)  addition  of  hypo-­‐‑osmotic  
aCSF  increased  the  Light  Transmittance  (LT)  of  the  cortical  slices  used  by  a  little  
under  4%  of  the  control  signal  (See  Figure  5.1).  
     
        139  
  
Figure  5.1:  Response  to  hypo-­‐‑osmotic  aCSF  application.  A  –  Time  course  of  LT  (black)  where  red  
line  shows  the  application  of  the  hypo-­‐‑osmotic  aCSF.  Baseline  (grey)  shows  experiments  where  the  
hypo-­‐‑osmotic  aCSF  was  not  added  to  bath.    B  –  Peaks  of  LT  (ΔT/average  of  control  and  washout  
LT)  of  baseline  and  experiment  with  hypo-­‐‑osmotic  aCSF  addition.  The  application  of  hypo-­‐‑osmotic  
aCSF  produced  a  peak  of  1.038±3.6*10^-­‐‑4,  whereas  the  baseline  experiment  showed  no  significant  
increase  in  the  signal.    
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        140  
5.3  Measuring  activity-­‐‑dependent  tissue  swelling    
  
Tissue  swelling  in  response  to  activity  was  measured.  In  order  to  determine  the  
relationship  between  the  extent  of  tissue  swelling  and  the  activity  of  the  tissue  the  
following  experiments  were  conducted.  Since  the  typical  activity  mimicking  
stimulation  of  the  cortex  is  Theta  Burst  stimulation  (Larson  and  Munkácsy  2015),  
experiments  with  1,  2  and  5  Theta  bursts  were  performed.  The  stimulus  strength  
for  the  fEPSP  was  set  around  30-­‐‑50  percent  of  the  maximal,  to  ensure  that  the  
network  was  not  over-­‐‑activated.  Figure  5.2  shows  time  courses  for  experiments  
with  1,  2  and  5  Theta  Bursts  (TBS1,  2  and  5  respectively)  stimulations.  No  
significant  difference  was  found  between  the  sizes  of  the  peaks  produced  by  
various  amounts  of  stimulations:  the  maximal  peak  responses  measured  were  
0.011±7.1*10^-­‐‑4,  0.01±3.8*10^-­‐‑4  and  0.011±1.3*10^-­‐‑4  for  one,  two  and  five  Theta  Bursts  
respectively  (Section  B,  Figure  5.2).  However,  it  was  noticed  that  the  time  delay  
between  the  onset  of  activity  and  the  peak  of  the  response  increased  with  greater  
strength  and  duration  of  stimulation.  Figure  5.3  illustrates  a  close  up  of  the  
average  peaks  (section  A)  and  the  time  delays  between  the  stimulation  and  the  
highest  peak  of  the  response  reached  in  different  conditions  (section  B).  It  appears  
that  at  higher  stimulation,  the  TBS5,  the  peak  is  less  acute,  and  takes  longer  time  to  
reach  maximum:  just  under  one  minute  whereas  it  takes  13  seconds  to  reach  the  
peak  response  in  experiments  with  only  one  Theta  Burst  stimulation.  Another  
difference  is  the  decay  of  the  LT  signal  following  the  peak.  In  experiments  with  
TBS5  stimulation  the  recovery  of  the  signal  is  slower,  showing  that  although  the  
size  of  the  peak  and  therefore  the  extent  of  the  tissue  swelling  does  not  vary  
significantly,  the  time  it  takes  to  restore  the  resting  state  volumes  of  the  extra-­‐‑
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Figure  5.  2:  Responses  to  different  stimulation  strengths.  A  –  time  course  of  LT  experiments  
where  1  (black),  2  (red)  and  5  (blue)  Theta  Bursts  were  given  to  the  slice.  B  –  peak  values;  the  
stimulation  yielded  0.011±7.1*10^-­‐‑4,  0.01±3.8*10^-­‐‑4  and  0.011±1.3*10^-­‐‑4  respectively.  The  peaks  were  
not  significantly  different  from  each  other  (as  tested  with  two-­‐‑sample  t  test).    
  
Figure  5.3:  The  peaks  of  responses  to  various  stimulation  strengths.  A  –  peaks  of  LT  responses  to  
TBS1,  TBS2  and  TBS5.  B  –  time  delay  between  stimulation  and  peak  in  experiments  with  1,  2  and  5  
Theta  Bursts  stimulations;  *  p<0.01  as  calculated  with  two-­‐‑sample  t  test.    
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5.4  Tissue  swelling  in  response  to  1  TBS  
  
The  minimal  stimulation  (1  Theta  Burst  Stimulation)  was  applied  to  test  whether  
at  this  level  of  activity  any  changes  to  the  LT  signal  can  be  introduced  either  by  
pharmacological  agents  or  if  slices  from  group  II  mice  (6-­‐‑9  months  Postnatal)  
show  any  difference  in  the  response  to  1  TBS.  Firstly,  the  effect  of  the  addition  of  
10  µμM  of  TFLLR  to  experiments  with  slices  from  young  adult  and  older  mice.  The  
strengths  of  responses  to  a  single  Theta  Burst  Stimulation  were  compared  in  slices  
from  young  adult  and  older  mice.  A  solution  of  high  potassium  (10  mM)  was  also  
applied  as  a  control.    
5.4.1  Tissue  swelling  in  young  adult  (1-­‐‑3  months  PN)  and  older  (5-­‐‑8  months  PN)  
mice  in  response  to  1TBS  
  
A  single  Theta  Burst  stimulation  was  applied  to  slices  from  young  adult  and  older  
mice,  in  order  to  investigate  whether  there  is  a  differential  effect  of  activity  on  the  
Light  Transmittance  signal  in  slices  of  different  ages.  It  was  hypothesised  that  
there  would  be  a  difference  in  the  response  profile  to  the  same  stimulation,  
because  astrocytes  are  thought  to  start  loosing  the  efficiency  of  their  potassium  
buffering  function  (Sofroniew  and  Vinters  2009).  As  can  be  seen  from  Figure  5.4,  
the  response  of  the  slice  to  a  Theta  Burst  stimulation  reduces  in  group  II  mice:  the  
peak  becomes  less  prominent  and  the  rate  of  restoration  of  the  signal  is  lower  in  
experiments  with  older  mice.  The  experiments  using  the  young  adult  mice  had  a  
maximal  response  peak  of  0.012±2.4*10^-­‐‑3,  whereas  the  peak  reached  in  the  slices  
from  older  mice  was  0.007±4.5*10^-­‐‑4  ΔT.  This  can  be  explained  by  two  factors,  
perhaps  working  individually  or  in  synergy.  Since  it  is  much  harder  to  elicit  an  
electrophysiological  response  to  stimulation  in  older  mice,  for  example  the  LTP  
(Long-­‐‑Term  Potentiation)  requires  a  much  stronger  stimulus  than  in  young  mice  
(Lynch  et  al.  2008),  the  lower  LT  peak  in  mice  of  group  II  can  be  due  to  the  same  
phenomenon.  Alternatively,  the  potassium  buffering  could  already  be  starting  to  
decline  from  group  II  (6-­‐‑9  months  old)  onwards.  
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Figure  5.4:  Comparing  response  to  1  TBS  in  young  adult  and  older  mice.  A  –  time  course  of  
experiments  with  TBS1  stimulation  in  young  adult  (1-­‐‑3  months)  and  older  (5-­‐‑8  months)  mice.  
Arrow  shows  the  onset  of  stimulation.  B  –  Bar  chart  representation  of  peaks  and  baselines  of  
responses.  The  maximal  response  peaks  recorded  for  slices  from  young  adult  mice  were  
0.012±2.4*10^-­‐‑3,  and  peak  for  experiments  with  older  mice  were  0.007±4.5*10^-­‐‑4  ΔT.  The  responses  
measured  in  young  adult  mice  were  significantly  greater  than  that  of  the  older  mice,  as  calculated  
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5.4.2  The  effect  of  TFLLR  on  tissue  swelling  in  young  adult  mice  
  
A  single  Theta  Burst  stimulation  was  used  to  evoke  a  light  transmittance  signal  in  
coronal  slices  from  young  adult  mice.  In  order  to  test  whether  activation  of  PAR-­‐‑1  
receptor  on  astrocytes  can  influence  the  process  of  potassium  buffering  via  the  
mechanism  described  in  Chapter  4.  Figure  5.5  illustrates  the  data  gathered  for  
these  experiments  –  there  is  no  significant  difference  in  the  size  of  the  response  or  
its  duration  in  experiments  with  the  addition  of  the  TFLLR,  although  there  is  a  
trend  for  an  increase  in  the  size  of  the  peak.  The  maximal  peak  reached  by  the  
control  experiments  was  0.011±7.8*10^-­‐‑4  and  the  experiments  with  the  addition  of  
TFLLR  yielded  0.013±9.36*10^-­‐‑4  peak  of  light  transmittance.  It  was  proposed  that  
with  a  small  stimulation,  such  as  a  single  Theta  Burst  stimulation,  it  was  possible  
that  the  possible  effect  might  not  be  seen.    
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Figure  5.5:  Addition  of  TFLLR  to  slices  from  young  adult  mice  undergoing  1TBS.  A  –  time  course  
of  control  (black)  and  experiments  with  the  addition  of  TFLLR  (blue)  with  the  application  of  1  TBS.  
B  –  peak  size  in  control  (black)  and  experiments  with  TFLLR  (blue).  Black  arrow  illustrates  the  
onset  of  the  stimulation.  The  maximal  response  reached  0.011±7.8*10^-­‐‑4  in  control  experiments,  and  
0.013±9.36*10^-­‐‑4  in  the  experiments  with  the  addition  of  TFLLR.  Responses  were  not  significantly  
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5.4.3  Tissue  swelling  in  response  to  single  TBS  and  TFLLR  application  in  group  
II  mice  
  
Similarly  to  comparing  the  effect  of  the  addition  of  TFLLR  in  young  adult  mice,  
these  experiments  were  repeated  again  using  slices  derived  from  group  II  mice.  It  
was  done  in  order  to  check  whether  in  older  mice  application  of  TFFLR  –  agonist  
to  PAR-­‐‑1  receptor,  has  the  same  effect  to  the  response  of  the  slice  to  a  single  Theta  
Burst  stimulation.    
  
Figure  5.6  illustrates  the  data  gathered  for  group  II.  When  10  µμM  TFLLR  was  
added  to  bath,  the  peak  of  the  response  was  smaller  than  the  maximal  response  
peak  generated  in  control  experiments,  0.0065±1.4*10^-­‐‑4  and  0.0034±5.4*10^-­‐‑4  
respectively.  Due  to  the  method  for  data  analysis  (the  peak  is  compared  to  the  
average  between  control  and  washout  levels  of  Light  Transmittance),  the  peak  
appears  even  smaller  in  the  experiments  with  TFLLR  addition,  since  the  rate  of  
restoration  of  the  signal  back  to  pre-­‐‑stimulation  levels  is  much  slower  than  in  
control  experiments.  It  can  be  assumed  that  the  activation  of  PAR-­‐‑1  receptors  sets  
off  the  molecular  mechanism  described  in  Chapter  4.  As  a  result  of  the  activation  
of  this  mechanism  the  outward  potassium  current  of  astrocytes  is  increased,  thus  
increasing  the  amount  of  potassium  ions  in  the  extracellular  space.  It  is  possible  
that  the  presence  of  TFLLR  prevents  the  astrocytes  from  being  able  to  fully  execute  
the  buffering  of  potassium  due  to  increased  outward  potassium  current,  which  is  
seen  in  the  course  of  the  experiment  as  a  slower  rate  of  recovery  of  the  light  
transmittance  signal.  
        147  
  
Figure  5.6:  Addition  of  TFLLR  to  slices  from  young  adult  mice  undergoing  1TBS.  A  –  time  course  
of  control  (black)  and  experiments  with  the  addition  of  TFLLR  (blue)  with  the  application  of  1  TBS.  
B  –  peak  size  in  control  (black)  and  experiments  with  TFLLR  (blue).  Black  arrow  illustrates  the  
onset  of  stimulation,  red  line  shows  the  application  of  10  µμM  TFLLR.  The  maximal  response  
reached  0.0065±1.4*10^-­‐‑4  in  control  experiments,  and  0.0034±5.4*10^-­‐‑4  in  the  experiments  with  the  
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5.4.4  Tissue  swelling  in  response  to  single  TBS  and  α,  β  methylene-­‐‑ATP  
application in  group  I  mice  
  
Analogously  to  the  experiments  with  the  addition  of  TFLLR  (see  sections  5.4.2  and  
5.4.3)  some  experiments  where  the  agonist  of  P2X1/5  receptors  was  used.  In  the  
previous  chapter  of  this  study  it  was  shown  that  the  application  of  α,  β  methylene-­‐‑
ATP  raises  the  outward  potassium  current.  Figure  5.7  illustrates  the  data  for  these  
experiments.  The  baseline  of  the  experiments  with  the  addition  of  α,  β  methylene-­‐‑
ATP  rise  a  lot  more  than  the  control  experiments,  and  does  not  restore  to  the  pre-­‐‑
stimulation  levels  after  the  maximal  response  peak,  reaching  a  plateau  around  
102.6  per  cent  of  the  control  signal.  The  maximal  peak  yielded  by  the  stimulation  
in  the  control  experiments  was  0.011±7.8*10^-­‐‑4  and  0.009±6*10^-­‐‑4  in  the  experiments  
with  the  addition  of  α,  β  methylene-­‐‑ATP.  However,  because  the  signal  in  the  
experiments  with  the  addition  of  α,  β  methylene-­‐‑ATP  does  not  recover  fully,  an  
alternative  data  analysis  was  performed.  When  the  maximal  response  was  
normalised  to  the  control  signal  only,  the  maximal  peak  was  calculated  to  be  
0.031±6.7*10^-­‐‑4.  
  
So  the  activation  of  the  mechanism  described  in  the  previous  chapter  by  α,  β  
methylene-­‐‑ATP  increase  the  extent  of  the  tissue  swelling  in  these  experiments  and  
also  reduced  the  rate  of  recovery  following  the  stimulation  of  the  slice.  It  can  
therefore  be  proposed  that  this  mechanism  in  can  play  a  significant  role  in  both  
the  activity  of  the  slice  and  consecutive  tissue  swelling.  
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Figure  5.7:  Addition  of  α,  β  methylene-­‐‑ATP  to  slices  from  young  adult  mice  undergoing  1  TBS.  
A  –  time  course  of  control  (black)  and  experiments  with  the  addition  of  α,  β  methylene-­‐‑ATP  
(green)  with  the  application  of  1  TBS.  B  –  peak  size  in  control  (black)  and  experiments  with  α,  β  
methylene-­‐‑ATP  (green).  Black  arrow  illustrates  the  onset  of  stimulation,  red  line  shows  the  
application  of  10  µμM  α,  β  methylene-­‐‑ATP.  The  maximal  response  reached  0.011±7.8*10^-­‐‑4  in  control  
experiments,  and  0.009±6*10^-­‐‑4  in  the  experiments  with  the  addition  of  α,  β  methylene-­‐‑ATP.  When  
the  maximal  response  was  normalised  to  the  control  signal  only,  the  maximal  peak  was  calculated  
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5.4.5  Tissue  swelling  in  response  to  single  TBS  and  addition  of  high  KCL  
  
As  a  control  measure,  some  experiments  were  performed  where  a  solution  
containing  high  concentration  of  potassium  chloride  (10  mM)  was  applied  and  a  
single  Theta  Burst  stimulation  was  given  (see  Figure  5.8).  The  peak  signal  reached  
upon  the  addition  of  the  high  potassium  aCSF  was  approximately  4  times  greater  
than  the  peak  from  the  Theta  Burst  stimulation,  4.26±1.17*10^-­‐‑4  per  cent  increase  
was  seen  in  the  Light  Transmittance  of  the  experiments  when  the  aCSF  with  high  
potassium  was  added.  The  peaks  recorded  from  the  stimulation  were  1.1±7.77*10^-­‐‑
4  and  0.98±1.31*10^-­‐‑4  per  cent  increase  in  the  light  transmittance  signal  in  control  
and  high  KCL  experiments  respectively.  The  peaks  corresponding  to  stimulation  










        151  
  
Figure  5.8:  Addition  of  10  mM  KCL  solution  to  slices  from  young  adult  mice  undergoing  1  TBS.  
A  –  time  course  of  control  (black)  and  experiments  with  the  addition  of  aCSF  with  high  potassium  
(blue)  with  the  application  of  1  TBS.  B  –  peak  size  in  control  (black)  and  experiments  with  high  
KCL  (blue).  Black  arrow  illustrates  the  onset  of  stimulation;  red  line  shows  the  application  of  aCSF  
with  10  mM  KCL.  The  maximal  peak  reached  0.011±7.8*10^-­‐‑4  in  control  experiments,  and  
0.009±1.3*10^-­‐‑4  in  the  experiments  with  the  addition  of  aCSF  containing  high  potassium.  The  
maximal  response  to  the  high  potassium  solution  was  calculated  to  be  0.043±1.1*10^-­‐‑4;  n.s.  –  no  
significant  difference,  *  -­‐‑  p<  0.00001  as  calculated  with  two-­‐‑sample  t  test.  
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5.5  Tissue  swelling  in  response  to  2  TBS2  
  
It  was  proposed  that  in  order  to  study  the  activity  of  the  tissue  a  greater  
stimulation  might  be  required  still.  In  the  cortex,  to  reach  the  Long-­‐‑Term  
Potentiation  a  much  greater  stimulus  is  required  compared  to  hippocampus  for  
example  (Malenka  1994;  Kuo  and  Dringenberg  2012).  For  this  reason  some  of  the  
experiments  were  performed  using  two  or  five  (see  Section  5.6)  Theta  Burst  
stimulation.  In  this  section  the  data  gathered  for  the  experiments  with  two  Theta  
Bursts  stimulations  are  described.  Both  time  courses  of  experiments  and  bar  charts  
representing  the  peak  responses  and  baselines  are  presented  as  averages  and  
standard  error  of  means.  
5.5.1  Comparing  the  response  to  2  TBS  of  slices  derived  from  young  adult  and  
older  mice  (groups  I  and  II  respectively)  
  
The  response  to  5  TBS  was  recorded  for  slices  derived  from  the  young  adult  and  
older  mice  (groups  I  and  II  respectively).  The  maximal  peaks  of  response  were  
compared  as  well  as  the  rate  of  decay  of  these  peaks.  The  data  gathered  for  these  
experiments  are  summarised  in  Figure  5.9.  The  maximal  peaks  of  the  response  to  
stimulation  were  not  significantly  different  in  experiments  with  two  age  groups:  
0.009±1.3*10^-­‐‑3  and  0.011±7.4*10^-­‐‑4  for  groups  I  and  II  respectively,  although  the  
trend  shows  the  increase  of  the  response  in  older  mice.  Also,  in  the  experiments  
with  slices  from  group  II  mice  the  rate  of  decay  of  the  signal  is  slower  and  the  
signal  remains  significantly  higher  than  in  the  control  experiments.  The  same  
effect  was  found  when  comparing  the  responses  to  a  single  Theta  Burst  
stimulation  in  experiments  with  different  ages  of  mice.  This  consistency  leads  to  
believe  that  it  might  be  an  important  difference,  that  is  apparent  between  groups  I  
and  II  already.    
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Figure  5.9:  Responses  to  2  TBS  in  young  adult  and  older  mice.  A  –  time  course  of  experiments  
with  TBS2  stimulation  in  young  adult  and  older  mice.  Arrow  shows  stimulation.  B  –  Bar  chart  
representation  of  peaks  and  baselines  of  responses.  The  maximal  peaks  were  recorded  to  be  
0.009±1.3*10^-­‐‑3  and  0.011±7.4*10^-­‐‑4  for  groups  I  and  II  respectively.  No  significant  difference  was  
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5.5.2  The  effect  of  the  addition  of  TFLLR  to  the  experiments  with  2  TBS  in  slices  
from  young  adult  mice  
  
The  experiments  with  the  addition  of  TFLLR  in  young  adult  mice  were  repeated  
with  two  Theta  Bursts  stimulations.  Figure  5.9  summarises  the  data  gathered.  
Under  the  addition  of  TFLLR  the  maximal  response  upon  the  stimulation  is  much  
smaller  than  that  of  the  control  experiments.  The  shape  of  the  peak  response  was  
different  from  that  of  the  control  experiment,  as  well  as  the  speed  of  restoration  of  
the  signal.  However,  no  significant  difference  was  measured  in  the  signal  
following  the  response  to  the  stimulation.    
  
The  effect  of  the  addition  of  TFLLR  in  experiments  with  1  Theta  Burst  stimulation  
yielded  a  response  that  was  not  significantly  different  from  the  control.  In  fact,  the  
trend  the  data  display  shows  a  decrease  in  the  maximal  peak  size  in  the  
experiments  with  a  single  stimulation.  The  data  displayed  on  Figure  5.9  show  a  
similar  trend:  the  peak  size  of  the  maximal  response  is  smaller  than  that  of  control  
experiments,  0.004±1.6*10^-­‐‑4  against  0.009±6.2*10^-­‐‑4.  However,  due  to  the  lack  of  
recovery  in  the  signal,  following  the  stimulations,  the  data  analysis  shows  the  
difference  in  the  peak  size  as  a  significant  result.  It  is  argued  that  if  the  maximal  
responses  were  only  compared  to  T0  (the  last  time  point  prior  to  stimulation),  then  
the  difference  between  the  experiments  with  the  addition  of  drug  and  without  
would  disappear.  Indeed,  this  alternative  method  of  analysis  produced  an  average  
peak  value  of  0.014±1.37*10^-­‐‑4  for  experiments  with  the  addition  of  TFLLR  and  
0.014±6.43*10^-­‐‑4  for  the  control  experiments.  No  significant  difference  was  detected  
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Figure  5.10:  Addition  of  TFLLR  to  slices  from  young  adult  mice  undergoing  2  TBS.  A  –  time  
course  of  control  (black)  and  experiments  with  the  addition  of  TFLLR  (purple)  with  the  application  
of  2  TBS.  B  –  peak  size  in  control  (black)  and  experiments  with  TFLLR  (purple).  Black  arrow  
illustrates  the  onset  of  stimulation;  red  line  shows  the  application  of  10  µμM  of  TFLLR.  The  maximal  
peak  reached  0.009±6.2*10^-­‐‑4  in  control  experiments,  and  0.004±1.6*10^-­‐‑4    in  the  experiments  with  
the  addition  of  TFLLR.  When  the  maximal  response  was  normalised  to  the  control  signal  only,  the  
maximal  peak  was  calculated  to  be  0.014±6.43*10^-­‐‑4  in  the  control  and  0.014±1.37*10^-­‐‑4  in  
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5.5.3  The  effect  of  the  addition  of  TFLLR  to  the  experiments  with  2  TBS  in  slices  
from  group  II  mice  
  
Similarly  to  experiments  with  the  addition  of  TFLLR  to  slices  cut  from  young  
adult  mice  (1-­‐‑3  months  postnatal)  some  experiments  were  performed  using  the  
slices  derived  from  mice  from  group  II  (6-­‐‑9  months  postnatal).  This  was  done  to  
investigate  whether  the  effect  of  the  drug  application  is  different  in  older  mice  
with  a  stronger  stimulation.  As  can  be  seen  from  Figure  5.10,  the  responses  
recorded  for  two  conditions  were  fairly  similar  in  shape,  but  not  in  peak  size.  
Application  of  10  µμM  TFLLR  caused  a  decrease  in  the  maximal  response  size,  
yielding  only  0.007±1.1*10^-­‐‑4  increase  whereas  control  experiments  had  an  increase  
in  the  light  transmittance  of  0.011±2.24*10^-­‐‑4.    The  data  collected  for  experiments  
with  TFLLR  with  young  adult  and  older  mice  demonstrates  a  similar  trend  for  
decrease  of  the  peak  size  when  compared  to  respective  control  experiments.    
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Figure  5.11:  Addition  of  TFLLR  to  experiments  with  2  TBS  in  group  II  mice.  A  –  time  course  of  
experiments  with  TBS2  stimulation  showing  control  experiments  (black)  and  experiments  with  
TFLLR  application  (green).  Arrow  shows  the  onset  of  stimulation.  B  –  Bar  chart  representation  of  
peaks  and  baselines  of  responses.  The  maximal  peak  of  the  experiments  with  TFLLR  application  
was  0.007±1.1*10^-­‐‑4  whereas  control  experiments  had  an  increase  in  the  light  transmittance  of  
0.011±2.24*10^-­‐‑4.  The  peak  in  control  experiments  was  significantly  greater  than  that  of  experiments  
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5.5.4  The  effect  of  the  addition  of  α,  β  methylene-­‐‑ATP  to  the  experiments  with  2  
TBS  in  slices  derived  from  group  I  mice  
  
Experiments  with  the  addition  of  α,  β  methylene-­‐‑ATP  were  performed  using  2  
Theta  Burst  stimulations,  in  order  to  investigate  whether  the  effect  of  the  drug  
application  varies  with  the  stronger  stimulus.  In  experiments  with  a  single  
stimulation  the  addition  of  α,  β  methylene-­‐‑ATP  yielded  a  diminished  maximal  
peak  response  to  the  stimulation.  When  comparing  those  data  with  experiments  
where  two  Theta  Burst  stimulations  were  applied  (see  Figure  5.11),  the  trend  
appears  to  stay  the  same.  Here  the  peak  response  measured  was  slightly  lower  
than  that  of  control  experiments:  0.009±6.2*10^-­‐‑4against  0.008±3.32*10^-­‐‑4.  However,  
due  to  an  increase  in  the  baseline  and  the  data  analysis  method  (the  peak  was  
normalised  to  the  average  between  control  and  washout  signals),  these  averages  
do  not  seem  to  reflect  the  true  pattern.    When  the  peaks  were  normalised  to  the  
control  signal  only,  the  maximal  responses  were  0.013±1.58*10^-­‐‑4  in  control  and  
0.022±1.81*10^-­‐‑4  in  experiments  with  α,  β  methylene-­‐‑ATP.  The  peaks  evoked  by  
stimulation  in  experiments  with  α,  β  methylene-­‐‑ATP  were  significantly  greater  
than  those  of  control  experiments,  as  calculated  with  the  two-­‐‑sample  t  test  
(p<0.0001).  
  
Following  this  inconclusiveness  of  the  data  it  was  decided  to  repeat  the  
experiments  with  the  addition  of  α,  β  methylene-­‐‑ATP  using  5  Theta  Burst  
stimulations  as  well  to  examine  the  role  of  the  stimulation  strength  for  this  effect.  
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Figure  5.12:  Addition  of  α,  β  methylene-­‐‑ATP  to  experiments  with  2  TBS  in  group  I  mice.  A  –  
time  course  of  experiments  with  TBS2  stimulation  showing  control  experiments  (dark  grey)  and  
experiments  with  α,  β  methylene-­‐‑ATP  application  (dark  cyan).  Arrow  shows  the  onset  of  
stimulation.  B  –  Bar  chart  representation  of  peaks  and  baselines  of  responses.  The  maximal  peak  of  
the  experiments  with  α,  β  methylene-­‐‑ATP  application  was  0.008±3.32*10^-­‐‑4  whereas  control  
experiments  had  an  increase  in  the  light  transmittance  of  0.009±6.2*10^-­‐‑4.  When  the  peaks  were  
normalised  to  the  control  signal  only,  the  maximal  responses  were  0.013±1.58*10^-­‐‑4  in  control  and  
0.022±1.81*10^-­‐‑4  in  experiments  with  α,  β  methylene-­‐‑ATP  .The  peak  in  control  experiments  was  
significantly  greater  than  that  of  experiments  with  the  addition  of  α,  β  methylene-­‐‑ATP,  as  
calculated  with  two-­‐‑sample  t  test;  n.s.  –  not  significant,  as  calculated  with  two-­‐‑sample  t  test.  
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5.5.5  The  effect  of  the  addition  of  TFLLR  to  the  experiments  with  2  TBS  and  
addition  of  high  KCL  in  slices  from  group  I  mice  
  
The  reaction  to  bath  application  of  high  KCL  aCSF  was  measured  in  experiments  
with  two  Theta  Burst  stimulations  under  the  control  and  application  of  10  µμM  
TFLLR  experiments.  It  was  hypothesised  that  the  application  of  TFLLR  should  
decrease  the  extent  of  tissue  swelling  upon  the  Theta  Burst  stimulations,  similarly  
to  the  results  obtained  in  the  experiments  with  two  Theta  Burst  stimulations.  Since  
the  addition  of  TFLLR  reduced  the  maximal  response  of  the  light  transmittance,  it  
was  also  assumed  that  the  addition  of  high  KCL  aCSF  would  yield  a  similar  data  
pattern.  Figure  5.12  shows  the  data  collected  for  these  experiments.  Two  Theta  
Burst  stimulations  yielded  a  peak  0.0130±2.0*10^-­‐‑4  compared  with  0.0128±4.2*10^-­‐‑4  
increase  in  light  transmittance  produced  by  two  Theta  Burst  stimulations  in  the  
presence  of  TFLLR.  As  in  the  previous  experiments  the  addition  of  TFLLR  lightly  
reduced  the  size  of  the  peak  in  the  response,  although  in  this  case  the  difference  
was  not  significant,  as  calculated  with  two-­‐‑sample  t  test.  This  was  not  the  case  for  
the  peak  generated  by  the  application  of  high  KCL.  The  presence  of  10  µμM  TFLLR  
increased  the  size  of  the  light  transmittance  by  0.0676±1.2*10^-­‐‑4  compared  to  
0.0569±1.0*10^-­‐‑4  ΔT  increase  in  control  experiments.  This  increase  in  the  signal  
response  to  high  KCL  solution  is  significantly  greater  in  experiments  with  TFLLR,  
as  calculated  with  two-­‐‑sample  t  test.  It  is  possible  that  the  application  of  TFLLR  
activates  the  mechanism,  described  in  Chapter  4  Results,  which  in  turn  causes  an  
increased  tissue  swelling,  producing  a  greater  change  in  the  light  transmittance  
signal  of  the  tissue  upon  the  second  depolarisation  achieved  with  high  KCL  aCSF.    
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Figure  5.13:  Addition  of  high  KCL  solution  to  slices  from  young  adult  mice  undergoing  2  TBS  
with  and  without  the  application  of  TFLLR.  A  –  time  course  of  control  (blue)  and  experiments  
with  the  addition  of  aCSF  with  high  potassium  (green)  with  the  application  of  2  TBS.  B  –  peak  size  
in  control  (blue)  and  experiments  with  high  KCL  (green).  Black  arrow  illustrates  the  onset  of  
stimulation;  red  line  shows  the  application  of  aCSF  with  10  mM  KCL  and  the  green  line  shows  the  
application  of  10  µμM  TFLLR.  The  maximal  peak  reached  0.0130±2.0*10^-­‐‑4  in  control  experiments  
(blue  bar  with  dense  fill),  and  0.0128±4.2*10^-­‐‑4  in  the  experiments  with  the  addition  of  TFLLR  
(green  bar  with  dense  fill).  The  peaks  reached  by  the  addition  of  aCSF  containing  high  potassium  
were  0.0569±1.0*10^-­‐‑4  in  control  (blue  bar  with  medium  fill)  and  0.0676±1.2*10^-­‐‑4  in  experiments  
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5.6  Tissue  swelling  in  response  to  5  TBS  
  
All  of  the  experiments  were  repeated  with  5  Theta  Burst  stimulations,  in  order  to  
study  the  STP  and  LTP  (Short-­‐‑Term  and  Long-­‐‑Term  Potentiation  respectively).  
Five  Theta  Bursts  stimulation  are  a  sufficient  stimulus  for  evoking  LTP  (Rasooli-­‐‑
Nejad  et  al.  2014).  Both  time  courses  of  experiments  and  bar  charts  representing  
the  peak  responses  and  baselines  are  presented  as  averages  and  standard  error  of  
means.    
  
5.6.1  Comparing  the  response  in  light  transmittance  signal  to  5  TBS  of  slices  
from  young  adult  and  older  mice  (groups  I  and  II  respectively)  
  
Similarly  to  experiments  with  one  and  two  Theta  Burst  stimulations,  the  changes  
in  light  transmittance  of  the  slices  of  different  age  groups  were  compared,  but  this  
time  a  stronger  stimulation  was  used.  Figure  5.13  summarises  the  data  collected  
for  these  experiments.  The  data  points  show  a  familiar  trend:  in  experiments  with  
older  mice  the  change  in  the  light  transmittance  and  therefore  the  extent  of  tissue  
swelling  does  not  fully  return  back  to  baseline  level  but  instead  the  swelling  
reaches  a  plateau  after  a  small  decrease.  Due  to  the  fact  that  the  peak  is  measured  
by  comparing  the  maximal  response  to  the  average  between  the  control  and  the  
washout  signals,  the  peak  size  does  not  appear  to  be  greater  in  experiments  with  
mice  of  group  II  as  oppose  to  young  adult  mice.  Experiments  with  group  I  yielded  
a  0.0147±1.6*10^-­‐‑4  increase,  whereas  the  signal  in  experiments  with  group  II  mice  
only  raised  the  signal  by  0.0131±2.6*10^-­‐‑4  per  cent.  However,  if  the  washout  
reading  was  taken  out  of  the  account,  then  the  maximal  responses  were  
0.0152±2.0*10^-­‐‑4  and  0.0187±2.5*10^-­‐‑4  for  groups  I  and  II  respectively.    
  
It  was  also  noted  that  in  the  experiments  with  5  TBS  stimulation,  the  difference  in  
the  signal  at  the  end  of  the  experiment  (15-­‐‑20  minutes  from  the  start)  were  
significantly  different  in  the  age  groups  used.  Following  the  stimulation,  the  slices  
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that  originated  from  group  II  mice  retained  a  higher  light  transmittance  signal  
than  before  the  stimulation.  This  means  that  the  older  slices  performed  less  
effective  potassium  buffering  and  therefore  had  a  greater  tissue  swelling  and  
depolarisation  of  the  tissue.  This  phenomenon  could  be  the  reason  for  the  
decreased  likelihood  of  LTP  generation  in  older  slices.    
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Figure  5.14:  Responses  to  5  Theta  Bursts  stimulations  in  young  adult  and  older  mice.  A  –  time  
course  of  experiments  with  TBS5  stimulation  in  young  adult  (black)  and  older  (green)  mice.  Black  
arrow  shows  the  onset  of  stimulation.  B  –  Bar  chart  representation  of  peaks  and  baselines  of  
responses.  The  maximal  peak  responses  recorded  upon  the  stimulation  were  0.0147±1.6*10^-­‐‑4  in  
young  and  0.0131±2.6*10^-­‐‑4  in  older  mice.  The  difference  between  peaks  was  significant  as  
calculated  with  two-­‐‑sample  t  test  (p<1.8*10^-­‐‑5).  The  difference  in  light  transmittance  signal  10  
minutes  after  the  onset  of  stimulation  was  also  significant.  When  alternative  analysis  method  was  
used,  where  the  peak  sizes  were  normalised  to  control  signal  only,  the  peaks  yielded  were  
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5.6.2  The  effect  of  the  addition  of  TFLLR  to  the  experiments  with  5  TBS  in  slices  
from  young  adult  mice  
  
As  stated  above,  the  experiments  with  addition  of  10  µμM  TFLLR  were  also  
repeated  with  five  Theta  Bursts  stimulations.  In  regular  Long-­‐‑Term  Potentiation  
experiments,  5  TBS  stimulus  consistently  produces  LTP  in  cortex(Lalo  et  al.  2014).  
Figure  5.13  illustrates  the  data  collected  for  these  experiments.  The  application  of  
10  µμM  TFLLR  prior,  during  and  just  after  the  onset  of  stimulation  causes  a  large  
increase  in  the  maximal  peak  of  the  light  transmittance  signal.  In  these  
experiments  with  slices  from  young  adult  mice  the  control  experiments  
experienced  a  0.0147±1.61*10^-­‐‑4  increase  in  the  signal,  whereas  the  experiments  
with  the  addition  of  TFLLR  had  0.0475±9.4*10^-­‐‑4  peak  upon  the  stimulation.  Not  
only  the  peak  size  increased  by  the  addition  of  the  drug.  The  rate  at  which  the  
signal  fell  after  the  stimulation  was  significantly  greater  in  experiments  with  
TFLLR,  although  it  did  not  quite  restore  back  to  the  resting  levels  completely,  thus  
keeping  the  washout  part  of  the  signal  still  higher  than  that  of  the  control  
experiments.  This  increase  did  not  take  place  in  any  previous  experiments,  
possibly  due  to  insufficient  stimulation  strength.  In  fact,  in  experiments  with  
weaker  stimuli  (see  Sections  5.4.2-­‐‑5.4.3  and  5.5.2-­‐‑5.5.3)  the  addition  of  10  µμM  
TFLLR  reduced  the  swelling  of  the  tissue.  It  can  be  concluded  that  the  presence  of  
TFLLR  in  the  experiments  with  5TBS  stimulation  increased  the  extent  of  the  tissue  
swelling  by  roughly  a  factor  of  3.  Since  the  assumption  is  that  this  PAR-­‐‑1  agonist  
caused  an  increase  in  the  outward  potassium  current,  this  increase  in  the  tissue  
swelling  can  be  attributed  to  the  outflow  of  potassium  from  the  astrocytes.  
However,  an  increase  in  the  rate  of  decay  of  the  signal  was  also  seen,  which  is  
assumed  to  be  due  to  an  increase  in  the  potassium  buffering  by  astrocytes.  It  is  
possible  then  to  speculate  that  there  can  be  a  two-­‐‑step  mechanism  for  switching  on  
this  potassium  buffering  function  of  the  syncytium.    
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Figure  5.15:  Addition  of  TFLLR  to  experiments  with  5  TBS  in  group  I  mice  (  1-­‐‑3  months  old).  A  –  
time  course  of  experiments  with  TBS5  stimulation  showing  control  experiments  (black)  and  
experiments  with  TFLLR  application  (burgundy).  Black  arrow  shows  the  onset  of  stimulation,  and  
the  red  lines  shows  the  application  of  TFLLR  in  experiments  where  the  drug  was  applied.  B  –  Bar  
chart  representation  of  peaks  and  baselines  of  responses,  normalised  to  the  average  between  the  
control  (T0)  and  washout  signals  (T15).  The  maximal  peak  of  the  experiments  with  TFLLR  
application  was  0.0475±9.4*10^-­‐‑4  whereas  control  experiments  had  an  increase  in  the  light  
transmittance  of  0.0147±1.61*10^-­‐‑4  ΔT.  The  peak  in  control  experiments  was  significantly  smaller  
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5.6.3  The  effect  of  the  addition  of  TFLLR  to  the  experiments  with  5  TBS  in  slices  
from  group  II  mice  
  
In  order  to  study  the  effect  of  age,  experiments  with  5  Theta  Burst  stimulations  
and  the  application  of  TFLLR  were  repeated,  this  time  with  slices  derived  from  
older  mice.  The  data  collected  for  these  experiments  are  summarised  in  Figure  
5.14.  The  data  are  visibly  different  from  those  collected  using  young  adult  mice.  In  
experiments  where  5-­‐‑8  months  old  mice  were  used,  there  was  no  greater  increase  
in  the  maximal  response  to  the  stimulation  in  the  experiments  with  TFLLR  
application  than  in  the  control  ones.  Both  the  amplitude  of  the  response  and  the  
speed  of  recovery  of  the  signal  appeared  largely  similar  to  those  of  the  control  
experiments.  It  is  surprising  that  the  effect  of  the  addition  of  TFLLR  to  young  
adult  slices  diminishes  to  this  extent  by  age  group  II.    
  
The  maximal  increase  of  the  response  reached  by  the  control  experiments  was  
0.0131±2.6*10^-­‐‑4  ΔT  whereas  the  experiments  with  the  addition  of  TFLLR  yielded  a  
peak  of  0.0145±3.3*10^-­‐‑4,  which  was  significantly  greater  than  the  control  peak,  as  
calculated  with  the  two-­‐‑sample  t  test.  However,  the  facilitation  effect  of  TFLLR  
addition  was  greatly  diminished  in  older  mice  of  group  II.  This  once  more  leads  to  
believe  that  there  is  a  mechanism  at  work  that  starts  to  fade  from  middle  age  
already.    
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Figure  5.16:  Addition  of  TFLLR  to  experiments  with  5  TBS  in  group  II  mice  (5-­‐‑8  months  
postnatal).  A  –  time  course  of  experiments  with  TBS5  stimulation  showing  control  experiments  
(navy)  and  experiments  with  TFLLR  application  (burgundy).  Black  arrow  shows  the  onset  of  
stimulation,  and  the  red  lines  shows  the  application  of  TFLLR  in  experiments  where  the  drug  was  
applied.  B  –  Bar  chart  representation  of  peaks  and  baselines  of  responses,  normalised  to  the  
average  between  the  control  (T0)  and  washout  signals  (T15).  The  maximal  peak  of  the  control  
experiments  was  0.0145±3.3*10^-­‐‑4  whereas  experiments  with  TFLLR  application  had  an  increase  in  
the  light  transmittance  of  0.0131±2.6*10^-­‐‑4  ΔT.  The  peaks  were  not  significantly  different,  as  
calculated  with  two-­‐‑sample  t  test.  
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5.6.4  The  effect  of  the  addition  of  α,  β  methylene-­‐‑ATP  to  the  experiments  with  5  
TBS  in  slices  from  young  adult  mice  
  
The  experiments  with  five  Theta  Bursts  stimulations  and  the  application  of  10  µμM  
α,  β  methylene-­‐‑ATP  were  performed  to  compare  the  effect  of  the  addition  of  this  
drug  in  the  experiments  with  a  stronger  stimulation.  The  data  collected  for  these  
experiments  is  presented  on  Figure  5.15.  The  control  experiments  showed  the  
maximal  response  of  0.0147±1.6*10^-­‐‑4,  whereas  the  addition  of  10  µμM  α,  β  
methylene-­‐‑ATP  yielded  a  peak  of  0.0260±7.3*10^-­‐‑4.  This  difference  was  significant,  
as  calculated  with  two-­‐‑sample  t  test.  Similarly  to  the  pattern,  displayed  by  the  
experiments  with  TFLLR  application,  both  the  size  of  the  peak  of  the  response  as  
well  as  the  speed  of  the  recovery  of  the  light  transmittance  signal  is  increased  
when  compared  to  control  experiments.    
  
Another  similarity  of  the  data  collected  for  α,  β  methylene-­‐‑ATP  and  TFLLR  
experiments  is  that  the  plateau  reached  by  the  signal  after  recovering  from  the  
stimulation  is  significantly  greater  than  the  washout  portion  of  the  signal  of  the  
control  experiments.  As  can  be  seen  from  Figure  5.14,  between  15  and  20  minutes  
after  the  start  of  the  experiment  the  average  signal  in  the  experiments  with  the  
addition  of  the  drug  was  measured  to  be  1.04±8.2*10^-­‐‑4,  and  this  was  significantly  
greater  than  99.8±6.9*10^-­‐‑3  per  cent  light  transmittance  signal  that  was  measured  in  
control  experiments.  The  consistency  of  these  data  patterns  increases  the  reliability  
of  the  hypothesis  that  the  mechanism  described  in  the  previous  chapter  is  linked  
to  potassium  buffering  function  of  astrocytes.      
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Figure  5.17:  Addition  of  α,  β  methylene-­‐‑ATP  to  experiments  with  5  TBS  in  group  I  mice  (1-­‐‑3  
months  postnatal).  A  –  time  course  of  experiments  with  TBS5  stimulation  showing  control  
experiments  (black)  and  experiments  with  α,  β  methylene-­‐‑ATP  application  (red).  Black  arrow  
shows  the  onset  of  stimulation,  and  the  red  line  shows  the  application  of  α,  β  methylene-­‐‑ATP  in  
experiments  where  the  drug  was  applied.  B  –  Bar  chart  representation  of  peaks  and  baselines  of  
responses,  normalised  to  the  average  between  the  control  (T0)  and  washout  signals  (T15).  The  
maximal  peak  in  the  experiments  with  α,  β  methylene-­‐‑ATP  application  was  0.0147±1.6*10^-­‐‑4  
whereas  control  experiments  had  an  increase  in  the  light  transmittance  of  0.0260±7.3*10^-­‐‑4  ΔT.  The  
peak  in  control  experiments  was  significantly  smaller  than  that  of  experiments  with  the  addition  of  
α,  β  methylene-­‐‑ATP,  as  calculated  with  two-­‐‑sample  t  test;  ***  –  p<0.0001.  
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5.6.5  The  effect  of  the  addition  of  memantine  to  the  experiments  with  5  TBS  in  
slices  from  young  adult  mice  
  
Another  drug  was  applied  to  the  experiments  with  5  Theta  Bursts  stimulation  –  
memantine.  Memantine  is  a  drug  used  currently  used  for  treatment  of  dementia,  
and  specifically  as  part  of  the  combinational  therapy  in  Alzheimer’s  disease  (J.  Ma,  
Mufti,  and  Leung  2015).  At  low  concentrations,  such  as  3  µμM  memantine  
preferentially  binds  to  NMDA  receptors  on  glial  cells  (Talantova  et  al.  2013).  Since  
memantine  acts  on  glial  NMDARs  it  was  assumed  that  it  could  also  have  an  effect  
on  the  mechanism  linking  stimulation  of  various  ionic  channels  of  glial  with  
increased  outward  potassium  current.  The  results  collected  for  these  experiments  
are  presented  on  Figure  5.16  below.  As  can  be  seen,  the  maximal  peak  of  the  
response  was  not  altered  significantly  by  the  addition  of  memantine.  The  increase  
measured  in  the  control  experiments  was  0.0147±1.6*10^-­‐‑4  whereas  in  experiments  
with  the  addition  of  memantine  the  increase  was  only  0.010±1.2*10^-­‐‑4  ΔT.  Due  to  
the  nature  of  the  data  analysis  used,  the  amplitude  of  the  peak,  normalised  to  the  
average  of  control  and  washout  light  transmittance  signal,  appears  to  be  smaller  in  
experiments  with  the  addition  of  memantine.  When  the  alternative  analysis  
method  was  used,  the  maximal  peaks  reached  by  the  control  and  memantine  
experiments  were  0.0152±2.0*10^-­‐‑4  and  0.0158±1.1*10^-­‐‑4  respectively.  Another  
peculiarity  was  the  rate  of  the  recovery  of  the  peak  -­‐‑  it  was  much  slower  in  the  
experiments  where  the  drug  was  applied.  Overall,  following  the  peak  of  the  
response  to  5  Theta  Bursts,  the  signal  in  recording  with  memantine  does  not  fall  
significantly  until  the  end  of  the  experiment,  thus  meaning  that  the  initial  tissue  
swelling  that  was  achieved  by  the  stimulation  was  not  reversed  completely  by  
potassium  buffering.  It  is  possible  that  by  blocking  astrocytic  NMDARs,  
memantine  prevents  the  triggering  of  the  mechanism  that  would  otherwise  set  off  
the  process  of  potassium  buffering.    
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Figure  5.18:  Addition  of  memantine  to  experiments  with  5  TBS  in  group  I  mice  (1-­‐‑3  months  
postnatal).  A  –  time  course  of  experiments  with  TBS5  stimulation  showing  control  experiments  
(navy)  and  experiments  with  memantine  application  (purple).  Black  arrow  shows  the  onset  of  
stimulation,  and  the  red  line  shows  the  application  of  memantine  in  experiments  where  the  drug  
was  applied.  B  –  Bar  chart  representation  of  peaks  and  baselines  of  responses,  normalised  to  the  
average  between  the  control  (T0)  and  washout  signals  (T15).  The  maximal  peak  in  the  experiments  
with  memantine  application  was  0.010±1.2*10^-­‐‑4  whereas  control  experiments  had  an  increase  in  
the  light  transmittance  of  0.0147±1.6*10^-­‐‑4  ΔT.  The  peak  in  experiments  with  the  addition  of  
memantine  was  significantly  smaller  than  that  of  control  experiments,  as  calculated  with  two-­‐‑








     
B  A  
        173  
5.7  Simultaneous  tissue  swelling  and  LTP  recordings  
  
Some  of  the  experiments  were  continued  for  a  longer  duration.  This  was  done  in  
order  to  collect  and  compare  data  for  both  light  transmittance  and  LTP  alike.  In  
this  section  the  data  collected  for  these  longer  experiments  are  presented.  
Similarly  to  the  data  described  previously,  the  time  courses  of  average  
experiments,  both  light  transmittance  and  electrophysiological  ones  are  presented  
as  well  as  bar  charts  of  peak  amplitudes,  signals  at  20-­‐‑22  minutes  and  slopes  of  
fEPSP.  All  data  are  presented  as  averages  with  standard  error  of  mean,  unless  
otherwise  stated.    
5.7.1  The  effect  of  the  addition  of  TFLLR  to  the  experiments  with  2  TBS  in  slices  
from  young  adult  mice  
  
Experiments  with  two  Theta  Burst  stimulations  and  TFLLR  application  were  
recorded  for  longer  durations,  to  measure  both  the  light  transmittance  signal  and  
the  fEPSP  slope.  Figure  5.17  illustrates  data  collected  for  both  the  light  
transmittance  signals  and  electrophysiological  recordings  made  for  both  
experimental  conditions.  Two  Theta  Burst  stimulations  normally  do  not  provide  a  
sufficient  stimulation  for  the  onset  for  LTP,  and  so  the  addition  of  10  µμM  TFLLR  
was  hypothesised  to  rectify  this.    
  
The  light  transmittance  signals  were  not  significantly  different  in  experiments  
with  the  addition  of  10  µμM  TFLLR,  with  the  maximal  peak  responses  reaching  
0.0080±2.99*10^-­‐‑4  and  0.0083±2.04*10^-­‐‑4  ΔT  respectively.  As  explained  above  the  
analysis  method  diminishes  the  effect  of  the  addition  of  TFLLR  on  the  maximal  
response  to  the  stimulation  and  therefore  appears  to  be  not  altered,  however  when  
the  peaks  were  normalised  to  control  signals  only  it  was  clearer  that  the  addition  
of  TFLLR  increases  the  peak.  The  data  also  did  not  display  differential  patterns  in  
the  second  half  of  the  recordings,  with  the  control  experiments  reaching  
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1.011±1.29*10^-­‐‑4  ΔT  and  experiments  with  TFLLR  0.009±2.5*10^-­‐‑4  ΔT  signal  
between  20  and  22  minutes  after  the  start  of  the  experiment.    
  
The  data  collected  through  electrophysiological  recordings  from  the  slices  
revealed  a  different  pattern.  Here,  similarly  to  the  light  transmittance  signal  both  
conditions  displayed  similar  fEPSP  slope  at  the  end  of  the  recordings  (50-­‐‑55  
minutes  measurements  that  correspond  to  early  phase  LTP  readings)  with  the  
control  experiments  reaching  only  102.1±3.77  per  cent  of  the  control  slope  and  the  
experiments  with  the  addition  of  TFLLR  reached  114.1±2.66  per  cent  of  control.  
These  readings  were  not  significantly  different  as  calculated  with  two-­‐‑sample  t  
test.    
  
However,  the  short-­‐‑term  potentiation,  normally  measured  around  20-­‐‑30  minutes  
after  the  stimulation  of  the  tissue  proved  to  vary  in  two  experimental  conditions.  
In  experiments  without  the  addition  of  TFLLR  the  slope  of  the  fEPSP  reduced  to  
83.5±3.07  per  cent  of  control  before  recovering  later  in  the  recordings.  In  those  
slices  where  10  µμM  TFLLR  was  added  there  was  no  reduction  in  the  slope  of  the  
EPSP;  instead  a  potentiation  was  measured  of  123.8±1.77  per  cent  of  control  slope  
measurement.  These  data  were  significantly  different  with  p<0.0001.    
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Figure  5.19:  Addition  of  TFLLR  to  experiments  with  5  TBS  in  group  I  mice  (1-­‐‑3  months  
postnatal).  A  –  time  course  of  experiments  with  TBS5  stimulation  showing  control  experiments  
(purple)  and  experiments  with  TFLLR  application  (green).  Black  arrow  shows  the  onset  of  
stimulation,  and  the  red  line  shows  the  application  of  TFLLR  in  experiments  where  the  drug  was  
applied.  B  –  Bar  chart  representation  of  peaks  and  baselines  of  responses,  normalised  to  the  
average  between  the  control  (T0)  and  washout  signals  (T15).  The  maximal  peak  in  the  experiments  
with  TFLLR  application  was  0.014±6.43*10^-­‐‑4  whereas  control  experiments  had  an  increase  in  the  
light  transmittance  of  0.014±6.43*10^-­‐‑4  ΔT.  There  were  no  significant  differences  detected  between  
the  light  transmittance  signals  of  two  experimental  conditions.  C  –  Time  course  showing  the  slopes  
of  fEPSPs,  purple  shows  control  experiments  and  green  –  the  experiments  with  TFLLR.  D  –  Box  
charts,  illustrating  the  comparison  between  the  peak  responses  to  stimulation  and  fEPSP  between  
20-­‐‑22  minutes  after  the  stimulation.  Boxes  show  mean  and  SEM  and  whiskers  show  SD.  The  slopes  
of  control  and  experiments  with  TFLLR  were  not  significantly  different  at  50-­‐‑55  minutes,  as  
calculated  with  two-­‐‑sample  t  test,  but  the  slopes  of  fEPSPs  at  20-­‐‑22  minutes  after  the  stimulation  
were  significantly  increased  in  experiments  with  TFLLR;  *  –  p<0.0001.  
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5.7.2  The  effect  of  the  addition  of  α,  β  methylene-­‐‑ATP  to  the  experiments  with  5  
TBS  in  slices  from  young  adult  mice  
  
Similar  to  experiments  described  in  section  5.7.1  some  experiments  with  five  Theta  
Burst  stimulations  and  addition  of  10  µμM  α,  β  methylene-­‐‑ATP  were  performed  
with  both  the  light  transmittance  and  electrophysiological  recordings  being  made  
simultaneously.  It  was  hypothesised  that  since  the  addition  of  10  µμM  α,  β  
methylene-­‐‑ATP  to  short  experiments  increased  the  amplitude  of  the  maximal  
response  to  the  peak  the  same  effect  should  be  achieved  in  these  experiments.  
Since  ATP  can  activate  glial  cells,  it  can  be  used  for  enhancing  LTP  and  so  it  was  
also  hypothesised  that  the  slope  of  fEPSP  would  be  increased  around  50-­‐‑55  
minutes  of  the  electrophysiological  recording.    
  
The  data  gathered  for  these  experiments  with  the  addition  of  10  µμM  α,  β  
methylene-­‐‑ATP  are  displayed  on  Figure  5.18.  The  light  transmittance  signals  in  
experiments  with  10  µμM  α,  β  methylene-­‐‑ATP  did  not  show  a  decrease  back  to  
control  levels  following  the  five  Theta  Burst  stimulations,  which  was  the  pattern  
displayed  by  the  control  experiments.  On  the  contrary,  after  the  response  to  the  
stimulation,  the  signal  in  experiments  with  the  drug  application  slightly  restored  
back  to  resting  levels  for  a  short  period  of  time  before  increasing  for  the  rest  of  the  
recording.  At  20-­‐‑22  minutes  of  the  recording  the  signal  of  the  control  experiments  
was  measured  to  be  0.022±2.6*10^-­‐‑4  whereas  the  experiments  with  α,  β  methylene-­‐‑
ATP  had  an  average  light  transmittance  signal  of  0.078±7.2*10^-­‐‑4  ΔT.  This  
difference  was  calculated  to  be  significant  with  the  p<0.0001.    
  
Sections  C  and  D  on  Figure  5.18  display  the  data  collected  for  the  field  recordings  
of  both  experimental  conditions.  Two  time  points  were  used  to  compare  the  slopes  
of  the  fEPSPs:  20-­‐‑22  and  50-­‐‑55  minutes  after  the  stimulation.  These  time  points  
correspond  to  short-­‐‑term  and  early  long-­‐‑term  potentiation  times.  The  average  
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slope  measured  in  experiments  with  the  addition  of  α,  β  methylene-­‐‑ATP  was  not  
significantly  different  from  the  slopes  in  control  experiments  at  both  time  points.  
Control  experiments  yielded  a  short-­‐‑term  potentiation  of  121.9±1.9  per  cent,  
whereas  the  average  slope  increase  in  experiments  with  α,  β  methylene-­‐‑ATP  was  
117.1±5.8  per  cent.  At  50-­‐‑55  minutes  control  experiments  showed  22.8±2.1  per  cent  
increase  in  slope,  experiments  with  the  drug  addition  –26.4±7.0  per  cent.  
Comparing  both  sets  of  data  revealed  no  significant  difference.    
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Figure  5.20:  Addition  of  α,  β  methylene-­‐‑ATP  to  experiments  with  5  TBS  in  group  I  mice  (1-­‐‑3  
months  postnatal).  A  –  time  course  of  experiments  with  TBS5  stimulation  showing  control  
experiments  (navy)  and  experiments  with  α,  β  methylene-­‐‑ATP  application  (green).  Black  arrow  
shows  the  onset  of  stimulation,  the  red  line  shows  the  application  of  α,  β  methylene-­‐‑ATP  in  
experiments  where  the  drug  was  applied.  B  –  Bar  chart  representation  of  peaks  and  baselines  of  
responses  normalised  to  average  signal  (T0  +  T15/2).  The  maximal  peak  in  the  experiments  with  α,  β  
methylene-­‐‑ATP  application  was  0.0260±7.32*10^-­‐‑4,  whereas  control  experiments  had  an  increase  in  
the  light  transmittance  of  0.0147±1.61*10^-­‐‑4  ΔT.  C  –  Time  course  showing  the  slopes  of  fEPSPs.  D  –  
Box  charts,  illustrating  the  comparison  between  the  peak  responses  to  stimulation  and  fEPSP  
between  20-­‐‑22  minutes  after  the  stimulation.  Boxes  show  mean±SEM,  whiskers  -­‐‑  SD.  At  20-­‐‑22  
minutes  control  experiments  showed  121.9±1.9  %  and  experiments  with  α,  β  methylene-­‐‑ATP  –  
117.1±5.8  %  of  baseline.  LTP  (50-­‐‑55  minutes)  in  control  experiments  showed  22.8±2.1  per  cent  
increase  in  slope,  experiments  with  the  drug  addition  –  26.4±7.0  per  cent;  ***  shows  p<0.001,  n.s.  –  
no  significant  difference.  
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5.7.3  The  effect  of  the  addition  of  memantine  to  the  experiments  with  5  TBS  in  
slices  from  young  adult  mice  
  
Finally,  the  long  experiments  with  simultaneous  field  and  light  transmittance  
recordings  were  repeated  with  five  Theta  Burst  stimulations  and  the  addition  of  
memantine.  As  explained  previously,  memantine  is  NMDA  receptor  blocker,  
which  at  low  concentrations  (such  as  3  µμM)  acts  as  a  specific  blocker  to  glial  
NMDARs  (Ahmed  et  al.  2004).  It  can  therefore  be  used  to  block  one  of  the  
pathways  of  the  mechanism,  described  in  Chapter  4.  Figure  5.19  below  
summarises  the  data  collected  for  these  experiments.    
  
As  can  be  seen  from  sections  A  and  B  of  Figure  5  the  application  of  3  µμM  of  
memantine  reduced  the  light  transmittance  signal,  with  both  the  maximal  
response  to  the  stimulation  as  well  as  the  signal  at  20-­‐‑22  minutes.  In  the  
experiments  with  the  addition  of  this  drug  the  maximal  peak  of  the  signal  was  
0.010±4.5*10^-­‐‑4  and  the  average  signal,  measured  between  20-­‐‑22  minutes  was  
0.016±3.9*10^-­‐‑4.  Both  of  these  measurements  were  significantly  smaller  than  the  
corresponding  data  in  the  control  experiments.  It  was  concluded  that  the  
application  of  memantine  reduced  the  amount  of  tissue  swelling  by  selectively  
blocking  the  glial  NMDA  receptors.  
  
Data  collected  through  field  recordings  are  presented  in  sections  C  and  D  of  
Figure  5.19.  It  was  found  that  the  application  of  memantine  to  the  recording  
chamber  reduced  the  slope  of  the  fEPSP  after  the  five  Theta  Burst  stimulations.  In  
control  experiments  both  short-­‐‑term  and  long-­‐‑term  potentiation  was  established  
upon  the  stimulation:  136.9±0.9  and  141.8±2.1  per  cent  respectively.  The  addition  
of  memantine  reversed  this  potentiation  and  the  slope  of  the  fEPSP  was  measured  
to  be  72.4±2.5  and  71.0±1.8  per  cent  of  the  control  measurement  at  20-­‐‑22  and  50-­‐‑55  
        180  
minutes  respectively.  Comparing  datasets  collected  for  two  experimental  
conditions  revealed  a  significant  difference  at  both  time  points  (p<0.0001).  
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Figure  5.21:  Addition  of  memantine  to  experiments  with  5  TBS  in  group  I  mice  (1-­‐‑3  months  
postnatal).  A  –  time  course  of  experiments  with  TBS5  stimulation  showing  control  experiments  
(navy)  and  experiments  with  memantine  application  (pink).  Black  arrow  shows  the  onset  of  
stimulation,  and  the  red  line  shows  the  application  of  memantine  in  experiments  where  the  drug  
was  applied.  B  –  Bar  chart  representation  of  peaks  and  baselines  of  responses.  The  maximal  peak  in  
the  experiments  with  memantine  application  was  0.010±4.5*10^-­‐‑4,  whereas  control  experiments  had  
an  increase  in  the  light  transmittance  of  0.0147±1.61*10^-­‐‑4  ΔT.  C  –  Time  course  showing  the  slopes  
of  fEPSPs.  Both  averages  are  normalised  to  T0  (the  last  reading  prior  to  the  stimulation).  D  –  Box  
charts,  illustrating  the  comparison  between  the  peak  responses  to  stimulation  and  fEPSP  between  
20-­‐‑22  minutes  after  the  stimulation.  Boxes  show  mean±SEM  and  whiskers  show  SD.  At  20-­‐‑22  
minutes  the  control  experiments  showed  121.9±1.9  %  and  experiments  with  memantine  –  72.4±2.5  
%  of  control  slope.  LTP  (50-­‐‑55  minutes)  in  control  experiments  showed  22.8±2.1  %  increase  in  
slope,  experiments  with  the  drug  addition  had  a  decrease  of  signal  to  71.0±1.8  %;  ***  –  p<0.001.  
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5.7.4  Comparing  the  response  to  5  TBS  of  slices  from  young  adult  and  older  
mice  (groups  I  and  II  respectively)  
  
In  order  to  study  the  effect  of  age  the  long  experiments  were  conducted  with  slices  
cut  from  young  adult  and  older  mice.  The  light  transmittance  signals  were  
compared  in  experiments  with  two  age  groups.  The  data  collected  for  these  
experiments  are  presented  below  on  Figure  5.20.  It  was  very  clear  that  there  are  no  
drastic  differences  between  the  responses  to  five  Theta  Burst  stimulations  in  
young  adult  and  older  mice.  Slices  form  group  I  had  a  maximal  peak  of  
0.0133±8.09*10^-­‐‑4  whereas  experiments  with  group  II  mice  had  an  increase  in  the  
light  transmittance  of  0.0136±2.89*10^-­‐‑4.  The  overall  trend  displayed  by  the  data  
was  towards  the  increase  of  the  overall  tissue  swelling  following  the  stimulation  
and  a  shorter  and  less  efficient  recovery  period.  For  example,  at  20-­‐‑22  minutes  the  
average  signal  measured  from  young  mice  was  0.0214±2.61*10^-­‐‑4  and  in  older  
mice  it  was  0.019±4.7*10^-­‐‑4.  However,  due  to  quite  strong  variability  of  the  signal  
these  differences  were  not  found  to  be  significant.  Overall,  it  was  seen  that  with  
higher  stimulations  the  differences  in  response  of  the  two  age  groups  were  
diminishing.  It  is  possible  that  this  trend  can  explain  the  lack  of  differences  found  
when  long-­‐‑term  potentiation  is  measured,  as  it  would  normally  be  evoked  by  a  
strong  stimulus  such  as  5TBS  or  above.       
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Figure  5.22:  Responses  to  5  TBS  in  group  I  (1-­‐‑3  months  postnatal)  and  group  II  (5-­‐‑8  months  
postnatal)  mice.  A  –  time  course  of  experiments  with  TBS5  stimulation  showing  experiments  with  
young  adult  (black)  and  experiments  with  older  (blue)  mice.  Black  arrow  shows  the  onset  of  
stimulation.  B  –  Bar  chart  representation  of  peaks  and  baselines  of  responses,  normalised  to  the  
average  between  the  control  (T0)  and  washout  signals  (T15).  The  maximal  peak  in  the  experiments  
with  mice  from  group  I  was  0.0133±8.09*10^-­‐‑4  whereas  experiments  with  group  II  mice  had  an  
increase  in  the  light  transmittance  of  0.0136±2.89*10^-­‐‑4  ΔT.  The  response  to  stimulation  in  light  
transmittance  signals  were  not  significant  different  in  two  age  groups  as  calculated  with  two-­‐‑
sample  t  test.  When  signals  were  compared  at  20-­‐‑22  minutes  the  experiments  with  older  slices  
showed  a  higher  extent  of  swelling,  although  this  difference  was  not  found  significant  with  the  
two-­‐‑sample  t  test.  
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5.8  Conclusions  
  
This  chapter  set  out  to  study  the  molecular  mechanism,  linking  a  number  of  
astrocytic  channels  with  their  voltage-­‐‑gated  potassium  currents  on  an  integrated  
network  level.  Once  the  nature  of  this  mechanism  was  established  at  the  level  of  
isolated  astrocytes,  the  next  step  naturally  was  to  consider  this  mechanism  and  its’  
implications  on  the  whole  network.  This  was  done  in  slices,  so  the  whole  
astrocytic  syncytium  was  intact  as  well  as  the  connections  between  the  neural  and  
astrocytic  components  of  the  cortex.    
  
Firstly,  it  was  shown  that  the  method  chosen  for  the  light  transmittance  
experiments  collects  similar  data  to  published  values.  For  example,  the  application  
of  hypo-­‐‑osmotic  increases  the  light  transmittance  signal,  similarly  to  literature  in  
the  field.  Another  control  experiment  involved  the  application  of  high  
concentration  KCL  aCSF.  The  light  transmittance  increased  as  a  result  of  this  
addition,  similarly  to  previously  published  data  (Syková  and  Chvátal  2000).  
Stimuli  of  various  strengths  were  applied  and  the  responses  in  light  transmittance  
were  compared  (see  Figures  5.2  and  5.3).  In  order  to  consider  the  age-­‐‑related  
differences,  that  can  potentially  influence  the  extent  or  pattern  of  tissue  swelling,  
slices  were  cut  from  mice  of  two  age  groups  –  young  adult  mice  (1-­‐‑3  months  
postnatal)  and  older  mice  (5-­‐‑8  months  postnatal).  It  was  found  that  the  slices  from  
older  mice  on  average  show  a  weaker  response  to  the  stimulation.  This  pattern  
was  the  same  in  experiments  with  single  Theta  Burst  stimulation  and  5TBS.  
However,  the  baseline  of  the  older  slices  had  a  greater  tendency  towards  swelling,  
often  failing  to  restore  its’  signal  to  pre-­‐‑stimulation  levels.  
  
A  number  of  pharmacological  agents  were  applied  in  an  attempt  to  affect  the  
molecular  mechanism,  linking  some  astrocytic  channels  and  outwards  potassium  
conductance.  To  activate  this  mechanism,  TFLLR  and  α,  β  methylene-­‐‑ATP  were  
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applied  at  10  µμM  concentration.  When  a  single  Theta  Burst  stimulation  was  
applied,  the  addition  of  TFLLR  caused  no  change  to  the  light  transmittance  signal  
in  young  adult  mice.  Older  slices,  however,  demonstrated  a  decrease  in  their  
response  to  stimulation  when  TFLLR  was  applied.  The  addition  of  α,  β  methylene-­‐‑
ATP  generated  different  data.  The  average  maximal  peak  of  the  response  
following  the  stimulation  was  increased  by  the  addition  of  this  analogue  of  ATP.    
  
These  experiments  were  repeated  with  a  stronger  stimulation  of  two  Theta  Burst  
stimulations.  Here  the  slices  from  older  mice  showed  an  increase  in  their  light  
transmittance  responses  compared  to  slices  derived  from  younger  mice.  The  
addition  of  TFLLR  in  both  groups  showed  a  slight  decrease  of  the  response  to  the  
stimulus,  and  the  addition  of  α,  β  methylene-­‐‑ATP  caused  an  increase  in  this  
signal.  These  data  were  similar  to  those  collected  for  the  experiments  with  a  single  
Theta  Burst  stimulation.  Another  set  of  experiments  with  two  Theta  Burst  
stimulations  and  TFLLR  application  was  conducted.  Here,  a  solution  of  high  KCL  
concentration  (10  mM)  was  applied  after  the  stimulation.  In  experiments  where  
TFLLR  was  present  the  secondary  response  to  the  changes  in  light  transmittance  
was  greater  than  that  of  the  control.    
  
Finally,  experiments  with  five  Theta  Burst  stimulations  were  performed.  It  was  
found  that  the  response  to  the  stimulation  in  slices  derived  from  older  mice  was  
weaker.  Both  sets  of  experiments  with  the  additions  of  TFLLR  and  α,  β  methylene-­‐‑
ATP  caused  a  great  increase  in  the  response  peak  to  the  stimulation.  It  was  
concluded  that  the  strength  of  stimulus  plays  an  important  role  in  the  effect  of  
these  drugs.  Memantine  was  used  to  inhibit  the  mechanism,  described  in  the  
previous  chapter.  Experiments  with  five  Theta  Burst  stimulations  showed  that  
application  of  memantine  reduces  the  signal  response  to  the  stimulation.    
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Some  longer  experiments  were  conducted  where  the  light  transmittance  signals  
were  compared  the  slopes  of  EPSPs.  When  two  age  groups  were  compared  in  their  
light  transmittance,  little  change  was  measured.  TFLLR  was  applied  to  
experiments  with  two  Theta  Burst  stimulations.  The  light  transmittance  signal  
showed  little  difference  over  the  peak  size  and  the  signal  level  at  20-­‐‑22  minutes  of  
the  recording.  Short-­‐‑term  potentiation  was  increased  in  the  experiments  with  
TFLLR,  but  the  long-­‐‑term  potentiation  was  not  significantly  changed.  It  is  possible  
that  the  effects  of  the  addition  of  TFLLR  might  be  different  if  a  stronger  
stimulation  was  applied.  When  α,  β  methylene-­‐‑ATP  was  applied  to  experiments  
with  5TBS  stimulation,  the  light  transmittance  signal  was  increased  at  both  time  
points:  in  response  to  the  stimulation  and  at  20-­‐‑22  minutes  of  the  recording.  The  
application  of  this  drug  did  not  significantly  increase  either  short  or  long-­‐‑term  
potentiation.  Finally,  the  addition  of  memantine  produced  significant  alterations  
to  both  light  transmittance  signal  and  the  slope  of  EPSP.  In  experiments  with  
memantine  both  the  response  to  the  stimulation  and  the  signal  at  20-­‐‑22  minutes  of  
the  recording  was  diminished.  The  slope  of  EPSP  was  decreased  by  the  
application  of  memantine  and  the  plasticity  was  reversed:  short  and  long  term  
depressions  were  achieved  instead  of  potentiation.    
  
Overall,  this  chapter  set  out  to  investigate  the  effects  of  potentiating  or  inhibiting  
the  mechanism  that  was  described  in  chapter  4  on  the  network  level.  It  was  shown  
that  the  effect  of  the  application  of  TFLLR,  α,  β  methylene-­‐‑ATP  and  memantine  
produced  distinct  results.  The  strength  of  the  stimulus  was  very  important  as  the  
data  collected  for  experiments  with  weak  stimulation  showed  different  effects  of  
the  addition  of  TFLLR.  The  potential  link  between  all  of  the  results  described  
above  and  the  implications  of  this  mechanism  on  the  functioning  and  plasticity  of  
the  cortex  are  evaluated  in  the  Discussion  chapter.    
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Chapter  6  –  Discussion  and  conclusion    
6.1  Overview  of  conclusions  
  
The  aim  of  this  study  was  to  investigate  a  possible  molecular  mechanism,  linking  
various  astrocytic  channels  (P2X1/5,  NMDARs  and  PAR-­‐‑1)  with  potassium  
conductance  of  isolated  cortical  astrocytes;  and  to  explore  whether  this  
modulation  takes  place  in  slice,  and  carries  importance  in  the  process  of  potassium  
buffering  and  the  shrinkage  of  extracellular  space.    
  
Firstly,  it  was  investigated  whether  age  alters  the  conductance  of  potassium  
current  subtypes  in  neocortical  astrocytes  from  layers  2/3  of  somatosensory  cortex.  
To  do  so,  the  currents  measured  in  young  (1-­‐‑3  months  old)  and  old  (9-­‐‑12  months  
old)  were  compared  with  the  fractions  of  the  overall  potassium  current  that  were  
susceptible  to  4-­‐‑aminopyridine  or  barium  chloride  or  both.  It  was  found  that  the  
capacitance  of  astrocytes  significantly  increased  in  size  from  young  adult  to  older  
mice,  meaning  that  the  cells,  or  at  least  the  cell  somas  increase  in  size,  as  the  
animal  grows  older.  This  conforms  to  the  current  understanding  of  astrocytic  age-­‐‑
related  changes:  increased  number  of  astrocytes  expresses  GFAP  and  show  
increased  soma  size  –  factors  that  can  later  on  lead  to  astrogliosis  (Goss,  Finch,  and  
Morgan  1990;  Correa-­‐‑Cerro  and  Mandell  2007).    
  
When  current  densities  were  compared,  it  was  found  that  the  inwardly  rectifying  
potassium  channel  conductance  does  not  increase  with  age,  unlike  voltage-­‐‑
dependent  potassium  currents.  Since  Kir4.1  channels  have  been  implicated  in  
potassium  buffering,  this  lack  of  increase  in  density  in  old  age  can  mean  that  
astrocytes  may  be  less  effective  at  clearing  the  extracellular  potassium  ions  
following  action  potentials;  this  could  potentially  lead  to  neuroinflammation  and  
astrogliosis(Rossi  2015;  Salminen  et  al.  2011;  Pekny  and  Nilsson  2005;  Pekny  and  
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Pekna  2014).  Alternatively,  this  observation  could  be  a  consequence  of  ageing  as  
opposed  to  a  cause.    
  
The  proportions  of  current  sensitive  to  4-­‐‑aminopyridine  and  barium  were  
compared  in  young  and  old  mice.  The  4-­‐‑aminopyridine  sensitive  fraction  of  the  
current  did  not  increase  with  age,  unlike  the  fraction  of  the  current  that  was  
sensitive  to  barium  chloride  –  young  mice  displayed  a  much  higher  barium  
sensitivity.  The  current  density  of  voltage-­‐‑gated  potassium  channel  increases  with  
age  (meaning  there  are  more  voltage-­‐‑gated  potassium  channels  expressed  on  the  
soma),  but  4-­‐‑aminopyridine-­‐‑sensitive  fraction  of  the  potassium  current  does  not  
rise  significantly.  This  is  the  opposite  of  the  inwardly  rectifying  potassium  current  
–  it  showed  no  change  in  the  current  density  but  a  significant  decrease  in  the  
fraction  of  the  current  that  is  sensitive  to  barium  chloride.  Since  the  greatest  
difference  was  measured  at  very  negative  voltage  steps  of  the  protocol,  aimed  at  
measuring  the  inwardly  rectifying  potassium  channel,  the  vast  majority  of  the  
current  should  be  conducted  via  the  Kir4.1  channels.  This  decrease  shows  a  
dramatic  change  in  the  electrophysiological  characteristic  of  cortical  astrocytes,  as  
a  decreased  conductance  of  inwardly  rectifying  channel  could  have  large  
implications  for  potassium  clearance  and  water  homeostasis  (Seifert  et  al.  2009;  
Nagelhus,  Mathiisen,  and  Ottersen  2004).    
  
The  addition  of  both  blockers  together  showed  blockage  of  a  smaller  proportion  of  
the  generic  current  than  the  application  of  blockers  separately.  Comparison  
between  young  and  older  mice  showed  an  increase  in  proportion  of  the  current  
that  is  sensitive  to  both  blockers.  Most  of  the  voltage  steps  across  three  protocols  
used  showed  no  significant  difference,  with  the  exception  of  highest  voltage  steps  
in  the  protocol  for  recording  inwardly  rectifying  potassium  current  (+50  and  
+70mV).  This  could  be  explained  by  a  great  degree  of  depolarization  of  astrocytes  
at  these  voltage  steps,  which  may  produce  an  artefact.  It  was  also  noticed  that  in  
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older  mice  more  patched  cells  experienced  the  so-­‐‑called  rundown,  which,  
although  filtered  where  possible  (experiments  with  a  clear  rundown  were  
excluded  from  analysis),  could  have  introduced  an  error.    
  
In  chapter  4  the  link  between  channels  of  astrocytes  and  the  potassium  currents  
was  investigated.  Firstly,  the  same  experiments  were  performed  on  neurons  to  
ensure  that  this  is  an  astrocytic  specific  mechanism.  It  was  expected  that  if  an  
astrocyte  detects  signs  of  activity,  e.g.  ATP  or  it’s  analogues,  it  would  increase  the  
inwardly  rectifying  potassium  current  in  order  to  instigate  the  process  of  
potassium  buffering.  However,  it  was  found  that  the  inwardly  rectifying  
potassium  channel  conductance  was  unaffected  by  the  addition  of  agonists  to  
P2X1/5,  NMDARs  or  PAR-­‐‑1  receptors.  Instead  it  was  determined  that  applying  an  
agonist  to  any  of  the  aforementioned  channels  causes  an  elevation  in  the  outward  
potassium  current.  This  mechanism  was  Calcium-­‐‑dependent,  as  it  is  known  that  
all  three  of  the  channels  are  able  to  pass  through  calcium  ions  (or  in  the  case  of  
PAR-­‐‑1  channel  cause  a  release  of  intracellular  calcium  store  as  a  secondary  
messenger).  This  effect  was  also  reliably  blocked  by  the  addition  of  high  EGTA.  It  
was  also  determined  that  this  mechanism  is  far  less  prominent  in  older  cells,  thus  
indicating  at  a  potential  neuroprotective  role  it  may  play  in  young  animals.    
  
To  further  dissect  this  mechanism,  4-­‐‑aminopyridine  and  barium  chloride  blockers  
were  used.  It  was  found  that  the  increased  current  is  susceptible  to  the  former  but  
not  latter  blocker,  thus  once  again  proving  that  it  is  not  the  inwardly  rectifying  
potassium  channel  being  involved.  On  the  contrary,  in  some  experiments  with  the  
addition  of  barium  blocker  the  facilitation  effect  of  adding  an  agonist  was  
increased  in  size.  The  following  hypothesis  was  built  on  the  basis  of  the  data  
collected:  activation  of  ionotropic  (P2X1/5  and  NMDARs)  or  metabotropic  (PAR-­‐‑1)  
receptors  can  cause  an  influx  of  calcium  ions  into  the  cell  and  a  consecutive  
increase  in  the  potassium  current  (via  the  intracellular  calcium  stores).  This  is  in  
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line  with  previous  findings  from  our  laboratory,  showing  that  activation  of  PAR-­‐‑1  
receptors  initiates  calcium  signalling  (Lalo  et  al.  2014),  and  that  P2X1/5  and  
NMDARs  are  permeable  to  calcium  in  astrocytes  (Palygin  et  al.  2010).  Whereas  in  
experiments  with  activation  of  P2X  and  NMDA  receptors  secondary  effects,  
arising  from  activating  neuronal  receptors  could  introduce  variability  into  data,  
PAR-­‐‑1  receptors  are  primarily  expressed  in  astrocytes,  thus  making  it  possible  to  
compare  these  data  sets.  Since  the  effects  seen  in  all  three  data  sets  are  similar,  it  
can  be  assumed  that  the  effects  seen  in  experiments  with  P2X  and  NMDARs  are  
due  to  experimental  stimulus  and  not  secondary  effects.  The  significance  of  this  
mechanism  is  unclear.  It  appears  that  similar  to  neurons,  astrocytes  can  respond  to  
activation  of  their  receptors  with  increased  outward  potassium  current.  It  is  
possible  that  this  is  a  necessary  first  step  for  the  process  of  potassium  buffering,  
but  further  investigation  is  required.  Alternatively,  this  mechanism  could  be  an  
auxiliary  pathway  to  recruit  more  astrocytic  branches  to  the  task  of  potassium  
uptake.  During  neuronal  activity,  there  spill  of  glutamate  and  other  
neurotransmitters  initiates  the  process  of  glutamate  buffering.  This  is  done  
through  transporter  channels,  which  utilise  energy  from  the  exchange  of  Na+,  K+  
and  H+.  As  a  result,  the  local  concentration  of  potassium  outside  the  astrocytic  
branch  increases  further.  Perhaps  the  mechanism,  discussed  in  Chapter  4,  mimics  
this  local  rise  in  potassium  current  and  thus  starts  the  process  of  potassium  uptake  
in  nearby  astrocytic  projections.    
  
Lastly,  Chapter  5  attempted  to  explore  the  significance  of  the  mechanism  
discovered  on  isolated  cells.  A  model  for  studying  tissue  swelling  and  potassium  
buffering  during  activity  was  chosen  in  order  to  test  whether  this  mechanism  
affects  the  process  of  potassium  clearance  (Kreisman  et  al.  1995;  Syková  and  
Chvátal  2000).  Various  stimulations  were  utilised  and  it  seemed  that  the  highest  
stimulation  used  -­‐‑  5  TBS  showed  the  most  prominent  results,  as  well  as  highest  
effect  of  the  drugs.  It  was  found  that  α,  β  methylene-­‐‑ATP  and  TFLLR  yielded  a  
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significant  increase  in  the  extent  of  tissue  swelling.  It  can  be  concluded  that  the  
activating  the  mechanism,  described  in  chapter  4,  increases  the  extent  of  tissue  
swelling  as  well  as  the  rate  of  recovery  of  the  signal.  This  means  that  the  
mechanism  is  involved  in  the  process  of  potassium  buffering,  making  the  voltage-­‐‑
gated  potassium  channels  important  in  this  astrocytic  function.  However,  it  was  
also  shown  that  the  current  density  of  voltage  gated  potassium  channels  increases  
with  age,  but  (in  the  case  for  experiments  with  NMDARs)  this  facilitation  is  
greatly  diminished  in  mice  of  age  group  III.  These  findings,  taken  together,  lead  to  
the  following  conclusions:  firstly,  voltage-­‐‑gated  potassium  channels  are  
implicated  in  the  process  of  potassium  buffering  by  astrocytes;  secondly,  
activating  astrocytes  by  agonist  applications  to  P2X,  NMDARs  or  PAR-­‐‑1  channels  
(the  channels  that  have  been  tested  in  this  study,  but  it’s  perfectly  possible  for  
others  to  be  involved  too)  increases  both  the  ‘’depolarisation’’  of  astrocytes  and  
consecutive  potassium  clearance.  Lastly,  this  mechanism  rapidly  diminishes  with  
non-­‐‑pathological  ageing,  and  it  almost  completely  non-­‐‑functional  in  group  III,  
therefore  the  loss  of  function  takes  place  between  1-­‐‑3  and  9-­‐‑12  months  old.  This  
happens  despite  the  increase  of  density  of  voltage-­‐‑gated  potassium  channels  in  
older  mice.    
  
Overall,  it  can  be  said  that  slices  from  older  mice  exhibited  a  greater  extent  of  
decline  in  the  baseline  signal,  showing  that  they  are  less  viable  than  the  younger  
slices.  Most  of  the  responses  to  activity  recorded  in  older  mice  were  weaker,  and  
so  were  the  effects  of  the  addition  of  agonists  to  P2X  or  PAR-­‐‑1  receptors.  Chapter  5  
also  covered  the  experiments  that  recorded  the  LTP  and  LT  experiments  
simultaneously.  Here,  the  application  of  TFLLR  with  2  TBS  did  not  manage  to  
increase  the  LT  signal  of  the  slice  nor  the  size  of  the  slope  of  fEPSP  significantly  at  
50  minutes,  but  a  slight  increase  in  the  short-­‐‑term  potentiation  was  measured.  At  
higher  stimulations,  the  addition  of  α,  β  methylene-­‐‑ATP  has  increased  the  LT  
signal,  but  failed  to  significantly  change  the  slope  of  the  fEPSP.  It  is  possible  that  
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more  experiments  are  needed  to  see  a  more  prominent  increase  in  the  synaptic  
plasticity  upon  the  addition  of  this  analogue  of  ATP,  as  it  has  been  shown  before  
that  application  of  non-­‐‑hydrolysable  analogues  of  ATP  can  rescue  the  LTP  
(Rasooli-­‐‑Nejad  et  al.  2014).  Lastly,  the  addition  of  memantine  was  expected  to  
reduce  the  signal  (via  selective  inhibition  of  glial  NMDARs  at  concentration  used),  
which  indeed  took  place.  The  slope  of  EPSP  was  decreased  plasticity  was  
reversed:  short  and  long  term  depressions  were  achieved  instead  of  potentiation.    
  
There  are  limitations  to  the  method  chosen  to  monitor  the  clearance  of  potassium  
from  the  extracellular  space.  Since  potassium  concentration  outside  the  cells  is  
linked  with  glutamate  uptake,  the  measured  increase  in  the  signal  can  be  partially  
attributed  to  glutamate  transport  into  the  cell,  as  well  as  the  influx  of  potassium  
ions.  However,  the  light  transmission  experiments  were  performed  to  investigate,  
if  the  mechanism,  described  previously,  is  relevant  in  situ.  The  most  prominent  
result  was  achieved  with  the  application  TFLLR,  which  should  have  no  secondary  
network  effects.  The  extent  of  tissue  swelling  in  experiments  with  activation  P2X  
and  NMDA  receptors  may  be  concealed  by  the  neuronal  responses  to  the  addition  
of  corresponding  agonists.  It  is  therefore  considered  that  for  the  purpose  of  testing  
the  relevance  of  the  molecular  mechanism,  described  in  Chapter  4,  this  method  
was  sufficient.  However,  for  any  further  investigations  perhaps  a  different  
approach  might  prove  to  yield  more  concrete  data.    
  
This  project  set  out  to  investigate  the  link  between  various  functions  of  astrocytes  
by  studying  the  connection  of  multiple  channels  expressed  in  astrocytes  and  
whether  these  connections  are  a  subject  to  age-­‐‑related  alterations.  Understanding  
how  astrocytes  participate  in  the  signalling  and  mediate  synaptic  plasticity  as  well  
as  carrying  out  the  homeostatic  functions  such  as  potassium  clearance.  The  
approach  utilised  in  this  study  was  to  start  with  a  single  cell  and  then  progress  
into  ex  vivo  models  that  are  more  representable  of  physiological  conditions.  The  
        193  
data  obtained  in  the  due  course  of  this  project  points  toward  voltage-­‐‑gated  
potassium  channels  as  an  important  player  in  potassium  clearance,  the  mechanism  
of  which  remains  unknown.  Further  investigations  are  needed  to  shed  light  on  
exact  mechanisms  of  connectivity  of  various  astrocytic  channels  with  voltage-­‐‑
gated  potassium  channels  and  potassium  buffering.  
6.2  Discussion    
6.2.1  NG2  vs  astrocytes    
  
A  study  by  Bernardinelli  et  al.  (2008)  reports  two  distinct  electrophysiological  
profiles  of  astrocytes.  The  authors  term  these  ‘’naïve’’  and  ‘’complex’’  astrocytes.  
Naïve  astrocytes  were  found  to  have  a  passive  electrophysiological  conductance  
with  little  of  voltage-­‐‑dependency  shown;  whereas  the  complex  astrocytes  were  
seen  to  have  a  distinct  KA  and  KD  voltage-­‐‑gated  currents.  In  the  study  animals  
used  were  15-­‐‑21  days  old  rats.  The  authors  report  the  majority  of  the  astrocytes  to  
be  naïve  (71%)  (Bernardinelli  and  Chatton  2008).  The  young  adult  group  used  in  
this  project  consisted  of  mice  that  were  3-­‐‑5  months  old,  thus  making  it  a  higher  
developmental  stage.    
  
Interestingly,  Wallraff  et  al.  describe  similar  types  of  glial  cells  based  on  their  
junction  coupling  in  a  mouse  hippocampus  (Wallraff  et  al.  2004).  These  authors  
denote  complex  astrocytes  as  GluR  cells  and  naïve  –  GluT.  The  former  cell  types  
appears  to  have  little  to  no  junction  coupling,  whereas  GluT  cells  form  a  large  
astrocytic  network.  Both  cell  types  were  identified  by  expression  of  EGFP,  
however  morphological  differences  are  reported  in:  such,  GluT  cells  are  described  
as  having  oval  somata  with  multiple  primary  branches  and  a  rich  network  of  tiny  
projections  radiating  from  these  projections.  GluR  cells,  however,  are  said  to  have  
a  smaller  and  more  round  somatic  body  as  well  as  fewer  primary  branches.  The  
distinction  in  the  amount  of  coupling  was  striking:  no  weak  or  intermediate  
amount  of  coupling  was  found  (Wallraff  et  al.  2004).  The  electrophysiological  
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profile  of  the  GluT  cells  reported  above  is  similar  to  the  current  recorded  in  this  
study.    
  
Following  a  relatively  short  period  of  uncertainty  about  their  identity  and  
distinction  from  astrocytes,  the  GluR  cells  were  renamed  as  NG2  cells,  and  at  
present  these  cells  are  considered  to  be  the  fourth  biggest  subclass  of  glial  cells  
(Nishiyama,  Yang,  and  Butt  2005).  NG2  glial  cells  have  been  shown  to  possess  a  
long  list  of  ion  channels  and  neurotransmitter  receptors  that  provide  them  with  
complex  electrophysiological  and  antigenic  profiles(V.  A.  Larson,  Zhang,  and  
Bergles  2016).  They  are  present  in  developmental  and  mature  CNS.  This  glial  cell  
types  can  also  proliferate  into  oligodendrocytes,  which  makes  they  a  crucial  player  
in  remyelination  process  following  injury  or  disease  (Richardson  et  al.  2011).  For  
experimental  purposes  it  is  important  to  be  able  to  confidently  distinguish  
between  the  true  astrocytes  and  the  NG2  cells.  Despite  a  range  of  commonly  
expressed  markers,  there  are  enough  distinctive  differences.  Such,  NG2  were  
never  shown  to  express  GFAP  or  glutamine  synthase  –  typical  astrocytic  markers;  
whereas  sodium  channels  are  expressed  on  NG2  cells  unlike  astrocytes(V.  A.  
Larson,  Zhang,  and  Bergles  2016).  Electrophysiologically,  NG2  glial  cells  are  
expected  to  display  smaller  currents  with  very  little  inward  conductance  as  well  as  
a  smaller  somatic  size  and  higher  input  resistance.  These  differences  are  sufficient  
to  allow  discrimination  between  these  cell  types  when  conducting  experiments.  In  
the  recent  years  many  new  studies  have  addressed  the  regional  differences  in  glial  
cells,  their  expression  patterns  and  functional  variations.  The  field  of  glial  
heterogeneity  promises  some  exciting  discoveries  in  the  near  future.    
6.2.2  Cellular  senescence    
  
It  has  been  shown  that  density  of  outward  voltage-­‐‑gated  potassium  channels  is  
increased  in  microglial  cells  of  aged  mice  (Schilling  and  Eder  2014),  and  in  
pyramidal  cells  of  layer  5  of  the  cortex  at  least  one  alpha  subunit  of  delayer  
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rectifying  potassium  channels  (Kv9.1)  are  up-­‐‑regulated  in  aged  humans  and  
primates  (Luebke  and  Chang  2007;  Erraji-­‐‑Benchekroun  et  al.  2005).  Together  with  
findings  of  this  study,  it  can  be  proposed  that  there  is  an  importance  of  this  
increased  numbers  of  voltage-­‐‑gated  potassium  channels  in  multiple  cell  types  in  
the  brain.  Since  it  has  also  been  shown  that  outward  (but  not  inwardly  rectifying)  
potassium  current  can  be  induced  in  microglial  cells  by  the  addition  of  β-­‐‑amyloid  
peptide,  it  can  be  proposed  that  this  increased  potassium  current  is  a  consequence  
of  the  deposition  of  senile  plaques  (S.  Chung  et  al.  2001).  Another  potential  factor,  
affecting  potassium  channels  in  physiological  ageing  is  the  accumulation  of  ROS  
(reactive  oxygen  species),  which  has  been  shown  to  affect  multiple  subunits  of  
potassium  channels  and  modify  their  functioning  (Sesti,  Liu,  and  Cai  2010).  It  is  
argued  that  the  AP  (action  potential)  amplitude,  as  well  as  after  hyperpolarisation  
(AHP)  in  sub-­‐‑populations  of  neurons  are  altered  during  ageing  and  these  changes  
arise  from  the  different  expression  patterns  of  K+  channels.  If  the  alteration  of  the  
expression  comes  from  accumulation  of  ROS,  astrocytic  potassium  channels  
should  also  be  subjected  to  these  changes.  However,  more  studies  are  required  to  
investigate  glial-­‐‑specific  expression  patterns  in  aged  animals  (Puthanveettil  2014).    
  
An  increase  in  some  outward  potassium  channels  has  been  reported  in  
pathological  states.  Such,  in  glioblastoma,  a  large-­‐‑conductance  BK  channels  have  
been  demonstrated  to  have  an  increased  sensitivity  to  Calcium  ions.  This  
sensitivity  can  allow  malignant  cells  to  remain  active  even  at  typical  resting  
potential  states  in  response  to  small  peaks  in  intracellular  Calcium  ions  (Ransom,  
Liu,  and  Sontheimer  2002).  Although  the  levels  of  expression  of  inwardly  
rectifying  potassium  channels  were  found  to  not  be  much  different  from  normal  
brain  tissue,  the  inwardly  rectifying  current  in  glioblastoma  was  greatly  reduced.  
It  was  determined  that  Kir  channels  in  glioblastoma  are  mislocalised,  and  targeted  
to  cell  nucleus  instead  of  the  plasma  membrane,  thus  contributing  to  decreased  
current  density  of  inward  potassium  current  (Molenaar  2011).  Glioblastoma  most  
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often  develops  in  individuals  of  40  years  old  and  above,  it  is  likely  that  some  
changes  in  potassium  channel  expression  or  post-­‐‑translational  modifications  that  
occur  prior  to  the  oncogenic  shift  are  identical  in  the  process  of  non-­‐‑pathological  
ageing.    
  
Astrocytes  appear  to  act  as  hubs  for  convergence  of  signals  from  multiple  
pathways  as  well  as  filters  for  plaques  and  ROS.  For  instance,  it  was  shown  that  
astrocytes  collect  Aβ42  protein  and  build  up  amyloid  plaques  inside,  leading  to  
enlarged  endosomes  and  as  a  consequence  –  a  greater  proportion  of  reactive  
astrocytes.  These  plaque  depositions  are  not  destroyed  but  persist,  thus  bring  
about  the  apoptotic  events  for  both  astrocytes  and  neurons  alike  (Nagele  et  al.  
2003;  Söllvander  et  al.  2016).  Amyloid  plaques  are  just  one  example  from  many  
other  risk  factors,  increasing  the  likelihood  of  development  of  disease.  It  is  also  
likely  then  that  astrocytes  accumulate  these  stresses  and  become  more  likely  to  
enter  cellular  senescence  state  and  express  senescence  –  associated  secretory  
phenotype.  This  includes  an  increased  expression  of  GFAP  and  vimentin  
filaments,  some  pro-­‐‑inflammatory  cytokines  as  well  as  accumulation  of  toxic  
aggregates  (Salminen  et  al.  2011).  It  is  believed  that  once  the  senescence  state  has  
been  achieved  by  the  astrocytes,  they  can  enhance  the  speed  of  neurodegeneration  
and  as  a  consequence  the  deterioration  of  functional  capacity  of  the  brain.  In  this  
study  we  have  seen  a  steady  increase  in  the  size  of  the  somata  of  astrocytes  from  
layers  2/3  of  somatosensory  cortex  as  well  as  density  of  voltage-­‐‑gated  potassium  
currents  from  young  adult  to  older  age.  This  could  be  a  marker  for  the  
accumulation  of  various  stresses,  leading  to  the  onset  of  cellular  senescence.    
6.2.3  Potassium  buffering  and  Kir  channels  
  
The  overview  of  potassium  buffering  by  astrocytes  can  be  found  in  the  
Introduction  chapter.  However,  it  is  important  to  point  out  that  most  of  the  glial  
studies  on  this  topic  focus  on  Kir4.1  channel  –  the  most  highly  expressed  inwardly  
        197  
rectifying  potassium  channel  subtype  in  astrocytes.  It’s  specific  subcellular  
location:  increased  density  near  the  perisynaptic  endfeet  and  co-­‐‑expression  with  
Aquaporin  4  hint  at  the  importance  of  these  channels  in  the  clearance  of  
potassium(Nagelhus,  Mathiisen,  and  Ottersen  2004;  Kofuji  et  al.  2002).    It  is  
considered  that  the  synapse  is  the  major  source  of  K+  ions.  It  has  been  shown  that  
neuronal  activity  can  induce  slow  inward  potassium  current  that  is  susceptible  to  
the  application  of  Barium  (Rouach  2013).  It  is  not,  however,  clear  what  is  the  
signal  that  initiates  the  inward  flux  of  Kir  channels.  We  have  shown  that  voltage-­‐‑
gated  potassium  currents,  present  in  cortical  astrocytes  are  affected  by  a  list  of  
neuro-­‐‑  and  gliotransmitters  in  both  isolated  and  in  slice  set-­‐‑ups.  Facilitation  these  
currents  introduced  changes  in  the  patterns  of  tissue  swelling  and  therefore  
potassium  buffering  of  slices.  It  is  possible  that  this  may  be  a  way  of  modulation  
of  the  buffering  process.  This  facilitation  of  potassium  current  was  not  a  necessary  
signal  for  inducing  the  buffering,  since  a  response  was  also  seen  in  control  
experiments.  However,  when  working  in  an  intact  slice  it  is  not  possible  to  dissect  
whether  there  was  endogenous  stimulation  of  this  mechanism  by  neuronal  or  glial  
transmitters.  Since  the  mechanism  was  measured  in  isolated  cells,  primarily  
consisting  of  cell  bodies,  it  cannot  be  said  whether  the  same  process  takes  place  in  
branches  of  astrocytes,  and  in  the  finest  of  projections.  Nevertheless,  it  can  be  
suggested  that  facilitation  of  outward  potassium  current  following  the  activation  
of  P2X1/5,  NMDARs  or  PAR-­‐‑1  receptors  may  be  a  way  of  propagating  the  buffering  
of  potassium  onto  other  branches  of  the  same  astrocytes.  Such,  the  cell  body  of  the  
astrocyte  would  expel  more  potassium  into  the  extracellular  matrix,  thus  
providing  a  stimulus  to  initiate  the  process  of  buffering  in  nearby  astrocytic  
processes.  
  
There  are  however,  clear  limitations  of  using  patch  clamping  technique  in  isolated  
cells  to  study  potassium  buffering.  Firstly,  as  pointed  out  above,  the  density  of  
Kir4.1  channels  is  highest  on  the  projections  of  astrocytes,  especially  the  endfeet  
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that  enwrap  the  blood  vessels.  Electrophysiological  recordings  are  by  and  large  
maid  by  patching  the  cell  body  of  the  cell,  therefore  leaving  out  the  finer  
projections,  as  it  is  hard  to  control  the  voltage  of  small  outgrowths  with  high  
resistance  and  low  volume.  It  is  therefore  hard  to  be  sure  what  voltage/current  
perturbations  can  take  place  in  the  branches  of  astrocytes.  Since  astrocytes  can  
depolarise  in  response  to  neuronal  activity  and  subsequent  influx  of  potassium,  
both  voltage  and  current  clamp  conditions  do  not  truly  reflect  the  parameters  of  
the  cell.  Such,  when  evoked  inward  current  is  measured  in  astrocyte  in  slice  it  
represents  the  current  imposed  onto  the  cell  by  having  a  set  resting  voltage  
potential.  Similarly,  current  clamp  mode  fails  to  show  K+  buffering  because  the  
equilibrium  potential  (EK)  of  potassium  can  change  depending  on  neuronal  
activity.  Rouach  et  al.  suggests  that  simultaneously  with  an  electrophysiological  
recording  the  extracellular  concentrations  of  potassium  should  be  measured  
(2013).    
  
6.2.4.  Plasticity  of  glia    
  
Another  important  field  that  arose  since  the  discovery  of  the  tripartite  synapse  
(Araque  et  al.  1999)  is  the  plasticity  of  glia,  and  their  interactions  with  neurons.  To  
date  multiple  types  of  glial  plasticity  have  been  reported.  Structural  changes,  such  
as  increased  coverage  of  the  tripartite  synapse  by  perisynaptic  astrocytic  processes  
(PAPS)  in  various  brain  regions  (Genoud  et  al.  2006;  Bernardinelli  et  al.  2014),  as  
well  as  alterations  in  calcium  signalling  (Sibille  et  al.  2015)  and  as  a  consequence  –  
synaptic  strength  (Pannasch  et  al.  2011).  There  is  also  a  body  of  literature  that  
reports  both  short-­‐‑  and  long-­‐‑term  plasticity  of  astrocytic  clearance  of  potassium  
and  glutamate  (for  a  recent  review  see  (Cheung  et  al.  2015)).    
  
The  data  presented  in  Chapter  4  of  this  project  provides  an  example  of  such  
plasticity  in  response  to  extracellular  transmitter  application.  It  is  proposed  that  
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the  link  between  P2X1/5,  NMDARs  and  PAR-­‐‑1  receptors,  located  on  the  plasma  
membrane  of  astrocytes  and  the  outward  potassium  currents  is  the  alterations  in  
the  intracellular  calcium  concentrations.  Since  these  changes  of  intracellular  
calcium  can  remain  extremely  local  within  distinct  compartments  of  a  single  
astrocyte  (Rusakov  2015),  calcium  ions  appear  to  be  the  master  regulator  of  
multiple  astrocytic  functions.  As  suggested  above,  the  increase  in  the  outward  
conductance  of  potassium  is  the  result  of  influx  of  calcium  into  the  cell  and  
potentially  signal  amplification  through  the  IP3  pathway.  The  measured  increase  
in  the  potassium  current  could  not  be  attributed  to  calcium-­‐‑activated  potassium  
channels  in  astrocytes.  This  is  because  the  calcium-­‐‑activated  potassium  channels  
that  are  expressed  in  astrocytes  are  primarily  located  on  the  perisynaptic  endfeet  
(Price  et  al.  2002;  Girouard  et  al.  2010).  However,  the  secondary  processes  were  
lost  during  the  isolation  process,  and  therefore  only  the  channels,  expressed  on  the  
cell  bodies  constituted  to  recordings.  The  voltage-­‐‑gated  potassium  channels,  such  
as  those  responsible  for  KD  and  KA  type  currents,  are  the  most  likely  candidates  to  
be  responsible  for  this  facilitation  effect.  It  was  shown  in  the  course  of  this  project  
that  astrocytes  respond  with  plasticity  to  certain  stimuli,  similarly  to  neurons,  
albeit  the  mechanisms  of  plasticity  of  astrocytes  as  well  as  the  downstream  effects  
remain  somewhat  elusive.  
6.2.5  Non-­‐‑excitable  cells  
  
Astrocytes  are  often  referred  to  as  non-­‐‑excitable  cells,  however  this  name  may  well  
be  mistaken.  A  whole  variety  of  channels  and  transporter  that  are  voltage-­‐‑
dependent  are  expressed  in  astrocytes,  such  as  Na+/K+  ATPases  and  Na+/HCO3-­‐‑  
transporters,  GLTs  and  some  potassium  channels(Xue  et  al.  2010;  Florence,  Baillie,  
and  Mulligan  2012;  Bekar  2004;  Smart,  Bosma,  and  Tempel  1997).  The  expression  
of  such  a  number  of  channels  that  are  affected  by  voltage  fluctuations  suggests  
that  astrocytes  are  indeed  a  subject  to  depolarisation.    
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Previously,  it  has  been  shown  in  our  laboratory  that  astrocytes  respond  rapidly  to  
a  group  of  chemical  transmitters  (Lalo,  Pankratov,  et  al.  2011).  This  project  has  
added  the  changes  in  the  outward  potassium  current  to  this  list  of  astrocytic  
responses.  In  Chapter  5  the  effect  of  the  facilitation  of  outward  potassium  current  
on  the  process  of  tissue  swelling  (as  a  marker  of  potassium  buffering)  was  
addressed.  At  higher  stimulation  the  tissue  showed  a  greatly  increased  extent  of  
swelling  in  experiments  where  PAR-­‐‑1  or  P2X1/5  receptors  were  activated.  This  
result  links  the  outward  potassium  currents  in  astrocytes  with  the  process  of  
buffering.  As  proposed  above,  it  is  possible  that  the  outward  potassium  current  on  
the  cell  some  may  act  a  propagator  of  the  buffering  by  initiating  the  process  of  
potassium  uptake  in  more  distal  astrocytic  processes.  Naturally,  more  experiments  
would  be  needed  to  test  this  hypothesis.  However,  the  existence  of  this  
mechanism  and  it’s  evolution  with  age  are  clear,  thus  proposing  an  importance  of  
this  molecular  link  in  the  process  of  ageing.    
6.3  Future  directions  
  
Further  experiments  to  collect  complementary  data  to  this  project  would  benefit  
from  would  employ  molecular  biological  techniques  and  imaging.  To  identify  the  
specific  subtypes  of  potassium  channel,  immunocytochemistry  could  be  employed  
to  test  which  voltage-­‐‑gated  potassium  channel  subtypes  are  most  prominent  in  
soma  bodies  of  the  astrocytes  isolated  form  layers  2/3  of  somatosensory  cortex.  
Experiments  in  the  intact  slices  with  simultaneous  recordings  of  intracellular  
calcium  levels  and  astrocytic  currents  may  provide  an  insight  the  amount  of  
calcium  allowed  into  the  cell  and  how  wide  spread  the  elevations  are.  Tissue  
swelling  experiments  with  a  simultaneous  monitoring  of  extracellular  potassium  
concentration  could  be  beneficial  when  comparing  the  effect  of  the  mechanism  in  
question.  Overall,  this  project  has  delivered  another  potential  player  in  the  process  
of  potassium  buffering  and  the  interplay  of  various  astrocytic  functions.  
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